| ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| ☑ | Accelerated filer | ☐ | ||||||||||||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | ||||||||||||||||||
| Emerging growth company | ||||||||||||||||||||
| Document Description | Form 10-K Part | |||||||
| Portions of the Registrant’s Proxy Statement for the Annual Meeting of Shareholders to be held March 13, 2024 | III | |||||||
Item 6. Reserved | |||||
Schedule II - Valuation and Qualifying Accounts | |||||
| End Market* | Percent of Fiscal 2023 Revenue | Percent of Fiscal 2022 Revenue | Percent of Fiscal 2021 Revenue | |||||||||||||||||
| Industrial | 53% | 51% | 55% | |||||||||||||||||
| Automotive | 24% | 20% | 17% | |||||||||||||||||
| Communications | 13% | 16% | 17% | |||||||||||||||||
| Consumer | 10% | 13% | 11% | |||||||||||||||||
| • Condition-based monitoring (CbM) | • Industrial power supplies | |||||||
| • Industrial robotics | • Industrial motion control | |||||||
| • Factory and process control | ||||||||
| • Automated test equipment | • Automotive and energy test | |||||||
| • Electronic test and measurement | • Life sciences and drug discovery | |||||||
| • Environmental and process analysis | ||||||||
| • Navigation systems | • Radar systems | |||||||
| • Space and satellite communications | • Security devices | |||||||
| • Communication systems | • Electronic surveillance and countermeasures | |||||||
| • Ultrasound systems | • Anesthesia equipment | |||||||
| • X-Ray equipment (CT and DR) | • Lab diagnostic equipment | |||||||
| • Image guided therapy | • Surgical tools and instruments | |||||||
| • Multi-parameter vital signs monitors | • Blood analyzers | |||||||
• Remote patient monitoring | • Point-of-care diagnostics | |||||||
| • Utility meters | • Wind turbines | |||||||
| • Electric vehicle charging infrastructure | • Solar inverters | |||||||
| • Substation relays and automation equipment | • Building energy automation/control | |||||||
| • | Car audio, voice processing and connectivity | • | Battery monitoring and management systems | |||||||||||
| • | Video processing and connectivity | |||||||||||||
| • Cellular base station equipment | • Satellite and terrestrial broadband access equipment | |||||||
| • Microwave backhaul systems | • Optical and cable networking equipment for data center and carrier providers | |||||||
| • Data centers and data storage | ||||||||
| • Portable devices (smart phones, tablets and wearable devices) for media and vital signs monitoring applications | • Prosumer audio/video equipment | |||||||
| Properties | Approximate | |||||||||||||
| Owned: | Use | Total Sq. Ft. | ||||||||||||
| Cavite, Philippines | Wafer probe and testing, warehouse, engineering and administrative offices | 1,486,000 sq. ft. | ||||||||||||
| Wilmington, MA | Corporate headquarters, wafer fabrication, testing, engineering, sales, marketing and administrative offices | 826,000 sq. ft. | ||||||||||||
| Limerick, Ireland | Wafer fabrication, wafer probe and testing, warehouse and distribution, engineering and administrative offices | 708,500 sq. ft. | ||||||||||||
Penang, Malaysia (1) | Wafer probe and testing, assembly and engineering offices | 696,680 sq. ft. | ||||||||||||
| Beaverton, OR | Wafer fabrication, engineering and administrative offices | 457,917 sq. ft. | ||||||||||||
| San Jose, CA | Engineering, sales, marketing and administrative offices | 435,000 sq. ft. | ||||||||||||
| Chonburi Province, Thailand | Wafer probe and testing, warehouse, engineering and administrative offices | 194,000 sq. ft. | ||||||||||||
| Chelmsford, MA | Final assembly of certain module and subsystem-level products, testing, engineering and administrative offices | 174,000 sq. ft. | ||||||||||||
| Camas, WA | Wafer fabrication | 105,000 sq. ft. | ||||||||||||
| Lease | ||||||||||||||||||||||||||
| Properties | Approximate | Termination | ||||||||||||||||||||||||
| Leased: | Use | Total Sq. Ft. | (fiscal year) | Renewals | ||||||||||||||||||||||
| Bangalore, India | Engineering and administrative offices | 175,000 sq. ft. | 2027 | 1, five-yr. period | ||||||||||||||||||||||
Durham, NC | Testing, engineering, and administrative offices | 156,000 sq. ft. | 2035 | 2, five-yr. periods | ||||||||||||||||||||||
| San Jose, CA | Manufacturing, marketing and administrative offices | 103,000 sq. ft. | 2033 | 1, five-yr. period | ||||||||||||||||||||||
| Period | Total Number of Shares Purchased (1) | Average Price Paid Per Share (2) | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs | ||||||||||||||||||||||
| July 30, 2023 through August 26, 2023 | 1,209,834 | $ | 184.50 | 1,162,168 | $ | 2,338,207,217 | ||||||||||||||||||||
| August 27, 2023 through September 23, 2023 | 464,040 | $ | 178.97 | 456,466 | $ | 2,256,508,676 | ||||||||||||||||||||
| September 24, 2023 through October 28, 2023 | 855,157 | $ | 168.57 | 744,321 | $ | 2,130,110,767 | ||||||||||||||||||||
| Total | 2,529,031 | $ | 178.10 | 2,362,955 | $ | 2,130,110,767 | ||||||||||||||||||||

| Fiscal Year | 2023 over 2022 | ||||||||||||||||||||||
| 2023 | 2022 | $ Change | % Change | ||||||||||||||||||||
| Revenue | $ | 12,305,539 | $ | 12,013,953 | $ | 291,586 | 2 | % | |||||||||||||||
| Gross margin % | 64.0 | % | 62.7 | % | |||||||||||||||||||
| Net income | $ | 3,314,579 | $ | 2,748,561 | $ | 566,018 | 21 | % | |||||||||||||||
| Net income as a % of revenue | 26.9 | % | 22.9 | % | |||||||||||||||||||
| Diluted EPS | $ | 6.55 | $ | 5.25 | $ | 1.30 | 25 | % | |||||||||||||||
Fiscal 2023 | Fiscal 2022 | ||||||||||||||||||||||||||||
| Revenue | % of Total Revenue (1) | Y/Y% | Revenue | % of Total Revenue (1) | |||||||||||||||||||||||||
| Industrial | $ | 6,555,222 | 53 | % | 6 | % | $ | 6,186,114 | 51 | % | |||||||||||||||||||
| Automotive | 2,915,199 | 24 | % | 19 | % | 2,442,705 | 20 | % | |||||||||||||||||||||
| Communications | 1,619,517 | 13 | % | (13) | % | 1,863,156 | 16 | % | |||||||||||||||||||||
| Consumer | 1,215,601 | 10 | % | (20) | % | 1,521,978 | 13 | % | |||||||||||||||||||||
| Total Revenue | $ | 12,305,539 | 100 | % | 2 | % | $ | 12,013,953 | 100 | % | |||||||||||||||||||
Fiscal 2023 | Fiscal 2022 | ||||||||||||||||||||||
| Revenue | % of Total Revenue (1) | Revenue | % of Total Revenue (1) | ||||||||||||||||||||
| Distributors | $ | 7,534,894 | 61 | % | $ | 7,458,478 | 62 | % | |||||||||||||||
| Direct customers | 4,603,166 | 37 | % | 4,423,883 | 37 | % | |||||||||||||||||
| Other | 167,479 | 1 | % | 131,592 | 1 | % | |||||||||||||||||
| Total Revenue | $ | 12,305,539 | 100 | % | $ | 12,013,953 | 100 | % | |||||||||||||||
| Fiscal Year | 2023 over 2022 | ||||||||||||||||||||||
| 2023 | 2022 | $ Change | % Change (1) | ||||||||||||||||||||
| United States | $ | 4,165,296 | $ | 4,025,398 | $ | 139,898 | 3 | % | |||||||||||||||
| Rest of North and South America | 88,579 | 72,497 | 16,082 | 22 | % | ||||||||||||||||||
| Europe | 3,001,871 | 2,534,423 | 467,448 | 18 | % | ||||||||||||||||||
| Japan | 1,397,119 | 1,221,549 | 175,570 | 14 | % | ||||||||||||||||||
| China | 2,229,631 | 2,563,536 | (333,905) | (13) | % | ||||||||||||||||||
| Rest of Asia | 1,423,043 | 1,596,550 | (173,507) | (11) | % | ||||||||||||||||||
| Total Revenue | $ | 12,305,539 | $ | 12,013,953 | $ | 291,586 | 2 | % | |||||||||||||||
| Fiscal Year | 2023 over 2022 | ||||||||||||||||||||||
| 2023 | 2022 | $ Change | % Change | ||||||||||||||||||||
| Gross margin | $ | 7,877,218 | $ | 7,532,474 | $ | 344,744 | 5 | % | |||||||||||||||
| Gross margin % | 64.0 | % | 62.7 | % | |||||||||||||||||||
| Fiscal Year | 2023 over 2022 | ||||||||||||||||||||||
| 2023 | 2022 | $ Change | % Change | ||||||||||||||||||||
| R&D expenses | $ | 1,660,194 | $ | 1,700,518 | $ | (40,324) | (2) | % | |||||||||||||||
| R&D expenses as a % of revenue | 13 | % | 14 | % | |||||||||||||||||||
| Fiscal Year | 2023 over 2022 | ||||||||||||||||||||||
| 2023 | 2022 | $ Change | % Change | ||||||||||||||||||||
| SMG&A expenses | $ | 1,273,584 | $ | 1,266,175 | $ | 7,409 | 1 | % | |||||||||||||||
| SMG&A expenses as a % of revenue | 10 | % | 11 | % | |||||||||||||||||||
| Fiscal Year | 2023 over 2022 | ||||||||||||||||||||||
| 2023 | 2022 | $ Change | % Change | ||||||||||||||||||||
| Amortization expenses | $ | 959,618 | $ | 1,012,572 | $ | (52,954) | (5) | % | |||||||||||||||
| Amortization expenses as a % of revenue | 8 | % | 8 | % | |||||||||||||||||||
| Fiscal Year | 2023 over 2022 | ||||||||||||||||||||||
| 2023 | 2022 | $ Change | % Change | ||||||||||||||||||||
| Special charges, net | $ | 160,710 | $ | 274,509 | $ | (113,799) | (41) | % | |||||||||||||||
| Special charges, net as a % of revenue | 1 | % | 2 | % | |||||||||||||||||||
| Fiscal Year | 2023 over 2022 | ||||||||||||||||||||||
| 2023 | 2022 | $ Change | % Change | ||||||||||||||||||||
| Operating income | $ | 3,823,112 | $ | 3,278,700 | $ | 544,412 | 17 | % | |||||||||||||||
| Operating income as a % of revenue | 31.1 | % | 27.3 | % | |||||||||||||||||||
| Fiscal Year | 2023 over 2022 | ||||||||||||||||||||||
| 2023 | 2022 | $ Change | % Change | ||||||||||||||||||||
Nonoperating expense (income) | $ | 215,109 | $ | 179,951 | $ | 35,158 | 20 | % | |||||||||||||||
| Fiscal Year | 2023 over 2022 | ||||||||||||||||||||||
| 2023 | 2022 | $ Change | % Change | ||||||||||||||||||||
| Provision for (benefit from) income taxes | $ | 293,424 | $ | 350,188 | $ | (56,764) | (16) | % | |||||||||||||||
| Effective income tax rate | 8.1 | % | 11.3 | % | |||||||||||||||||||
| Fiscal Year | 2023 over 2022 | ||||||||||||||||||||||
| 2023 | 2022 | $ Change | % Change | ||||||||||||||||||||
| Net income | $ | 3,314,579 | $ | 2,748,561 | $ | 566,018 | 21 | % | |||||||||||||||
| Net income, as a % of revenue | 26.9 | % | 22.9 | % | |||||||||||||||||||
| Diluted EPS | $ | 6.55 | $ | 5.25 | $ | 1.30 | 25 | % | |||||||||||||||
| Fiscal Year | |||||||||||
| 2023 | 2022 | ||||||||||
| Net cash provided by operating activities | $ | 4,817,634 | $ | 4,475,402 | |||||||
| Net cash provided by operating activities as a % of revenue | 39 | % | 37 | % | |||||||
Net cash used for investing activities | $ | (1,266,385) | $ | (657,368) | |||||||
| Net cash used for financing activities | $ | (4,063,760) | $ | (4,290,720) | |||||||
| Fiscal Year | ||||||||||||||||||||
| 2023 | 2022 | $ Change | % Change | |||||||||||||||||
| Accounts receivable, net | $ | 1,469,734 | $ | 1,800,462 | $ | (330,728) | (18) | % | ||||||||||||
Days sales outstanding (1) | 48 | 50 | ||||||||||||||||||
| Inventory | $ | 1,642,214 | $ | 1,399,914 | $ | 242,300 | 17 | % | ||||||||||||
Days cost of sales in inventory (1) | 125 | 106 | ||||||||||||||||||
| Payment due by period | ||||||||||||||||||||||||||||||||
| Less than | More than | |||||||||||||||||||||||||||||||
| (thousands) | Total | 1 Year | 1-3 Years | 3-5 Years | 5 Years | |||||||||||||||||||||||||||
Debt obligations (1) | $ | 7,064,301 | $ | 1,047,224 | $ | 400,000 | $ | 2,090,212 | $ | 3,526,865 | ||||||||||||||||||||||
| Interest payments associated with debt obligations | 2,253,446 | 209,595 | 341,514 | 273,176 | 1,429,161 | |||||||||||||||||||||||||||
Transition tax (2) | 484,244 | 196,066 | 288,178 | — | — | |||||||||||||||||||||||||||
Operating leases (3) | 494,662 | 80,998 | 148,565 | 118,203 | 146,896 | |||||||||||||||||||||||||||
| Inventory-related purchase commitments (4) | 705,607 | 170,042 | 361,255 | 130,977 | 43,333 | |||||||||||||||||||||||||||
| Total | $ | 11,002,260 | $ | 1,703,925 | $ | 1,539,512 | $ | 2,612,568 | $ | 5,146,255 | ||||||||||||||||||||||
| October 28, 2023 | October 29, 2022 | ||||||||||||||||||||||||||||||||||
| (thousands) | Principal Amount Outstanding | Fair Value | Fair Value given an increase in interest rates of 100 basis points | Principal Amount Outstanding | Fair Value | Fair Value given an increase in interest rates of 100 basis points | |||||||||||||||||||||||||||||
Commercial paper notes | $ | 547,225 | $ | 547,185 | $ | 546,875 | $ | — | $ | — | $ | — | |||||||||||||||||||||||
| 2024 Notes, due October 2024 | 500,000 | 499,473 | 495,058 | 500,000 | 491,982 | 483,035 | |||||||||||||||||||||||||||||
| 2025 Notes, due April 2025 | 400,000 | 385,231 | 380,013 | 400,000 | 383,378 | 374,686 | |||||||||||||||||||||||||||||
| 2026 Notes, due December 2026 | 900,000 | 851,023 | 826,888 | 900,000 | 851,479 | 820,203 | |||||||||||||||||||||||||||||
Maxim Notes, due June 2027 | — | — | — | 59,788 | 54,771 | 52,534 | |||||||||||||||||||||||||||||
| 2027 Notes, due June 2027 | 440,212 | 408,595 | 395,208 | 440,212 | 410,091 | 393,294 | |||||||||||||||||||||||||||||
| 2028 Notes, due October 2028 | 750,000 | 628,999 | 600,812 | 750,000 | 621,093 | 588,044 | |||||||||||||||||||||||||||||
| 2031 Notes, due October 2031 | 1,000,000 | 773,404 | 721,064 | 1,000,000 | 786,772 | 727,579 | |||||||||||||||||||||||||||||
| 2032 Notes, due October 2032 | 300,000 | 269,828 | 251,153 | 300,000 | 278,359 | 257,337 | |||||||||||||||||||||||||||||
| 2036 Notes, due December 2036 | 144,278 | 118,554 | 108,085 | 144,278 | 126,274 | 114,389 | |||||||||||||||||||||||||||||
| 2041 Notes, due October 2041 | 750,000 | 479,078 | 422,949 | 750,000 | 513,709 | 450,337 | |||||||||||||||||||||||||||||
| 2045 Notes, due December 2045 | 332,587 | 292,248 | 259,323 | 332,587 | 313,931 | 276,820 | |||||||||||||||||||||||||||||
| 2051 Notes, due October 2051 | 1,000,000 | 590,666 | 507,297 | 1,000,000 | 640,766 | 545,958 | |||||||||||||||||||||||||||||
| October 28, 2023 | October 29, 2022 | ||||||||||
| Fair value of forward exchange contracts | $ | (11,575) | $ | (16,984) | |||||||
| Fair value of forward exchange contracts after a 10% unfavorable movement in foreign currency exchange rates asset | $ | 49,284 | $ | 21,193 | |||||||
| Fair value of forward exchange contracts after a 10% favorable movement in foreign currency exchange rates liability | $ | (70,461) | $ | (51,604) | |||||||
| Revenue Recognition – Measuring Price Protection Credits | |||||
| Description of the Matter | As described in Note 2n to the consolidated financial statements, the Company's sales contracts provide certain distributors with credits for price protection and rights of return, which results in variable consideration. During 2023, sales to distributors were $7.5 billion net of expected price protection credits and rights of return for which the liability balance as of October 28, 2023 was $525.4 million, of which the vast majority relates to the price protection credits. Auditing the Company's measurement for price protection credits under distributor contracts involved especially challenging judgment because the calculation involves subjective management assumptions about estimates of expected price protection credits. For example, estimated price protection credits included in the transaction price reflects management's evaluation of contractual terms, historical experience and assumptions about future economic conditions. Changes in those assumptions can have a material effect on the amount recognized for price protection credits. | ||||
| How We Addressed the Matter in Our Audit | We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company's process to calculate the price protection credits. For example, we tested controls over the appropriateness of assumptions management used as well as controls over the completeness and accuracy of the data underlying estimates of expected price protection credits. Our audit procedures included, among others, inspecting contractual terms in distributor agreements and testing the underlying data used in management’s calculation for completeness and accuracy as well as evaluating the significant assumptions used in the estimation of the price protection credits. We evaluated the Company’s methods and assumptions used in the estimates, which included comparing the assumptions to historical trends. We inspected and tested the results of the Company's retrospective review analysis of actual price protection credits claimed by distributors, evaluated the estimates made based on historical experience and performed sensitivity analyses of the Company’s significant assumptions to assess the impact on the price protection credits. We also evaluated whether the Company appropriately considered new information that could significantly change the estimated future price protection credits. | ||||
| (thousands, except per share amounts) | 2023 | 2022 | 2021 | ||||||||||||||
| Revenue | |||||||||||||||||
| Revenue | $ | $ | $ | ||||||||||||||
| Costs and Expenses | |||||||||||||||||
| Cost of sales | |||||||||||||||||
| Gross margin | |||||||||||||||||
| Operating expenses: | |||||||||||||||||
| Research and development | |||||||||||||||||
| Selling, marketing, general and administrative | |||||||||||||||||
| Amortization of intangibles | |||||||||||||||||
| Special charges, net | |||||||||||||||||
Total operating expenses | |||||||||||||||||
| Operating income: | |||||||||||||||||
| Nonoperating expense (income): | |||||||||||||||||
| Interest expense | |||||||||||||||||
| Loss on extinguishment of debt | |||||||||||||||||
| Interest income | ( | ( | ( | ||||||||||||||
| Other, net | ( | ( | ( | ||||||||||||||
Total nonoperating expense (income) | |||||||||||||||||
| Earnings | |||||||||||||||||
| Income before income taxes | |||||||||||||||||
| Provision for (benefit from) income taxes | ( | ||||||||||||||||
| Net income | $ | $ | $ | ||||||||||||||
| Shares used to compute earnings per common share — basic | |||||||||||||||||
| Shares used to compute earnings per common share — diluted | |||||||||||||||||
| Basic earnings per common share | $ | $ | $ | ||||||||||||||
| Diluted earnings per common share | $ | $ | $ | ||||||||||||||
| (thousands) | 2023 | 2022 | 2021 | ||||||||||||||
| Net income | $ | $ | $ | ||||||||||||||
| Foreign currency translation adjustment | ( | ( | |||||||||||||||
| Change in unrecognized gains/losses on derivative instruments designated as cash flow hedges: | |||||||||||||||||
Changes in fair value of derivatives (net of tax of $ | ( | ||||||||||||||||
Adjustment for realized loss reclassified into earnings (net of tax of $ | |||||||||||||||||
| Total change in derivative instruments designated as cash flow hedges, net of tax | |||||||||||||||||
| Changes in accumulated other comprehensive loss — pension plans: | |||||||||||||||||
Change in actuarial (loss)/gain (net of tax of $ | ( | ||||||||||||||||
Other comprehensive income (loss) | ( | ||||||||||||||||
| Comprehensive income | $ | $ | $ | ||||||||||||||
| (thousands, except per share amounts) | 2023 | 2022 | |||||||||
| ASSETS | |||||||||||
| Current Assets | |||||||||||
| Cash and cash equivalents | $ | $ | |||||||||
Accounts receivable less allowances of $ | |||||||||||
| Inventories | |||||||||||
| Prepaid expenses and other current assets | |||||||||||
| Total current assets | |||||||||||
| Other Assets | |||||||||||
| Net property, plant and equipment | |||||||||||
| Goodwill | |||||||||||
| Intangible assets, net | |||||||||||
| Deferred tax assets | |||||||||||
| Other assets | |||||||||||
Total non-current assets | |||||||||||
TOTAL ASSETS | $ | $ | |||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||||||
| Current Liabilities | |||||||||||
| Accounts payable | $ | $ | |||||||||
| Income taxes payable | |||||||||||
Debt, current | |||||||||||
Commercial paper notes | |||||||||||
| Accrued liabilities | |||||||||||
| Total current liabilities | |||||||||||
| Non-current Liabilities | |||||||||||
| Long-term debt | |||||||||||
| Deferred income taxes | |||||||||||
| Income taxes payable | |||||||||||
| Other non-current liabilities | |||||||||||
| Total non-current liabilities | |||||||||||
| Commitments and contingencies (Note 10) | |||||||||||
| Shareholders’ Equity | |||||||||||
Preferred stock, $ | |||||||||||
Common stock, $ | |||||||||||
| Capital in excess of par value | |||||||||||
| Retained earnings | |||||||||||
| Accumulated other comprehensive loss | ( | ( | |||||||||
| Total shareholders’ equity | |||||||||||
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $ | $ | |||||||||
| Capital in | Accumulated Other | ||||||||||||||||||||||||||||
| Common Stock | Excess of | Retained | Comprehensive | ||||||||||||||||||||||||||
| (thousands) | Shares | Amount | Par Value | Earnings | (Loss) Income | ||||||||||||||||||||||||
BALANCE, OCTOBER 31, 2020 | $ | $ | $ | $ | ( | ||||||||||||||||||||||||
Net Income — 2021 | |||||||||||||||||||||||||||||
Dividends declared and paid - $ | ( | ||||||||||||||||||||||||||||
| Issuance of stock under stock plans and other | |||||||||||||||||||||||||||||
| Issuance of stock in connection with Acquisition | |||||||||||||||||||||||||||||
| Stock-based compensation expense | |||||||||||||||||||||||||||||
| Replacement share-based awards issued in connection with Acquisition | |||||||||||||||||||||||||||||
Other comprehensive income | |||||||||||||||||||||||||||||
| Common stock repurchased | ( | ( | ( | ||||||||||||||||||||||||||
BALANCE, OCTOBER 30, 2021 | ( | ||||||||||||||||||||||||||||
Net Income — 2022 | |||||||||||||||||||||||||||||
Dividends declared and paid - $ | ( | ||||||||||||||||||||||||||||
| Issuance of stock under stock plans and other | |||||||||||||||||||||||||||||
| Stock-based compensation expense | |||||||||||||||||||||||||||||
Other comprehensive loss | ( | ||||||||||||||||||||||||||||
| Common stock repurchased | ( | ( | ( | ||||||||||||||||||||||||||
BALANCE, OCTOBER 29, 2022 | ( | ||||||||||||||||||||||||||||
Net Income — 2023 | |||||||||||||||||||||||||||||
Dividends declared and paid - $ | ( | ||||||||||||||||||||||||||||
| Issuance of stock under stock plans and other | |||||||||||||||||||||||||||||
| Stock-based compensation expense | |||||||||||||||||||||||||||||
Other comprehensive income | |||||||||||||||||||||||||||||
| Common stock repurchased | ( | ( | ( | ||||||||||||||||||||||||||
BALANCE, OCTOBER 28, 2023 | $ | $ | $ | $ | ( | ||||||||||||||||||||||||
| (thousands) | 2023 | 2022 | 2021 | ||||||||||||||
| Cash flows from operating activities: | |||||||||||||||||
| Net income | $ | $ | $ | ||||||||||||||
| Adjustments to reconcile net income to net cash provided by operations: | |||||||||||||||||
| Depreciation | |||||||||||||||||
| Amortization of intangibles | |||||||||||||||||
| Cost of goods sold for inventory acquired | |||||||||||||||||
| Stock-based compensation expense | |||||||||||||||||
| Loss on extinguishment of debt | |||||||||||||||||
| Non-cash impairment charge | |||||||||||||||||
| Deferred income taxes | ( | ( | ( | ||||||||||||||
| Other | ( | ( | |||||||||||||||
| Change in operating assets and liabilities: | |||||||||||||||||
| Accounts receivable | ( | ( | |||||||||||||||
| Inventories | ( | ( | ( | ||||||||||||||
| Prepaid expenses and other current assets | ( | ( | |||||||||||||||
| Accounts payable and accrued liabilities | ( | ||||||||||||||||
| Income taxes payable, current | ( | ( | ( | ||||||||||||||
| Other assets | ( | ( | |||||||||||||||
| Other liabilities | ( | ( | |||||||||||||||
| Total adjustments | |||||||||||||||||
| Net cash provided by operating activities | |||||||||||||||||
| Cash flows from investing activities: | |||||||||||||||||
| Additions to property, plant and equipment, net | ( | ( | ( | ||||||||||||||
| Cash received from acquisition of Maxim, net of cash paid | |||||||||||||||||
| Other | ( | ||||||||||||||||
| Net cash (used for) provided by investing activities | ( | ( | |||||||||||||||
| Cash flows from financing activities: | |||||||||||||||||
| Proceeds from debt | |||||||||||||||||
| Early termination of debt | ( | ( | ( | ||||||||||||||
| Payments on revolver | ( | ( | |||||||||||||||
| Proceeds from revolver | |||||||||||||||||
| Proceeds from commercial paper notes | |||||||||||||||||
| Payments of commercial paper notes | ( | ||||||||||||||||
| Payment on derivative instrument | ( | ||||||||||||||||
| Prepayment for stock repurchases | ( | ||||||||||||||||
| Dividend payments to shareholders | ( | ( | ( | ||||||||||||||
| Repurchase of common stock | ( | ( | ( | ||||||||||||||
| Proceeds from employee stock plans | |||||||||||||||||
| Other | ( | ( | |||||||||||||||
| Net cash used for financing activities | ( | ( | ( | ||||||||||||||
| Effect of exchange rate changes on cash | ( | ||||||||||||||||
| Net (decrease) increase in cash and cash equivalents | ( | ( | |||||||||||||||
| Cash and cash equivalents at beginning of year | |||||||||||||||||
| Cash and cash equivalents at end of year | $ | $ | $ | ||||||||||||||
| 2023 | 2022 | ||||||||||
| Cash | $ | $ | |||||||||
| Available-for-sale securities | |||||||||||
| Total cash and cash equivalents | $ | $ | |||||||||
| 2023 | 2022 | 2021 | |||||||||||||||
| Cash paid during the fiscal year for: | |||||||||||||||||
| Income taxes | $ | $ | $ | ||||||||||||||
| Interest | $ | $ | $ | ||||||||||||||
| Noncash issuance of common stock for the Acquisition | $ | $ | $ | ||||||||||||||
Fair value of partially vested equity replacement awards issued for the Acquisition | $ | $ | $ | ||||||||||||||
| 2023 | 2022 | ||||||||||
| Raw materials | $ | $ | |||||||||
| Work in process | |||||||||||
| Finished goods | |||||||||||
| Total inventories | $ | $ | |||||||||
| 2023 | 2022 (1) | ||||||||||
| Land and buildings | $ | $ | |||||||||
| Machinery and equipment | |||||||||||
| Office equipment | |||||||||||
| Leasehold improvements | |||||||||||
| Less accumulated depreciation and amortization | |||||||||||
| Net property, plant and equipment | $ | $ | |||||||||
| Buildings | Up to | ||||
| Machinery & equipment | |||||
| Office equipment | |||||
| Leasehold improvements | |||||
| Land and buildings | $ | ||||
| Less accumulated depreciation and amortization | ( | ||||
| Net property, plant and equipment reclassified to Prepaid expenses and other current assets | $ | ||||
| 2023 | 2022 | ||||||||||
| Balance at beginning of year | $ | $ | |||||||||
Acquisition of Maxim (1) | |||||||||||
| Foreign currency translation adjustment and other adjustments | ( | ||||||||||
| Balance at end of year | $ | $ | |||||||||
| October 28, 2023 | October 29, 2022 | ||||||||||||||||||||||
| Gross Carrying Amount | Accumulated Amortization | Gross Carrying Amount | Accumulated Amortization | ||||||||||||||||||||
| Customer relationships | $ | $ | $ | $ | |||||||||||||||||||
| Technology-based | |||||||||||||||||||||||
| Trade-name | |||||||||||||||||||||||
| Backlog | |||||||||||||||||||||||
| Assembled workforce | |||||||||||||||||||||||
| IPR&D | — | — | |||||||||||||||||||||
Total (1) | $ | $ | $ | $ | |||||||||||||||||||
| Fiscal Year | Amortization Expense | ||||
| 2024 | $ | ||||
| 2025 | $ | ||||
| 2026 | $ | ||||
| 2027 | $ | ||||
| 2028 | $ | ||||
| Fair Value At | |||||||||||||||||
| Balance Sheet Location | October 28, 2023 | October 29, 2022 | |||||||||||||||
| Forward foreign currency exchange contracts | Accrued liabilities | $ | $ | ||||||||||||||
| October 29, 2022 | ||||||||
| Gross amount of recognized liabilities | $ | ( | ||||||
| Gross amounts of recognized assets | ||||||||
| $ | ( | |||||||
| October 28, 2023 | ||||||||||||||
| Balance Sheet Location | Loss on Swaps | Gain on Note | ||||||||||||
| Accrued liabilities | $ | $ | ||||||||||||
Long-term debt | $ | $ | ||||||||||||
| October 28, 2023 | |||||||||||||||||
| Fair Value measurement at Reporting Date using: | |||||||||||||||||
| Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Total | |||||||||||||||
| Assets | |||||||||||||||||
| Cash equivalents: | |||||||||||||||||
| Available-for-sale: | |||||||||||||||||
| Government and institutional money market funds | $ | $ | $ | ||||||||||||||
| Other assets: | |||||||||||||||||
Forward foreign currency exchange contracts (1) | |||||||||||||||||
| Deferred compensation investments | |||||||||||||||||
| Total assets measured at fair value | $ | $ | $ | ||||||||||||||
| Liabilities | |||||||||||||||||
Forward foreign currency exchange contracts (1) | $ | $ | $ | ||||||||||||||
Interest rate derivatives (2) | |||||||||||||||||
| Total liabilities measured at fair value | $ | $ | $ | ||||||||||||||
| October 29, 2022 | |||||||||||||||||
| Fair Value measurement at Reporting Date using: | |||||||||||||||||
| Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Total | |||||||||||||||
| Assets | |||||||||||||||||
| Cash equivalents: | |||||||||||||||||
| Available-for-sale: | |||||||||||||||||
| Government and institutional money market funds | $ | $ | $ | ||||||||||||||
| Other assets: | |||||||||||||||||
| Deferred compensation investments | |||||||||||||||||
| Total assets measured at fair value | $ | $ | $ | ||||||||||||||
| Liabilities | |||||||||||||||||
| Forward foreign currency exchange contracts (1) | $ | $ | $ | ||||||||||||||
| Total liabilities measured at fair value | $ | $ | $ | ||||||||||||||
| October 28, 2023 | October 29, 2022 | ||||||||||||||||||||||
| Principal Amount Outstanding | Fair Value | Principal Amount Outstanding | Fair Value | ||||||||||||||||||||
Commercial paper notes | $ | $ | $ | $ | |||||||||||||||||||
| 2024 Notes, due October 2024 | |||||||||||||||||||||||
| 2025 Notes, due April 2025 | |||||||||||||||||||||||
| 2026 Notes, due December 2026 | |||||||||||||||||||||||
| Maxim 2027 Notes, due June 2027 | |||||||||||||||||||||||
| 2027 Notes, due June 2027 | |||||||||||||||||||||||
| 2028 Notes, due October 2028 | |||||||||||||||||||||||
| 2031 Notes, due October 2031 | |||||||||||||||||||||||
| 2032 Notes, due October 2032 | |||||||||||||||||||||||
| 2036 Notes, due December 2036 | |||||||||||||||||||||||
| 2041 Notes, due October 2041 | |||||||||||||||||||||||
| 2045 Notes, due December 2045 | |||||||||||||||||||||||
| 2051 Notes, due October 2051 | |||||||||||||||||||||||
| Total Debt | $ | $ | $ | $ | |||||||||||||||||||
| Foreign currency translation adjustment | Unrealized holding gains/losses on derivatives | Pension plans | Total | ||||||||||||||||||||
| October 29, 2022 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| Other comprehensive income before reclassifications | ( | ( | ( | ||||||||||||||||||||
| Amounts reclassified out of other comprehensive loss | |||||||||||||||||||||||
| Tax | ( | ( | ( | ||||||||||||||||||||
| Other comprehensive income | ( | ( | |||||||||||||||||||||
| October 28, 2023 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
| Comprehensive Income Component | 2023 | 2022 | Location | |||||||||||||||||
| Changes in unrealized holding gains/losses on derivatives | ||||||||||||||||||||
| Currency forwards | $ | $ | Cost of sales | |||||||||||||||||
| Research and development | ||||||||||||||||||||
| ( | Selling, marketing, general and administrative | |||||||||||||||||||
| Interest rate derivatives | Interest expense | |||||||||||||||||||
| Total before tax | ||||||||||||||||||||
| ( | ( | Tax | ||||||||||||||||||
| $ | $ | Net of tax | ||||||||||||||||||
| Amortization of pension components included in the computation of net periodic benefit cost | ||||||||||||||||||||
| Actuarial losses | $ | $ | Net of tax | |||||||||||||||||
| Total amounts reclassified out of AOCI, net of tax | $ | $ | ||||||||||||||||||
| 2023 | 2022 | 2021 | |||||||||||||||
| Net income (1) | $ | $ | $ | ||||||||||||||
| Basic shares: | |||||||||||||||||
| Weighted-average shares outstanding | |||||||||||||||||
| Earnings per common share basic | $ | $ | $ | ||||||||||||||
| Diluted shares: | |||||||||||||||||
| Weighted-average shares outstanding | |||||||||||||||||
| Assumed exercise of common stock equivalents | |||||||||||||||||
| Weighted-average common and common equivalent shares | |||||||||||||||||
| Earnings per common share diluted | $ | $ | $ | ||||||||||||||
| Anti-dilutive shares related to: | |||||||||||||||||
| Outstanding stock options | |||||||||||||||||
| 2021 | ||||||||
| Options granted (in thousands) | ||||||||
| Weighted-average exercise price | $ | |||||||
| Weighted-average grant-date fair value | $ | |||||||
| Assumptions: | ||||||||
| Weighted-average expected volatility | % | |||||||
| Weighted-average expected term (in years) | ||||||||
| Weighted-average risk-free interest rate | % | |||||||
| Weighted-average expected dividend yield | % | |||||||
| 2023 | 2022 | 2021 | ||||||||||||||||||
| Cost of sales | $ | $ | $ | |||||||||||||||||
| Research and development | ||||||||||||||||||||
| Selling, marketing, general and administrative | ||||||||||||||||||||
| Special charges, net | ||||||||||||||||||||
| Total stock-based compensation expense | $ | $ | $ | |||||||||||||||||
| Options Outstanding (in thousands) | Weighted- Average Exercise Price Per Share | Weighted- Average Remaining Contractual Term in Years | Aggregate Intrinsic Value | ||||||||||||||||||||
Options outstanding at October 29, 2022 | $ | ||||||||||||||||||||||
| Options exercised | ( | $ | |||||||||||||||||||||
| Options forfeited | ( | $ | |||||||||||||||||||||
Options outstanding at October 28, 2023 | $ | $ | |||||||||||||||||||||
Options exercisable at October 28, 2023 | $ | $ | |||||||||||||||||||||
Options vested or expected to vest at October 28, 2023 (1) | $ | $ | |||||||||||||||||||||
| Restricted Stock Units/Awards Outstanding (in thousands) | Weighted- Average Grant- Date Fair Value Per Share | ||||||||||
Restricted stock units/awards outstanding at October 29, 2022 | $ | ||||||||||
| Units/Awards granted | $ | ||||||||||
| Restrictions lapsed | ( | $ | |||||||||
| Forfeited | ( | $ | |||||||||
Restricted stock units/awards outstanding at October 28, 2023 | $ | ||||||||||
| 2023 | 2022 | 2021 | |||||||||||||||||||||||||||||||||
| Revenue | % of Total Revenue (1) | Revenue | % of Total Revenue (1) | Revenue | % of Total Revenue (1) | ||||||||||||||||||||||||||||||
| Industrial | $ | % | $ | % | $ | % | |||||||||||||||||||||||||||||
| Automotive | % | % | % | ||||||||||||||||||||||||||||||||
| Communications | % | % | % | ||||||||||||||||||||||||||||||||
| Consumer | % | % | % | ||||||||||||||||||||||||||||||||
| Total revenue | $ | % | $ | % | $ | % | |||||||||||||||||||||||||||||
| 2023 | 2022 | 2021 | ||||||||||||||||||||||||||||||||||||
| Revenue | % of Total Revenue (1) | Revenue | % of Total Revenue (1) | Revenue | % of Total Revenue (1) | |||||||||||||||||||||||||||||||||
| Distributors | $ | % | $ | % | $ | % | ||||||||||||||||||||||||||||||||
| Direct customers | % | % | % | |||||||||||||||||||||||||||||||||||
| Other | % | % | % | |||||||||||||||||||||||||||||||||||
| Total revenue | $ | % | $ | % | $ | % | ||||||||||||||||||||||||||||||||
| 2023 | 2022 | 2021 | |||||||||||||||
| Revenue | |||||||||||||||||
| United States | $ | $ | $ | ||||||||||||||
| Rest of North and South America | |||||||||||||||||
| Europe | |||||||||||||||||
| Japan | |||||||||||||||||
| China | |||||||||||||||||
| Rest of Asia | |||||||||||||||||
Subtotal all foreign regions | |||||||||||||||||
| Total revenue | $ | $ | $ | ||||||||||||||
| Property, plant and equipment | |||||||||||||||||
| United States | $ | $ | $ | ||||||||||||||
| Ireland | |||||||||||||||||
| Philippines | |||||||||||||||||
| Thailand | |||||||||||||||||
| Malaysia | |||||||||||||||||
All other regions | |||||||||||||||||
Subtotal all foreign regions | |||||||||||||||||
| Total property, plant and equipment | $ | $ | $ | ||||||||||||||
| Accrued Special Charges | Closure of Manufacturing Facilities | Global Repositioning Actions | Q4 2023 Plan | |||||||||||||||||
Balance at October 31, 2020 | $ | $ | $ | |||||||||||||||||
| Employee severance and benefit costs | ||||||||||||||||||||
| Facility closure costs | ||||||||||||||||||||
| Severance and benefit payments | ( | ( | ||||||||||||||||||
| Facility closure cost payments | ( | |||||||||||||||||||
| Effect of foreign currency on accrual | ||||||||||||||||||||
Balance at October 30, 2021 | $ | $ | $ | |||||||||||||||||
| Employee severance and benefit costs | ||||||||||||||||||||
| Facility closure costs | ||||||||||||||||||||
| Severance and benefit payments | ( | ( | ||||||||||||||||||
| Facility closure cost payments | ( | |||||||||||||||||||
| Effect of foreign currency on accrual | ( | |||||||||||||||||||
Balance at October 29, 2022 | $ | $ | $ | |||||||||||||||||
| Employee severance and benefit costs | ||||||||||||||||||||
| Severance and benefit payments | ( | ( | ( | |||||||||||||||||
Balance at October 28, 2023 | $ | $ | $ | |||||||||||||||||
| Accrued liabilities | $ | $ | $ | |||||||||||||||||
| Other non-current liabilities | $ | $ | $ | |||||||||||||||||
Cash consideration (a) | $ | ||||
Issuance of common stock (b) | |||||
Fair value of partially vested restricted stock and restricted stock unit replacement awards (c) | |||||
Total purchase consideration | $ | ||||
| Cash and cash equivalents | $ | |||||||
| Accounts receivable | ||||||||
| Inventories | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Property, plant and equipment | ||||||||
| Intangible assets (Note 2f) | ||||||||
| Goodwill (Note 2f) | ||||||||
| Other long-term assets | ||||||||
| Total assets | $ | |||||||
| Accounts payable | ||||||||
| Income taxes payable | ||||||||
| Accrued liabilities | ||||||||
| Long-term debt | ||||||||
| Deferred income taxes | ||||||||
| Other non-current liabilities | ||||||||
| Total liabilities | $ | |||||||
| Total purchase consideration | $ | |||||||
Fair Value (in thousands) | Weighted Average Useful Life (in Years) | ||||||||||
Customer relationships | $ | ||||||||||
Developed technology | |||||||||||
Backlog | |||||||||||
Total amortizable intangible assets | $ | ||||||||||
Pro Forma Twelve Months Ended (unaudited) | ||||||||
October 30, 2021 | ||||||||
Revenue | $ | |||||||
Net income | $ | |||||||
Basic net income per common share | $ | |||||||
Diluted net income per common share | $ | |||||||
| 2023 | 2022 | ||||||||||
| Distributor price adjustments and other revenue reserves | $ | $ | |||||||||
| Accrued compensation and benefits | |||||||||||
| Accrued special charges | |||||||||||
| Interest rate swap | |||||||||||
| Lease liabilities | |||||||||||
| Accrued interest | |||||||||||
| Accrued taxes | |||||||||||
| Accrued withholdings related to ESPP | |||||||||||
| Other | |||||||||||
| Total accrued liabilities | $ | $ | |||||||||
| October 28, 2023 | October 29, 2022 | ||||||||||
| Assets | |||||||||||
| $ | $ | ||||||||||
| Liabilities | |||||||||||
| $ | $ | ||||||||||
| $ | $ | ||||||||||
October 28, 2023 | October 29, 2022 | |||||||||||||
| Lease expense | $ | $ | ||||||||||||
| Cash paid for amounts included in the measurement of operating lease liabilities | ||||||||||||||
Cash flows from operating leases | $ | $ | ||||||||||||
| Lease assets obtained in exchange for new lease liabilities | $ | $ | ||||||||||||
| Weighted average remaining lease term | ||||||||||||||
| Weighted average discount rate | ||||||||||||||
| Fiscal year | |||||
2024 | $ | ||||
| 2025 | |||||
| 2026 | |||||
| 2027 | |||||
| 2028 | |||||
| Thereafter | |||||
| Total future minimum operating lease payments | |||||
| Less: imputed interest | ( | ||||
| Present value of operating lease liabilities | $ | ||||
| Fiscal year | |||||
2024 | $ | ||||
| 2025 | |||||
| 2026 | |||||
| 2027 | |||||
| 2028 | |||||
| Thereafter | |||||
| Total future minimum cash receipts | $ | ||||
| 2023 | 2022 | 2021 | |||||||||||||||
| Service cost | $ | $ | $ | ||||||||||||||
| Interest cost | |||||||||||||||||
| Expected return on plan assets | ( | ( | ( | ||||||||||||||
| Recognized actuarial loss | |||||||||||||||||
| Subtotal | $ | $ | $ | ||||||||||||||
| Settlement impact | ( | ( | |||||||||||||||
| Net periodic benefit cost | $ | $ | $ | ||||||||||||||
| 2023 | 2022 | ||||||||||
| Change in Benefit Obligation | |||||||||||
| Benefit obligation at beginning of year | $ | $ | |||||||||
| Service cost | |||||||||||
| Interest cost | |||||||||||
| Acquisition of Maxim benefit obligation | ( | ||||||||||
| Settlement | ( | ( | |||||||||
| Actuarial gain | ( | ||||||||||
| Benefits paid | ( | ( | |||||||||
| Exchange rate adjustment | ( | ||||||||||
| Benefit obligation at end of year | $ | $ | |||||||||
| Change in Plan Assets | |||||||||||
| Fair value of plan assets at beginning of year | $ | $ | |||||||||
| Actual return on plan assets | ( | ( | |||||||||
| Employer contributions | |||||||||||
| Settlements | ( | ( | |||||||||
| Benefits paid | ( | ( | |||||||||
| Exchange rate adjustment | ( | ||||||||||
| Fair value of plan assets at end of year | $ | $ | |||||||||
| Reconciliation of Funded Status | |||||||||||
| Funded status | $ | ( | $ | ( | |||||||
| Amounts Recognized in the Balance Sheet | |||||||||||
| Non-current assets | $ | $ | |||||||||
| Current liabilities | $ | ( | $ | ( | |||||||
| Non-current liabilities | ( | ( | |||||||||
| Net amount recognized | $ | ( | $ | ( | |||||||
| 2023 | 2022 | ||||||||||
| Reconciliation of Amounts Recognized in the Statement of Financial Position | |||||||||||
| Prior service credit | ( | ( | |||||||||
| Net loss | ( | ( | |||||||||
| Accumulated other comprehensive loss | ( | ( | |||||||||
| Accumulated contributions less than net periodic benefit cost | ( | ( | |||||||||
| Net amount recognized | $ | ( | $ | ( | |||||||
| Changes Recognized in Other Comprehensive Income (Loss) | |||||||||||
| Changes in plan assets and benefit obligations recognized in other comprehensive income (loss) | |||||||||||
| Net gain/loss arising during the year | $ | $ | ( | ||||||||
| Effect of exchange rates on amounts included in AOCI | ( | ( | |||||||||
| Amounts recognized as a component of net periodic benefit cost | |||||||||||
| Amortization or settlement recognition of net loss | ( | ( | |||||||||
| Total recognized in other comprehensive gain/loss | $ | $ | ( | ||||||||
| Total recognized in net periodic cost and other comprehensive loss | $ | $ | ( | ||||||||
| Estimated amounts that will be amortized from AOCI over the next fiscal year | |||||||||||
| Net loss | $ | ( | $ | ( | |||||||
| 2023 | 2022 | ||||||||||
| Plans with projected benefit obligations in excess of plan assets: | |||||||||||
| Projected benefit obligation | $ | $ | |||||||||
| Fair value of plan assets | $ | $ | |||||||||
| Plans with accumulated benefit obligations in excess of plan assets: | |||||||||||
| Projected benefit obligation | $ | $ | |||||||||
| Accumulated benefit obligation | $ | $ | |||||||||
| Fair value of plan assets | $ | $ | |||||||||
| 2023 | 2022 | ||||||||||
| Discount rate | % | % | |||||||||
| Rate of increase in compensation levels | % | % | |||||||||
| 2023 | 2022 | ||||||||||
| Discount rate | % | % | |||||||||
| Expected long-term return on plan assets | % | % | |||||||||
| Rate of increase in compensation levels | % | % | |||||||||
| October 28, 2023 | October 29, 2022 | |||||||||||||||||||||||||||||||||||||
| Fair Value Measurement at Reporting Date Using: | Fair Value Measurement at Reporting Date Using: | |||||||||||||||||||||||||||||||||||||
| Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Total | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | Total | |||||||||||||||||||||||||||||||||
| Unit trust funds(1) | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
| Equities(1) | ||||||||||||||||||||||||||||||||||||||
| Fixed income securities(2) | ||||||||||||||||||||||||||||||||||||||
| Property (3) | ||||||||||||||||||||||||||||||||||||||
| Investment Funds (4) | ||||||||||||||||||||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||||||||||||||||||||
| Total assets measured at fair value | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||
| Expected Company Contributions | |||||
| 2024 | $ | ||||
| Expected Benefit Payments | |||||
| 2024 | $ | ||||
| 2025 | $ | ||||
| 2026 | $ | ||||
| 2027 | $ | ||||
| 2028 | $ | ||||
| 2029 through 2033 | $ | ||||
| 2023 | 2022 | 2021 | |||||||||||||||
| U.S. federal statutory tax rate | % | % | % | ||||||||||||||
| Income tax provision reconciliation: | |||||||||||||||||
| Tax at statutory rate | $ | $ | $ | ||||||||||||||
| Net foreign income subject to lower tax rate | ( | ( | ( | ||||||||||||||
| State income taxes, net of federal benefit | ( | ( | |||||||||||||||
| Valuation allowance | ( | ||||||||||||||||
| Federal research and development tax credits | ( | ( | ( | ||||||||||||||
| Change in uncertain tax positions | ( | ||||||||||||||||
| Amortization of purchased intangibles | |||||||||||||||||
| Acquisition and integration costs | |||||||||||||||||
| Taxes attributable to the Tax Cuts and Jobs Act of 2017 | ( | ||||||||||||||||
| U.S. effects of international operations | ( | ( | ( | ||||||||||||||
| Windfalls (under ASU 2016-09) | ( | ( | ( | ||||||||||||||
| Intra-entity transfer of intangible assets | ( | ||||||||||||||||
| Other, net | |||||||||||||||||
| Total income tax provision (benefit) | $ | $ | $ | ( | |||||||||||||
| Income before income taxes (1) | 2023 | 2022 | 2021 | ||||||||||||||
| Domestic | $ | $ | $ | ||||||||||||||
| Foreign | |||||||||||||||||
| Income before income taxes | $ | $ | $ | ||||||||||||||
| 2023 | 2022 | 2021 | |||||||||||||||
| Current: | |||||||||||||||||
| Federal tax | $ | $ | $ | ||||||||||||||
| State | |||||||||||||||||
| Foreign | |||||||||||||||||
| Total current | $ | $ | $ | ||||||||||||||
| Deferred: | |||||||||||||||||
| Federal | $ | ( | $ | ( | $ | ||||||||||||
| State | ( | ( | |||||||||||||||
| Foreign | ( | ||||||||||||||||
| Total deferred | $ | ( | $ | ( | $ | ( | |||||||||||
| Provision for (benefit from) income tax | $ | $ | $ | ( | |||||||||||||
| 2023 | 2022 | ||||||||||
| Deferred tax assets: | |||||||||||
| Inventory reserves | $ | $ | |||||||||
| Reserves for compensation and benefits | |||||||||||
| Tax credit carryovers | |||||||||||
| Stock-based compensation | |||||||||||
| Net operating losses | |||||||||||
| Intangible assets | |||||||||||
| Lease liability | |||||||||||
Capitalization of R&D expenses (1) | |||||||||||
| Other | |||||||||||
| Total gross deferred tax assets | |||||||||||
| Valuation allowance | ( | ( | |||||||||
| Total deferred tax assets | |||||||||||
| Deferred tax liabilities: | |||||||||||
| Depreciation | ( | ( | |||||||||
| Deferred GILTI tax liabilities | ( | ( | |||||||||
| Right of use asset | ( | ( | |||||||||
| Acquisition-related intangibles | ( | ( | |||||||||
| Total gross deferred tax liabilities | ( | ( | |||||||||
| Net deferred tax liabilities | $ | ( | $ | ( | |||||||
| Unrealized Tax Benefits | |||||
Balance, October 31, 2020 | $ | ||||
| Additions for tax positions related to current year | |||||
Additions for tax positions related to prior years | |||||
| Additions for tax positions related to the Acquisition | |||||
| Reductions due to lapse of applicable statute of limitations | ( | ||||
Balance, October 30, 2021 | $ | ||||
| Additions for tax positions related to the Acquisition | |||||
| Additions for tax positions related to current year | |||||
Additions for tax positions related to prior years | |||||
| Reductions due to lapse of applicable statute of limitations | ( | ||||
Balance, October 29, 2022 | $ | ||||
| Additions for tax positions related to current year | |||||
| Additions for tax positions related to prior years | |||||
| Reductions due to lapse of applicable statute of limitations | ( | ||||
Balance, October 28, 2023 | $ | ||||
| October 28, 2023 | October 29, 2022 | ||||||||||||||||||||||
| Principal | Unamortized discounts, debt issuance costs and fair value adjustments | Principal | Unamortized discount and debt issuance costs | ||||||||||||||||||||
| 2024 Notes, due October 2024 | $ | $ | $ | $ | |||||||||||||||||||
| 2025 Notes, due April 2025 | |||||||||||||||||||||||
| 2026 Notes, due December 2026 | |||||||||||||||||||||||
Maxim Notes, due June 2027 | ( | ||||||||||||||||||||||
| 2027 Notes, due June 2027 | ( | ( | |||||||||||||||||||||
| 2028 Notes, due October 2028 | |||||||||||||||||||||||
2031 Notes, due October 2031 (1) | |||||||||||||||||||||||
| 2032 Notes, due October 2032 | |||||||||||||||||||||||
| 2036 Notes, due December 2036 | |||||||||||||||||||||||
| 2041 Notes, due October 2041 | |||||||||||||||||||||||
| 2045 Notes, due December 2045 | |||||||||||||||||||||||
| 2051 Notes, due October 2051 | |||||||||||||||||||||||
| Total Long-Term Debt | |||||||||||||||||||||||
| 2024 Notes, due October 2024 | |||||||||||||||||||||||
Commercial paper notes | |||||||||||||||||||||||
Total Current Debt | |||||||||||||||||||||||
| Total Debt | $ | $ | $ | $ | |||||||||||||||||||
| 1. | Financial Statements | ||||
| — | Consolidated Statements of Income for the years ended October 28, 2023, October 29, 2022 and October 30, 2021 | |||||||
| — | Consolidated Statements of Comprehensive Income for the years ended October 28, 2023, October 29, 2022 and October 30, 2021 | |||||||
| — | Consolidated Balance Sheets as of October 28, 2023 and October 29, 2022 | |||||||
| — | Consolidated Statements of Shareholders’ Equity for the years ended October 28, 2023, October 29, 2022 and October 30, 2021 | |||||||
| — | Consolidated Statements of Cash Flows for the years ended October 28, 2023, October 29, 2022 and October 30, 2021 | |||||||
| Exhibit No. | Description | ||||||||||
| 2.1 | Agreement and Plan of Merger, dated as of July 12, 2020, by and among Analog Devices, Inc., Maxim Integrated Products, Inc. and Magneto Corp., filed as exhibit 2.1 to the Company’s Current Report on Form 8-K (File No. 1-7819) as filed with the Commission on July 15, 2020 and incorporated herein by reference. | ||||||||||
| 3.1 | Restated Articles of Organization of Analog Devices, Inc., as amended, filed as exhibit 3.1 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended May 3, 2008 (File No. 1-7819) as filed with the Commission on May 20, 2008 and incorporated herein by reference. | ||||||||||
| 3.2 | Amendment to Restated Articles of Organization of Analog Devices, Inc., filed as exhibit 3.1 to the Company's Current Report on Form 8-K (File No. 1-7819) as filed with the Commission on December 8, 2008 and incorporated herein by reference. | ||||||||||
| 3.3 | Amended and Restated By-Laws of Analog Devices, Inc., filed as exhibit 3.1 to the Company's Current Report on Form 8-K (File No. 1-7819) as filed with the Commission on December 8, 2022 and incorporated herein by reference. | ||||||||||
4.1 | Indenture, dated as of June 3, 2013, by and between Analog Devices, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee, filed as exhibit 4.1 to the Company's Current Report on Form 8-K (File No. 1-7819) as filed with the Commission on June 3, 2013 and incorporated herein by reference. | ||||||||||
4.2 | Supplemental Indenture, dated as of June 3, 2013, by and between Analog Devices, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of note contained therein), filed as exhibit 4.2 to the Company's Current Report on Form 8-K (File No. 1-7819) as filed with the Commission on June 3, 2013 and incorporated herein by reference. | ||||||||||
4.3 | Supplemental Indenture, dated December 14, 2015, between Analog Devices, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (including the forms of note contained therein), filed as exhibit 4.2 to the Company's Current Report on Form 8-K (File No. 1-7819) as filed with the Commission on December 14, 2015 and incorporated herein by reference. | ||||||||||
4.4 | Supplemental Indenture, dated December 5, 2016, between Analog Devices, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (including the forms of note contained therein), filed as exhibit 4.2 to the Company's Current Report on Form 8-K (File No. 1-7819) as filed with the Commission on December 5, 2016 and incorporated herein by reference. | ||||||||||
4.5 | Supplemental Indenture, dated March 12, 2018, between Analog Devices, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (including the forms of note contained therein), filed as exhibit 4.2 to the Company's Current Report on Form 8-K (File No. 1-7819) as filed with the Commission on March 12, 2018 and incorporated herein by reference. | ||||||||||
| Exhibit No. | Description | ||||||||||
4.6 | Supplemental Indenture, dated April 8, 2020, between Analog Devices, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of note contained therein), filed as exhibit 4.2 to the Company’s Current Report on Form 8-K (File No. 1-7819) as filed with the Commission on April 8, 2020 and incorporated herein by reference. | ||||||||||
4.7 | Supplemental Indenture, dated October 5, 2021, between Analog Devices, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (including the forms of note contained therein), filed as exhibit 4.2 to the Company's Current Report on Form 8-K (File No. 1-7819) as filed with the Commission on October 5, 2021 and incorporated herein by reference. | ||||||||||
4.8 | Supplemental Indenture, dated September 15, 2022, between Analog Devices, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of note contained therein), filed as exhibit 4.2 to the Company's Current Report on Form 8-K (File No. 1-7819) as filed with the Commission on September 15, 2022 and incorporated herein by reference. | ||||||||||
4.9 | Supplemental Indenture, dated as of October 7, 2022, between Analog Devices, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of note contained therein), filed as exhibit 4.2 to the Company's Current Report on Form 8-K (File No. 1-7819) as filed with the Commission on October 7, 2022 and incorporated herein by reference. | ||||||||||
4.10 | Registration Rights Agreement, dated as of October 7, 2022, between Analog Devices, Inc. and TD Securities (USA) LLC, filed as exhibit 4.5 to the Company's Current Report on Form 8-K (File No. 1-7819) as filed with the Commission on October 7, 2022, and incorporated herein by reference. | ||||||||||
4.11 | Description of the Registrant's Securities, filed as exhibit 4.6 to the Company's Annual Report on Form 10-K for the fiscal year ended November 2, 2019 (File No. 1-7819) as filed with the Commission on November 26, 2019 and incorporated herein by reference. | ||||||||||
| *10.1 | Analog Devices, Inc. Amended and Restated Deferred Compensation Plan, filed as exhibit 10.1 to the Company's Current Report on Form 8-K as filed with the Commission on December 8, 2008 (File No. 1-7819) and incorporated herein by reference. | ||||||||||
| *10.2 | First Amendment to the Analog Devices, Inc. Amended and Restated Deferred Compensation Plan, filed as exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended July 30, 2011 (File No. 1-7819) as filed with the Commission on August 16, 2011 and incorporated herein by reference. | ||||||||||
| *10.3 | Second Amendment to the Analog Devices, Inc. Amended and Restated Deferred Compensation Plan, filed as exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended August 1, 2015 (File No. 1-7819) as filed with the Commission on August 18, 2015 and incorporated herein by reference. | ||||||||||
| *10.4 | Third Amendment to the Analog Devices, Inc. Amended and Restated Deferred Compensation Plan, filed as exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended July 29, 2017 (File No. 1-7819) as filed with the Commission on August 30, 2017 and incorporated herein by reference. | ||||||||||
| *10.5 | Fourth Amendment to the Analog Devices, Inc. Amended and Restated Deferred Compensation Plan, filed as exhibit 10.5 to the Company's Annual Report on Form 10-K for the fiscal year ended November 2, 2019 (File No. 1-7819) as filed with the Commission on November 26, 2019 and incorporated herein by reference. | ||||||||||
| *10.6 | Fifth Amendment to the Analog Devices, Inc. Amended and Restated Deferred Compensation Plan, filed as exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended July 31, 2021 (File No. 1-7819) as filed with the Commission on August 18, 2021 and incorporated herein by reference. | ||||||||||
†*10.7 | Analog Devices, Inc. Amended and Restated Deferred Compensation Plan effective as of January 1, 2024. | ||||||||||
*10.8 | Trust Agreement for Deferred Compensation Plan dated as of October 1, 2003 between Analog Devices, Inc. and Fidelity Management Trust Company, filed as exhibit 10.28 to the Company's Annual Report on Form 10-K for the fiscal year ended November 1, 2003 (File No. 1-7819) as filed with the Commission on December 23, 2003 and incorporated herein by reference. | ||||||||||
*10.9 | First Amendment to Trust Agreement for Deferred Compensation Plan between Analog Devices, Inc. and Fidelity Management Trust Company dated as of January 1, 2005, filed as exhibit 10.3 to the Company's Annual Report on Form 10-K for the fiscal year ended October 28, 2006 (File No. 1-7819) as filed with the Commission on November 20, 2006 and incorporated herein by reference. | ||||||||||
*10.10 | Second Amendment to Trust Agreement for Deferred Compensation Plan between Analog Devices, Inc. and Fidelity Management Trust Company dated as of December 10, 2007, filed as exhibit 10.41 to the Company's Annual Report on Form 10-K for the fiscal year ended November 1, 2008 (File No. 1-7819) as filed with the Commission on November 25, 2008 and incorporated herein by reference. | ||||||||||
*10.11 | Amended and Restated 2006 Stock Incentive Plan of Analog Devices, Inc., filed as exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended February 1, 2014 (File No. 1-7819) as filed with the Commission on February 18, 2014 and incorporated herein by reference. | ||||||||||
*10.12 | Analog Devices, Inc. Amended and Restated 2010 Equity Incentive Plan, filed as Exhibit 4.2 to the Post-Effective Amendment No. 1 on Form S-8 to the Company's Registration Statement on Form S-4 (File No. 333-213454) as filed with the Commission on March 15, 2017 and incorporated herein by reference. | ||||||||||
| Exhibit No. | Description | ||||||||||
*10.13 | Form of Global Non-Qualified Stock Option Agreement for Employees for usage under the Company's Amended and Restated 2006 Stock Incentive Plan, filed as exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended February 2, 2019 (File No. 1-7819) as filed with the Commission on February 20, 2019 and incorporated herein by reference. | ||||||||||
*10.14 | Form of Non-Qualified Stock Option Agreement for Directors for usage under the Company's Amended and Restated 2006 Stock Incentive Plan, filed as exhibit 10.4 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 28, 2017 (File No. 1-7819) as filed with the Commission on February 15, 2017 and incorporated herein by reference. | ||||||||||
*10.15 | Analog Devices, Inc. 2020 Equity Incentive Plan, filed as Appendix B to the Company’s Definitive Proxy Statement on Schedule 14A (File No. 1-7819), as filed with the Commission on January 24, 2020 and incorporated herein by reference. | ||||||||||
*10.16 | Form of Financial Metric Performance Restricted Stock Unit Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan, filed as exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended February 1, 2020 (File No. 1-7819) as filed with the Commission on February 19, 2020 and incorporated herein by reference. | ||||||||||
*10.17 | Form of Global Non-Qualified Stock Option Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan, filed as exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended February 1, 2020 (File No. 1-7819) as filed with the Commission on February 19, 2020 and incorporated herein by reference. | ||||||||||
*10.18 | Form of Global Restricted Stock Unit Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan, filed as exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended February 1, 2020 (File No. 1-7819) as filed with the Commission on February 19, 2020 and incorporated herein by reference. | ||||||||||
*10.19 | Form of Restricted Stock Unit Agreement for Directors for usage under the Company's 2020 Equity Incentive Plan, filed as exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended February 1, 2020 (File No. 1-7819) as filed with the Commission on February 19, 2020 and incorporated herein by reference. | ||||||||||
*10.20 | Form of Relative Total Shareholder Return Performance Restricted Stock Unit Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan, filed as exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended February 1, 2020 (File No. 1-7819) as filed with the Commission on February 19, 2020 and incorporated herein by reference. | ||||||||||
*10.21 | Non-Qualified Performance Stock Option Agreement – CEO Performance Stock Option Award, filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-07819) as filed with the Commission on December 17, 2020 and incorporated herein by reference. | ||||||||||
*10.22 | Form of Performance Restricted Stock Unit Agreement – Integration Award, filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K (File No. 001-07819) as filed with the Commission on December 17, 2020 and incorporated herein by reference. | ||||||||||
*10.23 | Form of Restricted Stock Unit Agreement for Non-Employee Directors for usage under the Company’s 2020 Equity Incentive Plan adopted December 8, 2020, filed as exhibit 10.3 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 30, 2021 (File No. 1-7819) as filed with the Commission on February 17, 2021 and incorporated herein by reference. | ||||||||||
*10.24 | Form of Global Non-Qualified Stock Option Agreement for Employees for usage under the Company’s 2020 Equity Incentive Plan adopted December 8, 2020, filed as exhibit 10.4 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 30, 2021 (File No. 1-7819) as filed with the Commission on February 17, 2021 and incorporated herein by reference. | ||||||||||
*10.25 | Form of Global Restricted Stock Unit Agreement for Employees for usage under the Company’s 2020 Equity Incentive Plan adopted December 8, 2020, filed as exhibit 10.5 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 30, 2021 (File No. 1-7819) as filed with the Commission on February 17, 2021 and incorporated herein by reference. | ||||||||||
*10.26 | Form of Relative Total Shareholder Return Performance Restricted Stock Unit Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan adopted December 8, 2020, filed as exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 30, 2021 (File No. 1-7819) as filed with the Commission on February 17, 2021 and incorporated herein by reference. | ||||||||||
*10.27 | Form of Financial Metric Performance Restricted Stock Unit Agreement for Employees for usage under the 2020 Equity Incentive Plan adopted December 8, 2020, filed as exhibit 10.7 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 30, 2021 (File No. 1-7819) as filed with the Commission on February 17, 2021 and incorporated herein by reference. | ||||||||||
*10.28 | Form of Financial Metric Performance Restricted Stock Unit Agreement for China Employees for usage under the 2020 Equity Stock Incentive Plan adopted December 8, 2020, filed as exhibit 10.8 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 30, 2021 (File No. 1-7819) as filed with the Commission on February 17, 2021 and incorporated herein by reference. | ||||||||||
| Exhibit No. | Description | ||||||||||
*10.29 | Form of Restricted Stock Unit Agreement for Non-Employee Directors for usage under the Company’s 2020 Equity Incentive Plan adopted December 7, 2021, filed as exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 29, 2022 (File No. 1-7819) as filed with the Commission on February 16, 2022 and incorporated herein by reference. | ||||||||||
*10.30 | Form of Global Restricted Stock Unit Agreement for Employees for usage under the Company’s 2020 Equity Incentive Plan adopted December 7, 2021, filed as exhibit 10.2 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 29, 2022 (File No. 1-7819) as filed with the Commission on February 16, 2022 and incorporated herein by reference. | ||||||||||
*10.31 | Form of Relative Total Shareholder Return Performance Restricted Stock Unit Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan adopted December 7, 2021, filed as exhibit 10.4 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 29, 2022 (File No. 1-7819) as filed with the Commission on February 16, 2022 and incorporated herein by reference. | ||||||||||
*10.32 | Form of Financial Metric Performance Restricted Stock Unit Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan adopted December 7, 2021, filed as exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended January 29, 2022 (File No. 1-7819) as filed with the Commission on February 16, 2022 and incorporated herein by reference. | ||||||||||
*10.33 | Form of EVP Global Restricted Stock Unit Agreement for Employees for usage under the Company’s 2020 Equity Incentive Plan adopted March 7, 2022, filed as exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended April 30, 2022 (File No. 1-7819) as filed with the Commission on May 18, 2022 and incorporated herein by reference. | ||||||||||
*10.34 | Form of EVP Performance Restricted Stock Unit Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan adopted March 7, 2022, filed as exhibit 10.2 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended April 30, 2022 (File No. 1-7819) as filed with the Commission on May 18, 2022 and incorporated herein by reference. | ||||||||||
*10.35 | Form of Relative Total Shareholder Return Performance Restricted Stock Unit Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan adopted April 4, 2022, filed as exhibit 10.3 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended April 30, 2022 (File No. 1-7819) as filed with the Commission on May 18, 2022 and incorporated herein by reference. | ||||||||||
*10.36 | Form of Executive Relative Total Shareholder Return Performance Restricted Stock Unit Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan adopted June 6, 2022, filed as exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended July 30, 2022 (File No. 1-7819) as filed with the Commission on August 17, 2022 and incorporated herein by reference. | ||||||||||
*10.37 | Form of Executive Financial Performance Restricted Stock Unit Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan adopted June 6, 2022, filed as exhibit 10.2 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended July 30, 2022 (File No. 1-7819) as filed with the Commission on August 17, 2022 and incorporated herein by reference. | ||||||||||
*10.38 | Form of Global Non-Qualified Stock Option Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan adopted December 5, 2022, filed as exhibit 10.4 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 28, 2023 (File No. 1-7819) as filed with the Commission on February 15, 2023 and incorporated herein by reference. | ||||||||||
*10.39 | Form of Global Restricted Stock Unit Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan adopted December 5, 2022, filed as exhibit 10.5 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 28, 2023 (File No. 1-7819) as filed with the Commission on February 15, 2023 and incorporated herein by reference. | ||||||||||
*10.40 | Form of Restricted Stock Unit Agreement for Non-Employee Directors for usage under the Company's 2020 Equity Incentive Plan adopted December 5, 2022, filed as exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 28, 2023 (File No. 1-7819) as filed with the Commission on February 15, 2023 and incorporated herein by reference. | ||||||||||
*10.41 | Form of Financial Metric Performance Restricted Stock Unit Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan adopted December 5, 2022, filed as exhibit 10.7 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 28, 2023 (File No. 1-7819) as filed with the Commission on February 15, 2023 and incorporated herein by reference. | ||||||||||
*10.42 | Form of Relative Total Shareholder Return Performance Restricted Stock Unit Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan adopted December 5, 2022, filed as exhibit 10.8 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 28, 2023 (File No. 1-7819) as filed with the Commission on February 15, 2023 and incorporated herein by reference. | ||||||||||
*10.43 | Form of Relative Total Shareholder Return Performance Restricted Stock Unit Agreement for Employees for usage under the Company's 2020 Equity Incentive Plan adopted April 3, 2023, filed as exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended April 29, 2023 (File No. 1-7819) as filed with the Commission on May 24, 2023 and incorporated herein by reference. | ||||||||||
| Exhibit No. | Description | ||||||||||
*10.44 | RSU Equity Award Conversion Agreement, filed as exhibit 10.9 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 28, 2023 (File No. 1-7819) as filed with the Commission on February 15, 2023 and incorporated herein by reference. | ||||||||||
*10.45 | RSA Equity Award Conversion Agreement, filed as exhibit 10.11 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 28, 2023 (File No. 1-7819) as filed with the Commission on February 15, 2023 and incorporated herein by reference. | ||||||||||
*10.46 | MSU Equity Award Conversion Agreement, filed as exhibit 10.13 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 28, 2023 (File No. 1-7819) as filed with the Commission on February 15, 2023 and incorporated herein by reference. | ||||||||||
*10.47 | Form of Performance Restricted Stock Unit Agreement - 2021 Integration Award, filed as exhibit 10.15 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 28, 2023 (File No. 1-7819) as filed with the Commission on February 15, 2023 and incorporated herein by reference. | ||||||||||
*10.48 | Amended and Restated 1996 Stock Incentive Plan, filed as exhibit 10.36 to the Company's Annual Report on Form 10-K for the fiscal year ended October 30, 2021 (File No. 1-7819) as filed with the Commission on December 3, 2021 and incorporated herein by reference. | ||||||||||
*10.49 | Form of Global Restricted Stock Unit Agreement for usage under the Amended and Restated 1996 Stock Incentive Plan, filed as exhibit 10.37 to the Company's Annual Report on Form 10-K for the fiscal year ended October 30, 2021 (File No. 1-7819) as filed with the Commission on December 3, 2021 and incorporated herein by reference. | ||||||||||
*10.50 | Form of Global Non-Qualified Stock Option Agreement for usage under the Amended and Restated 1996 Stock Incentive Plan, filed as exhibit 10.38 to the Company's Annual Report on Form 10-K for the fiscal year ended October 30, 2021 (File No. 1-7819) as filed with the Commission on December 3, 2021 and incorporated herein by reference. | ||||||||||
*10.51 | Form of Global Restricted Stock Unit Agreement for Employees for usage under the Company’s 1996 Stock Incentive Plan adopted December 7, 2021, filed as exhibit 10.3 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 29, 2022 (File No. 1-7819) as filed with the Commission on February 16, 2022 and incorporated herein by reference. | ||||||||||
*10.52 | Form of Global Non-Qualified Stock Option Agreement for usage under the Company's Amended and Restated 1996 Stock Incentive Plan adopted December 5, 2022, filed as exhibit 10.2 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 28, 2023 (File No. 1-7819) as filed with the Commission on February 15, 2023 and incorporated herein by reference. | ||||||||||
*10.53 | Form of Global Restricted Stock Unit Agreement for Employees for usage under the Company's Amended and Restated 1996 Stock Incentive Plan adopted December 5, 2022, filed as exhibit 10.3 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 28, 2023 (File No. 1-7819) as filed with the Commission on February 15, 2023 and incorporated herein by reference. | ||||||||||
*10.54 | Form of Employee Retention Agreement, filed as exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended May 5, 2012 (File No. 1-7819) as filed with the Commission on May 22, 2012 and incorporated herein by reference. | ||||||||||
*10.55 | Employee Change in Control Severance Policy of Analog Devices, Inc., as amended, filed as exhibit 10.20 to the Company's Annual Report on Form 10-K for the fiscal year ended October 30, 1999 (File No. 1-7819) as filed with the Commission on January 28, 2000 and incorporated herein by reference. | ||||||||||
*10.56 | Senior Management Change in Control Severance Policy of Analog Devices, Inc., as amended, filed as exhibit 10.21 to the Company's Annual Report on Form 10-K for the fiscal year ended October 30, 1999 (File No. 1-7819) as filed with the Commission on January 28, 2000 and incorporated herein by reference. | ||||||||||
*10.57 | Offer Letter for Prashanth Mahendra-Rajah, dated August 4, 2017, filed as exhibit 10.28 to the Company's Annual Report on Form 10-K for the fiscal year ended October 28, 2017 (File No. 1-7819) as filed with the Commission on November 22, 2017 and incorporated herein by reference. | ||||||||||
*10.58 | Form of Indemnification Agreement for Directors and Officers, filed as exhibit 10.30 to the Company's Annual Report on Form 10-K for the fiscal year ended November 1, 2008 (File No. 1-7819) as filed with the Commission on November 25, 2008 and incorporated herein by reference. | ||||||||||
*10.59 | Credit Agreement, dated as of June 28, 2019, among Analog Devices, Inc., as Borrower, JPMorgan Chase Bank, N.A. as Administrative Agent and each lender from time to time party thereto, filed as exhibit 10.1 to the Company's Current Report on Form 8-K (File No. 1-7819) as filed with the Commission on July 1, 2019 and incorporated herein by reference. | ||||||||||
*10.60 | Third Amended and Restated Credit Agreement, dated as of June 23, 2021, among Analog Devices, Inc., as Borrower, Bank of America, N.A. as Administrative Agent, Swing Line Lender and L/C Issuer, and each lender from time to time party thereto, filed as exhibit 10.1 to the Company's Current Report on Form 8-K (File No. 1-7819) as filed with the Commission on June 23, 2021 and incorporated herein by reference. | ||||||||||
| Exhibit No. | Description | ||||||||||
10.61 | Amendment No. 1 to Third Amended and Restated Credit Agreement, dated as of December 20, 2022, filed as exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended January 28, 2023 (File No. 1-7819) as filed with the Commission on February 15, 2023 and incorporated herein by reference. | ||||||||||
10.62 | Amendment No. 2 to Third Amended and Restated Credit Agreement, dated as of July 24, 2023, filed as exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended July 29, 2023 (File No. 1-7819) as filed with the Commission on August 23, 2023 and incorporated herein by reference. | ||||||||||
†10.63 | |||||||||||
*10.64 | Offer Letter for Gregory Bryant dated December 14, 2021, filed as exhibit 10.4 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended April 30, 2022 (File No. 1-7819) as filed with the Commission on May 18, 2022 and incorporated herein by reference. | ||||||||||
*10.65 | Executive Performance Incentive Plan, filed as exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended April 30, 2022 (File No. 1-7819) as filed with the Commission on May 18, 2022 and incorporated by reference herein. | ||||||||||
*10.66 | Maxim Integrated Products, Inc. Form of Global Restricted Stock Unit Agreement effective July 12, 2020, filed as exhibit 10.28 to Maxim Integrated Products, Inc.'s Annual Report on Form 10-K for the fiscal year ended June 27, 2020 (File No. 1-34192) as filed with the Commission on August 19, 2020 and incorporated herein by reference. | ||||||||||
*10.67 | Maxim Integrated Products, Inc. Form of Global Restricted Stock Unit Agreement, filed as exhibit 10.5 to Maxim Integrated Products, Inc.'s Quarterly Report on Form 10-Q for the fiscal quarter ended September 26, 2020 (File No. 1-34192) as filed with the Commission on October 28, 2020 and incorporated herein by reference. | ||||||||||
*10.68 | Maxim Integrated Products, Inc. Form of Global Performance Share Agreement for September 2019 Grants, filed as exhibit 10.1 to Maxim Integrated Products, Inc.'s Quarterly Report on Form 10-Q for the fiscal quarter ended September 28, 2019 (File No. 1-34192) as filed with the Commission on October 30, 2019 and incorporated herein by reference. | ||||||||||
| †21 | |||||||||||
| †23 | |||||||||||
| †31.1 | |||||||||||
| †31.2 | |||||||||||
| †32.1 | |||||||||||
| †32.2 | |||||||||||
†97 | |||||||||||
| 101. INS | The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the inline XBRL document.** | ||||||||||
| 101. SCH | Inline XBRL Schema Document.** | ||||||||||
| 101. CAL | Inline XBRL Calculation Linkbase Document.** | ||||||||||
| 101. LAB | Inline XBRL Labels Linkbase Document.** | ||||||||||
| 101. PRE | Inline XBRL Presentation Linkbase Document.** | ||||||||||
| 101. DEF | Inline XBRL Definition Linkbase Document** | ||||||||||
| 104 | Cover page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101). | ||||||||||
| † | Filed herewith. | |||||||
| * | Management contracts and compensatory plan or arrangements required to be filed as an Exhibit pursuant to Item 15(b) of Form 10-K. | |||||||
| ** | Submitted electronically herewith. | |||||||
| Description | Balance at Beginning of Period | Additions (Reductions) Charged to Income Statement | Other | Balance at End of Period | ||||||||||||||||||||||
| Valuation Allowance for Deferred Tax Asset: | ||||||||||||||||||||||||||
| Year ended October 30, 2021 | $ | $ | $ | (1) | $ | |||||||||||||||||||||
| Year ended October 29, 2022 | $ | $ | $ | ( | $ | |||||||||||||||||||||
| Year ended October 28, 2023 | $ | $ | ( | $ | $ | |||||||||||||||||||||
| ANALOG DEVICES, INC. | |||||||||||
Date: November 21, 2023 | By: | /s/ Vincent Roche | |||||||||
| Vincent Roche Chief Executive Officer and Chair of the Board of Directors (Principal Executive Officer) | |||||||||||
| Name | Title | Date | ||||||||||||
| /s/ Vincent Roche | Chief Executive Officer and Chair of the Board of Directors (Principal Executive Officer) | November 21, 2023 | ||||||||||||
| Vincent Roche | ||||||||||||||
| /s/ James Mollica | Interim Chief Financial Officer | November 21, 2023 | ||||||||||||
| James Mollica | (Principal Financial Officer) | |||||||||||||
| /s/ Michael Sondel | Corporate Vice President and Chief Accounting Officer (Principal Accounting Officer) | November 21, 2023 | ||||||||||||
| Michael Sondel | ||||||||||||||
| /s/ André Andonian | Director | November 21, 2023 | ||||||||||||
| André Andonian | ||||||||||||||
| /s/ James A. Champy | Director | November 21, 2023 | ||||||||||||
| James A. Champy | ||||||||||||||
| /s/ Anantha P. Chandrakasan | Director | November 21, 2023 | ||||||||||||
| Anantha P. Chandrakasan | ||||||||||||||
| /s/ Edward H. Frank | Director | November 21, 2023 | ||||||||||||
| Edward H. Frank | ||||||||||||||
| /s/ Laurie H. Glimcher | Director | November 21, 2023 | ||||||||||||
| Laurie H. Glimcher | ||||||||||||||
| /s/ Karen M. Golz | Director | November 21, 2023 | ||||||||||||
| Karen M. Golz | ||||||||||||||
/s/ Stephen Jennings | Director | November 21, 2023 | ||||||||||||
Stephen Jennings | ||||||||||||||
| /s/ Mercedes Johnson | Director | November 21, 2023 | ||||||||||||
| Mercedes Johnson | ||||||||||||||
| /s/ Kenton J. Sicchitano | Director | November 21, 2023 | ||||||||||||
| Kenton J. Sicchitano | ||||||||||||||
| /s/ Ray Stata | Director | November 21, 2023 | ||||||||||||
| Ray Stata | ||||||||||||||
| /s/ Susie Wee | Director | November 21, 2023 | ||||||||||||
| Susie Wee | ||||||||||||||
| ARTICLE I Introduction | |||||
1.1 History. | |||||
1.2 Statement of Purpose and Compliance with Law. | |||||
| ARTICLE II Definitions | |||||
2.1 Account. | |||||
2.2 Administrative Procedures. | |||||
2.3 Annual Bonus. | |||||
2.4 Base Salary. | |||||
2.5 Beneficiary. | |||||
2.6 Board. | |||||
2.7 Change in Control. | |||||
2.8 Class Year. | |||||
2.9 Code. | |||||
2.10 Commissions. | |||||
2.11 Committee. | |||||
2.12 Compensation. | |||||
2.13 Company Contribution Account. | |||||
2.14 Company Contribution Amount. | |||||
2.15 Company. | |||||
2.16 Deferral Account. | |||||
2.17 Deferral Benefit. | |||||
2.18 Deferral Election. | |||||
2.19 Disability. | |||||
2.20 Eligible Employee. | |||||
2.21 Employer. | |||||
2.22 Investment Return Rate. | |||||
2.23 Other Bonus. | |||||
2.24 Participant. | |||||
2.25 Participation Election. | |||||
2.26 Plan. | |||||
2.27 Plan Year. | |||||
2.28 Recordkeeper. | |||||
2.29 Retirement. | |||||
2.30 Section 409A. | |||||
2.31 Selected Affiliate. | |||||
2.32 Special Account. | |||||
2.33 Specified Payment Date. | |||||
2.34 TIP. | |||||
2.35 Unforeseeable Emergency. | |||||
2.36 Valuation Date. | |||||
| ARTICLE III Eligibility and Participation | |||||
3.1 Eligibility. | |||||
3.2 Participation. | |||||
3.3 Change in Participation Status. | |||||
| ARTICLE IV Deferral of Compensation | |||||
4.1 Deferral Elections. | |||||
4.2 Crediting Deferred Compensation and Company Contribution Amounts. | |||||
| ARTICLE V Benefit Accounts | |||||
5.1 Valuation of Account. | |||||
5.2 Crediting of Investment Return. | |||||
5.3 Statement of Accounts. | |||||
5.4 Vesting of Account. | |||||
5.5 Investment Vehicles. | |||||
| ARTICLE VI Payment of Benefits | |||||
6.1 Distribution of Account. | |||||
6.2 Acceleration of Payments upon Death or Disability. | |||||
6.3 Unforeseeable Emergency. | |||||
6.4 Form of Payment. | |||||
6.5 Commencement of Payments for Key Employees. | |||||
6.6 Small Benefit. | |||||
6.7 Changes in Distributions. | |||||
| ARTICLE VII Beneficiary Designation | |||||
7.1 Beneficiary Designation. | |||||
7.2 Change of Beneficiary Designation. | |||||
7.3 No Designation. | |||||
7.4 Effect of Payment. | |||||
| ARTICLE VIII Administration | |||||
8.1 Committee. | |||||
8.2 Agents. | |||||
8.3 Binding Effect of Decisions. | |||||
8.4 Indemnification of Committee. | |||||
| ARTICLE IX Amendment and Termination of the Plan | |||||
9.1 Amendment. | |||||
9.2 Termination. | |||||
| ARTICLE X Miscellaneous | |||||
10.1 Funding. | |||||
10.2 Nonassignability. | |||||
10.3 Legal Fees and Expenses. | |||||
10.4 Captions. | |||||
10.5 Governing Law. | |||||
10.6 Successors. | |||||
10.7 Right to Continued Service. | |||||
| Distribution Type | Form of Payment Available | ||||
| Death or Disability | •A single lump sum within 60 days of the death or Disability. | ||||
| Separation from Service, | •A single lump sum within 60 days of the Separation from Service, death or Disability; •A single lump sum on the 1st or 2nd anniversary of the Participant’s Separation from Service; or •Annual installments over 2 to 10 years. | ||||
| Specified Payment Date | •Annual installments over 2 to 5 years; or •A single lump sum | ||||
ANALOG DEVICES, INC. | ||||||||
| By: | /s/ Edward H. Frank | |||||||
Edward H. Frank, Chair, Compensation and Talent | ||||||||
Committee of the Board of Directors | ||||||||
| Name of Subsidiary | State or Other Jurisdiction of Incorporation or Organization | ||||
| Acuitas Silicon Limited | Ireland | ||||
| Analog Devices (China) Co. Ltd. | China | ||||
| Analog Devices (China) Holdings Co., Ltd. | China | ||||
| Analog Devices (China) Holdings Co., Ltd. - Shanghai Pudong Branch | China | ||||
| Analog Devices (China) Holdings Co., Ltd. - Shenzen Branch | China | ||||
| Analog Devices (China) Holdings Co., Ltd. - Wuhan Branch | China | ||||
| Analog Devices (China) Holdings Co., Ltd. - Xi'an Branch | China | ||||
| Analog Devices (Finland) OY | Finland | ||||
| Analog Devices (Hangzhou) Co., Ltd. | China | ||||
| Analog Devices (Thailand) Co., Ltd. | Thailand | ||||
| Analog Devices A.B. | Sweden | ||||
| Analog Devices A/S | Denmark | ||||
| Analog Devices Atlantic Unlimited Company | Ireland | ||||
| Analog Devices Australia Pty. Ltd. | Australia | ||||
| Analog Devices Canada, Ltd. | Canada | ||||
| Analog Devices Federal LLC | United States | ||||
| Analog Devices Gen. Trias, Inc. | Philippines | ||||
| Analog Devices GmbH | Austria | ||||
| Analog Devices GmbH | Germany | ||||
| Analog Devices GmbH - Sediu Permanent Desemnat (Branch) | Romania | ||||
| Analog Devices GmbH Predstavnistvo Analog Devices GmbH Beograd (Representative Office) | Serbia | ||||
| Analog Devices Holdings B.V. | Netherlands | ||||
| Analog Devices India Private Limited | India | ||||
| Analog Devices International Unlimited Company | Ireland | ||||
| Analog Devices International, Inc. - Belgium Branch | Belgium | ||||
| Analog Devices International, LLC | United States | ||||
| Analog Devices International, LLC - Singapore Branch | Singapore | ||||
| Analog Devices Israel, Ltd. | Israel | ||||
| Analog Devices Korea, Ltd. | Korea, Republic of | ||||
| Analog Devices Limerick Unlimited Company | Ireland | ||||
| Analog Devices Limited | United Kingdom | ||||
| Analog Devices Limited Egypt LLC | Egypt | ||||
| Analog Devices LLC | United States | ||||
| Name of Subsidiary | State or Other Jurisdiction of Incorporation or Organization | ||||
| Analog Devices Mexico, S. de R.L. de C.V. | Mexico | ||||
| Analog Devices Microelectronics | Egypt | ||||
| Analog Devices Mikroelektronik Sanayi Ve Ticaret Limited Şirketi | Turkey | ||||
| Analog Devices Nederland, B.V. | Netherlands | ||||
| Analog Devices Norway AS | Norway | ||||
| Analog Devices Pty. Ltd. | Australia | ||||
| Analog Devices Realty Holdings, Inc. | Philippines | ||||
| Analog Devices Romania S.R.L. | Romania | ||||
| Analog Devices S.A.S. | France | ||||
| Analog Devices S.L. | Spain | ||||
| Analog Devices Sdn Bhd | Malaysia | ||||
| Analog Devices SP. Z o.o. | Poland | ||||
| Analog Devices Srl | Italy | ||||
| Analog Devices Taiwan Ltd | Taiwan (Province of China) | ||||
| Analog Devices Taiwan Ltd- Malaysia branch | Malaysia | ||||
| Analog Devices, Inc. | United States | ||||
| Analog Devices, K.K. | Japan | ||||
| Calvatec Limited | United Kingdom | ||||
| Cambridge Analog Technologies, Inc. | United States | ||||
| Electric Motors Test, S.L. | Spain | ||||
| Hittite Microwave Holding LLC | United States | ||||
| Hittite Microwave LLC | United States | ||||
| Icron Technologies Corporation | Canada | ||||
| Innova Card | France | ||||
| Innovasic, Inc. | United States | ||||
| L&L Engineering, LLC | United States | ||||
| Linear Technology (Israel) Ltd. | Israel | ||||
| Linear Technology GK | Japan | ||||
| Linear Technology Holding LLC | United States | ||||
| Linear Technology KK | Japan | ||||
| Linear Technology PTE Ltd | Singapore | ||||
| Linear Technology Semiconductor India Private Limited | India | ||||
| Maxim (I.P.) Enterprise Solutions Corporation | Philippines | ||||
| Maxim Dallas (Shanghai) Semiconductor Trading Co. Ltd. | China | ||||
| Maxim France SARL | France | ||||
| Maxim India Integrated Circuit Design Private Limited | India | ||||
| Maxim Integrated Acquisition GmbH | Germany | ||||
| Maxim Integrated GmbH | Austria | ||||
| Name of Subsidiary | State or Other Jurisdiction of Incorporation or Organization | ||||
| Maxim Integrated Products Asia Limited | Hong Kong | ||||
| Maxim Integrated Products GmbH (Austria) | Austria | ||||
| Maxim Integrated Products India Sales Private Limited | India | ||||
| Maxim Integrated Products International Limited | Ireland | ||||
| Maxim Integrated Products International Sales Ireland Ltd, Filial Sweden | Sweden | ||||
| Maxim Integrated Products International Sales Japan GK | Japan | ||||
| Maxim Integrated Products International Sales Limited | Ireland | ||||
| Maxim Integrated Products International Sales Limited France Branch Office | France | ||||
| Maxim Integrated Products International Sales Limited Italian Branch Office | Italy | ||||
| Maxim Integrated Products International Sales Limited Singapore Branch | Singapore | ||||
| Maxim Integrated Products International Sales Limited Türkiye Istanbul rtibat Bürosu | Turkey | ||||
| Maxim Integrated Products International Sales Limited UK Branch Office | United Kingdom | ||||
| Maxim Integrated Products International Sales Limited, Dublin (Ireland), Zurich Branch | Switzerland | ||||
| Maxim Integrated Products International Sales Limited, Korean Branch | Korea, Republic of | ||||
| Maxim Integrated Products International Sales Limited, Philippines Branch Office | Philippines | ||||
| Maxim Integrated Products International Sales Limited, Taiwan Branch (Ireland) | Taiwan (Province of China) | ||||
| Maxim Integrated Products Korea, Inc. | Korea, Republic of | ||||
| Maxim Integrated Products UK Limited | United Kingdom | ||||
| Maxim Integrated Products UK Limited Italian Branch | Italy | ||||
| Maxim Integrated Products, Inc. | United States | ||||
| Maxim Integrated Products, Inc. Singapore Branch Office | Singapore | ||||
| Maxim International Holding, Inc. | United States | ||||
| Maxim Island Holdings Corporation | Canada | ||||
| Maxim Japan Co., Ltd | Japan | ||||
| Maxim Mikroelektronik Tasarım ve Geliştirme Limited Şirketi | Turkey | ||||
| Maxim Phil. Holding Corporation | Philippines | ||||
| Maxim Phil. Land Corporation | Philippines | ||||
| Maxim Phil. Operating Corporation | Philippines | ||||
| Maxim Semiconductor Corporation (Taiwan) | United States | ||||
| Mobilygen Corporation | United States | ||||
| Multigig, Inc. | United States | ||||
| OneTree MicroDevices, Inc. | United States | ||||
| Name of Subsidiary | State or Other Jurisdiction of Incorporation or Organization | ||||
| Otosense Inc. | United States | ||||
| Phyworks Limited | United Kingdom | ||||
| Scintera Networks LLC | United States | ||||
| Security Bank Corp. (trustee of Maxim EE Retirement Plan) | Philippines | ||||
| TagArray, Inc. | United States | ||||
| Teridian Semiconductor Corp. | United States | ||||
| Teridian Semiconductor Holdings Corp. | United States | ||||
| Teridian Semiconductor Intermediate Holding Corp. | United States | ||||
| Trinamic Motion Control GmbH & Co. KG | Germany | ||||
| Trinamic OÜ | Estonia | ||||
| Trinamic Verwaltungsgesellschaft mbH | Germany | ||||
| Volterra Asia Pte. Ltd. | Singapore | ||||
| Volterra Semiconductor LLC | United States | ||||
| /s/ Vincent Roche | |||||
| Vincent Roche | |||||
| Chief Executive Officer and Chair of the Board of | |||||
| Directors | |||||
| (Principal Executive Officer) | |||||
Dated: November 21, 2023 | |||||
| /s/ James Mollica | |||||
| James Mollica | |||||
| Interim Chief Financial Officer | |||||
| (Principal Financial Officer) | |||||
Dated: November 21, 2023 | |||||
| /s/ Vincent Roche | |||||
| Vincent Roche | |||||
| Chief Executive Officer | |||||
Dated: November 21, 2023 | |||||
| /s/ James Mollica | |||||
| James Mollica | |||||
| Interim Chief Financial Officer | |||||
Dated: November 21, 2023 | |||||
.?VC/A;X
MHC\?:/X^_9Z_9:N/&/A7XT^(M3\;:UXA^(7A6U\5:M#;^*;S4'TVW2_BBNYH
M_+\JS\QRJRVZ%$'S[(_J_P#8J_X+>-\(/V*/@)X"TKX<+\3_ !K;_#W0+.#1
M/"7BV#7-'[J2S\5?$2XMO!&A3Q?ZVUN]3F6T^U)Z_9HI);H_[-LQYQBO
M6/!'@S3?ASX+TCP]HUK'8Z/H-E#IUC;1CY;>"&-8XT'LJJ!^%>)^./\ B\W_
M 4-\':"/WND?!KP_-XPOEZJ-6U/S]-T[VREI'K18=1Y\)XR,_0% !1110 4
M5P'[1_[4?@']D;X?)XI^(OB2T\,Z)-=II\$TL4LTEW^45\__P##6'Q/\+
MX,_9W\;!&_U=_P"--;TWP[8R?\!BEN[U??=:#VSSCE_C%\2/C3\.? UQXH^)
M?Q8_9W_9]\)P.L5Q=RVUQK/D,YPB)J-[<6$
1<)).L;&-U,*AB*Z[_@F;8:9H_P"P9\,;'2-0\1ZA9Z=HZV177I+9
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M^6OH#TW_ *UM^>GJ=Y17G'Q\_:I\+?LU_8CXEL?B!!'FE=P#$9"G''^*_P#@I7\&_!>B>']3O_$FKC3?$6B6GB5+
MR#PMJUS;Z3I=T,V][J%+WQAXT2VSO34&N/$6L67EQ%,(S>83YF1MV_O%^Y/@K;
M?M)Z+I6L?#[QEH\'B/3;_29FM/']KJ>G^%YM-DET\".R@TZV2[,1AN 4\\R2
M8+%PLBHJGZPHH _,N/\ X(]?$WX@?!V"?QH="\3?$8:HN1XY^+WC'QCH::>(
M&()MXVTZ,W!N",Q^5Y6P'#98BOK'PK^R3XT\(W]CX
'O!/PX\5?$35=9U"QD:+1K[2;06"6U[;W+/*
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MDCCV/M\,_P""AW['OC'XE^*/%>B_"32OB]X./!W_!.3Q;\2/V?X?\ A._$/]FVNI:+<>'Q!JCW5A)-"9[NR!$D
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M)OA=$[XT:A\.]:\)7?@C2_#\^N6JV/A73+@\I:1QVJ">6-=J1S7_VN6-%V
MJP#/NT?B/_P20^''Q/TCQ[97^M>-XHOB)\.=,^&.I&WO+56@TVP:9H9H=UN=
MMR3.^YFW(<+B->
,=!\?:AH6FWEE'I
M5[K.CJB6MQ('M7N"&CC"21^<(V^\%60*XZGX\ !.?0/A'\6YM>\-^/?BCH
MOA>X\1WOBZ3P+9:Q#;>'9-4N]YN)G\N!;V2)Y)'E-J]TUKYAW>3P .:*DZ7+
M)^]9J_GRTE?TYE6:M_-%.R^&ZGQ/DVO^%ZCM\DZ2=_Y9-7?Q?,_[#W_!7'XM
M_&S]G#X-V]]\._"GC/XQ_%+2=<\5);6WB232-*AT73[L0--+*;&1H[AI94@B
MMHXY@VP/).FXX]$^"'_!7C4_VLOCGX"\,_"OX96>L:#XM^'-K\2K_5M>\4-I
M=QI-H^I36$]FMK#9W/GW<;PMM7S$C
Audit Information |
12 Months Ended |
|---|---|
Oct. 28, 2023 | |
| Auditor Information [Abstract] | |
| Auditor Name | Ernst & Young |
| Auditor Firm ID | 42 |
| Auditor Location | Boston, Massachusetts |
CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Revenue | |||
| Revenue | $ 12,305,539 | $ 12,013,953 | $ 7,318,286 |
| Costs and Expenses | |||
| Cost of sales | 4,428,321 | 4,481,479 | 2,793,274 |
| Gross margin | 7,877,218 | 7,532,474 | 4,525,012 |
| Operating expenses: | |||
| Research and development | 1,660,194 | 1,700,518 | 1,296,126 |
| Selling, marketing, general and administrative | 1,273,584 | 1,266,175 | 915,418 |
| Amortization of intangibles | 959,618 | 1,012,572 | 536,811 |
| Special charges, net | 160,710 | 274,509 | 84,456 |
| Total operating expenses | 4,054,106 | 4,253,774 | 2,832,811 |
| Operating income | 3,823,112 | 3,278,700 | 1,692,201 |
| Nonoperating expense (income): | |||
| Interest expense | 264,641 | 200,408 | 184,825 |
| Loss on extinguishment of debt | 0 | 0 | 215,150 |
| Interest income | (41,287) | (6,906) | (1,220) |
| Other, net | (8,245) | (13,551) | (35,268) |
| Total nonoperating (income) expense | 215,109 | 179,951 | 363,487 |
| Earnings | |||
| Income before income taxes | 3,608,003 | 3,098,749 | 1,328,714 |
| Provision for (benefit from) income taxes | 293,424 | 350,188 | (61,708) |
| Net income | $ 3,314,579 | $ 2,748,561 | $ 1,390,422 |
| Shares used to compute earnings per share - basic (in shares) | 502,232 | 519,226 | 397,462 |
| Shares used to compute earnings per share - diluted (in shares) | 505,959 | 523,178 | 401,288 |
| Basic earnings per common share (in dollars per share) | $ 6.60 | $ 5.29 | $ 3.50 |
| Diluted earnings per common share (in dollars per share) | $ 6.55 | $ 5.25 | $ 3.46 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Statement of Comprehensive Income [Abstract] | |||
| Net income | $ 3,314,579 | $ 2,748,561 | $ 1,390,422 |
| Foreign currency translation adjustment | (408) | (46,341) | 1,057 |
| Change in unrecognized gains/losses on derivative instruments designated as cash flow hedges: | |||
| Changes in fair value of derivatives (net of tax of $486 in 2023, $2,902 in 2022 and $14,217 in 2021) | 7,948 | (30,331) | 41,817 |
| Adjustment for realized loss reclassified into earnings (net of tax of $3,311 in 2023, $5,054 in 2022 and $189 in 2021) | 9,622 | 34,472 | 7,099 |
| Total change in derivative instruments designated as cash flow hedges, net of tax | 17,570 | 4,141 | 48,916 |
| Changes in accumulated other comprehensive loss — pension plans: | |||
| Change in actuarial (loss)/gain (net of tax of $312 in 2023, $7,756 in 2022 and $637 in 2021) | (7,312) | 30,613 | 12,923 |
| Other comprehensive income (loss) | 9,850 | (11,587) | 62,896 |
| Comprehensive income | $ 3,324,429 | $ 2,736,974 | $ 1,453,318 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Statement of Comprehensive Income [Abstract] | |||
| Changes in fair value of derivatives, net of tax | $ 486 | $ 2,902 | $ 14,217 |
| Adjustment for realized loss reclassified into earnings, net of tax | 3,311 | 5,054 | 189 |
| Change in actuarial (loss)/gain, net of tax | $ 312 | $ 7,756 | $ 637 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands |
Oct. 28, 2023 |
Oct. 29, 2022 |
|---|---|---|
| Current Assets | ||
| Cash and cash equivalents | $ 958,061 | $ 1,470,572 |
| Accounts receivable less allowances of $2,763 ($4,571 in 2022) | 1,469,734 | 1,800,462 |
| Inventories | 1,642,214 | 1,399,914 |
| Prepaid expenses and other current assets | 314,013 | 267,044 |
| Total current assets | 4,384,022 | 4,937,992 |
| Other Assets | ||
| Net property, plant and equipment | 3,219,157 | 2,401,304 |
| Goodwill | 26,913,134 | 26,913,134 |
| Intangible assets, net | 11,311,957 | 13,265,406 |
| Deferred tax assets | 2,223,272 | 2,264,888 |
| Other assets | 742,936 | 519,626 |
| Total non-current assets | 44,410,456 | 45,364,358 |
| TOTAL ASSETS | 48,794,478 | 50,302,350 |
| Current Liabilities | ||
| Accounts payable | 493,041 | 582,160 |
| Income taxes payable | 309,046 | 265,845 |
| Debt, current | 499,052 | 0 |
| Commercial paper notes | 547,224 | 0 |
| Accrued liabilities | 1,352,608 | 1,594,650 |
| Total current liabilities | 3,200,971 | 2,442,655 |
| Non-current Liabilities | ||
| Long-term debt | 5,902,457 | 6,548,625 |
| Deferred income taxes | 3,127,852 | 3,622,538 |
| Income taxes payable | 417,076 | 707,846 |
| Other non-current liabilities | 581,000 | 515,363 |
| Total non-current liabilities | 10,028,385 | 11,394,372 |
| Commitments and contingencies (Note 10) | ||
| Shareholders’ Equity | ||
| Preferred stock, $1.00 par value, 471,934 shares authorized, none outstanding | 0 | 0 |
| Common stock, $0.16 2/3 par value, 1,200,000,000 shares authorized, 496,261,678 shares outstanding (509,295,941 on October 29, 2022) | 82,712 | 84,880 |
| Capital in excess of par value | 25,313,914 | 27,857,270 |
| Retained earnings | 10,356,798 | 8,721,325 |
| Accumulated other comprehensive loss | (188,302) | (198,152) |
| Total shareholders’ equity | 35,565,122 | 36,465,323 |
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $ 48,794,478 | $ 50,302,350 |
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands |
Oct. 28, 2023 |
Oct. 29, 2022 |
|---|---|---|
| Statement of Financial Position [Abstract] | ||
| Accounts receivable, allowances | $ 2,763 | $ 4,571 |
| Preferred stock, par value (in dollars per share) | $ 1.00 | $ 1.00 |
| Preferred stock, shares authorized (in shares) | 471,934 | 471,934 |
| Preferred stock, shares outstanding (in shares) | 0 | 0 |
| Common stock, par value (in dollars per share) | $ 0.16 | $ 0.16 |
| Common stock, shares authorized (in shares) | 1,200,000,000 | 1,200,000,000 |
| Common stock, shares outstanding (in shares) | 496,261,678 | 509,295,941 |
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($) $ in Thousands |
Total |
Common Stock |
Capital in Excess of Par Value |
Retained earnings |
Accumulated Other Comprehensive (Loss) Income |
|---|---|---|---|---|---|
| Beginning balance (in shares) at Oct. 31, 2020 | 369,485,000 | ||||
| Beginning balance at Oct. 31, 2020 | $ 61,582 | $ 4,949,586 | $ 7,236,238 | $ (249,461) | |
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
| Net income | $ 1,390,422 | 1,390,422 | |||
| Dividends declared and paid | (1,109,344) | ||||
| Issuance of stock under stock plans and other (in shares) | 2,738,000 | ||||
| Issuance of stock under stock plans and other | $ 355 | 62,750 | |||
| Issuance of stock in connection with Acquisition (in shares) | 169,233,000 | ||||
| Issuance of stock in connection with Acquisition | $ 28,204 | 27,725,957 | |||
| Stock-based compensation expense | 243,611 | ||||
| Replacement share-based awards issued in connection with Acquisition | 194,890 | ||||
| Other comprehensive income (loss) | 62,896 | ||||
| Common stock repurchased (in shares) | (16,125,000) | ||||
| Common stock repurchased | $ (2,587) | (2,602,557) | |||
| Ending balance (in shares) at Oct. 30, 2021 | 525,331,000 | ||||
| Ending balance at Oct. 30, 2021 | $ 87,554 | 30,574,237 | 7,517,316 | (186,565) | |
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
| Net income | $ 2,748,561 | 2,748,561 | |||
| Dividends declared and paid | (1,544,552) | ||||
| Issuance of stock under stock plans and other (in shares) | 2,701,000 | ||||
| Issuance of stock under stock plans and other | $ 449 | 33,438 | |||
| Stock-based compensation expense | 323,487 | ||||
| Other comprehensive income (loss) | (11,587) | ||||
| Common stock repurchased (in shares) | (18,736,000) | ||||
| Common stock repurchased | $ (3,123) | (3,073,892) | |||
| Ending balance (in shares) at Oct. 29, 2022 | 509,295,941 | 509,296,000 | |||
| Ending balance at Oct. 29, 2022 | $ 36,465,323 | $ 84,880 | 27,857,270 | 8,721,325 | (198,152) |
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||
| Net income | $ 3,314,579 | 3,314,579 | |||
| Dividends declared and paid | (1,679,106) | ||||
| Issuance of stock under stock plans and other (in shares) | 3,440,000 | ||||
| Issuance of stock under stock plans and other | $ 574 | 118,034 | |||
| Stock-based compensation expense | 299,823 | ||||
| Other comprehensive income (loss) | 9,850 | ||||
| Common stock repurchased (in shares) | (16,474,000) | ||||
| Common stock repurchased | $ (2,742) | (2,961,213) | |||
| Ending balance (in shares) at Oct. 28, 2023 | 496,261,678 | 496,262,000 | |||
| Ending balance at Oct. 28, 2023 | $ 35,565,122 | $ 82,712 | $ 25,313,914 | $ 10,356,798 | $ (188,302) |
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (Parenthetical) - $ / shares |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Statement of Stockholders' Equity [Abstract] | |||
| Dividends (in dollars per share) | $ 3.34 | $ 2.97 | $ 2.69 |
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Cash flows from operating activities: | |||
| Net income | $ 3,314,579 | $ 2,748,561 | $ 1,390,422 |
| Adjustments to reconcile net income to net cash provided by operations: | |||
| Depreciation | 334,704 | 283,338 | 231,275 |
| Amortization of intangibles | 1,958,399 | 2,014,161 | 843,359 |
| Cost of goods sold for inventory acquired | 0 | 271,396 | 331,083 |
| Stock-based compensation expense | 299,823 | 323,487 | 243,611 |
| Loss on extinguishment of debt | 0 | 0 | 215,150 |
| Non-cash impairment charge | 0 | 91,953 | 0 |
| Deferred income taxes | (452,946) | (326,755) | (406,922) |
| Other | 8,665 | (47,074) | (4,854) |
| Change in operating assets and liabilities: | |||
| Accounts receivable | 330,728 | (343,908) | (114,504) |
| Inventories | (242,299) | (470,725) | (65,114) |
| Prepaid expenses and other current assets | 4,543 | (64,584) | (59,117) |
| Accounts payable and accrued liabilities | (499,316) | 171,772 | 208,444 |
| Income taxes payable, current | (263,716) | (91,852) | (6,797) |
| Other assets | (25,819) | 397 | (39,329) |
| Other liabilities | 50,289 | (84,765) | (31,638) |
| Total adjustments | 1,503,055 | 1,726,841 | 1,344,647 |
| Net cash provided by operating activities | 4,817,634 | 4,475,402 | 2,735,069 |
| Cash flows from investing activities: | |||
| Additions to property, plant and equipment, net | (1,261,463) | (699,308) | (343,676) |
| Cash received from acquisition of Maxim, net of cash paid | 0 | 0 | 2,450,550 |
| Other | (4,922) | 41,940 | 36,651 |
| Net cash (used for) provided by investing activities | (1,266,385) | (657,368) | 2,143,525 |
| Cash flows from financing activities: | |||
| Proceeds from debt | 0 | 296,130 | 3,939,640 |
| Early termination of debt | (65,688) | (519,116) | (3,591,982) |
| Payments on revolver | 0 | (400,000) | (400,000) |
| Proceeds from revolver | 0 | 400,000 | 400,000 |
| Proceeds from commercial paper notes | 5,287,124 | 0 | 0 |
| Payments of commercial paper notes | (4,739,900) | 0 | 0 |
| Payment on derivative instrument | 0 | 0 | (153,161) |
| Prepayment for stock repurchases | 0 | 0 | (500,000) |
| Dividend payments to shareholders | (1,679,106) | (1,544,552) | (1,109,344) |
| Repurchase of common stock | (2,963,955) | (2,577,015) | (2,605,144) |
| Proceeds from employee stock plans | 118,608 | 33,887 | 63,105 |
| Other | (20,843) | 19,946 | (2,778) |
| Net cash used for financing activities | (4,063,760) | (4,290,720) | (3,959,664) |
| Effect of exchange rate changes on cash | 0 | (34,706) | 3,174 |
| Net (decrease) increase in cash and cash equivalents | (512,511) | (507,392) | 922,104 |
| Cash and cash equivalents at beginning of year | 1,470,572 | 1,977,964 | 1,055,860 |
| Cash and cash equivalents at end of year | $ 958,061 | $ 1,470,572 | $ 1,977,964 |
Description of Business |
12 Months Ended |
|---|---|
Oct. 28, 2023 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| Description of Business | Description of BusinessAnalog Devices, Inc. (Analog Devices or the Company) is a global semiconductor leader dedicated to solving its customers' most complex engineering challenges. Since its inception in 1965, the Company has played a critical role at the intersection of the physical and digital worlds by providing the building blocks to sense, measure, interpret, connect and power. The Company designs, manufactures, tests and markets a broad portfolio of solutions, including integrated circuits (ICs), software and subsystems that leverage high-performance analog, mixed-signal and digital signal processing technologies. The Company's comprehensive product portfolio, deep domain expertise and advanced manufacturing capabilities extend across high-performance precision and high-speed mixed-signal, power management and processing technologies – including data converters, amplifiers, power management, radio frequency ICs, edge processors and other sensors. The Company's focus is largely on the business-to-business end markets of Industrial, Automotive and Communications and related applications, as well as Consumer applications, with the goal of driving sustainable and profitable growth over the long term. |
Summary of Significant Accounting Policies |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary of Significant Accounting Policies | Summary of Significant Accounting Policies a.Principles of Consolidation The Consolidated Financial Statements include the accounts of the Company and all of its subsidiaries. Upon consolidation, all intercompany accounts and transactions are eliminated. Certain amounts reported in previous years have been reclassified to conform to the presentation for the fiscal year ended October 28, 2023 (fiscal 2023). Such reclassified amounts are immaterial. The Company’s fiscal year is the 52-week or 53-week period ending on the Saturday closest to the last day in October. Fiscal 2023, the fiscal year ended October 29, 2022 (fiscal 2022) and the fiscal year ended October 30, 2021 (fiscal 2021) were 52-week fiscal periods. On August 26, 2021 (Acquisition Date), the Company completed the acquisition of Maxim Integrated Products, Inc. (Maxim), an independent manufacturer of innovative analog and mixed-signal products and technologies. Pursuant to the Agreement and Plan of Merger, dated as of July 12, 2020 (the Merger Agreement), Maxim stockholders received, for each outstanding share of Maxim common stock, 0.6300 of a share of the Company’s common stock as of the Acquisition Date for total consideration of approximately $28.0 billion of the Company's common stock. The acquisition of Maxim is referred to as the Acquisition. The consolidated financial statements included in this Annual Report on Form 10-K include the financial results of Maxim prospectively from the Acquisition Date. See Note 6, Acquisitions, of the Notes to Consolidated Financial Statements for additional information. b.Cash and Cash Equivalents Cash and cash equivalents are highly liquid investments with insignificant interest rate risk and maturities of ninety days or less at the time of acquisition. Cash and cash equivalents consist primarily of government and institutional money market funds, corporate obligations such as commercial paper and floating rate notes, bonds, demand deposit accounts, money market deposit accounts, and bank time deposits. The Company classifies its investments in readily marketable debt and equity securities as “held-to-maturity,” “available-for-sale” or “trading” at the time of purchase. There were no transfers between investment classifications in any of the fiscal years presented. Held-to-maturity securities, which are carried at amortized cost, include only those securities the Company has the positive intent and ability to hold to maturity. Securities such as bank time deposits, which by their nature are typically held to maturity, are classified as such. The Company’s other readily marketable cash equivalents are classified as available-for-sale. Available-for-sale securities are carried at fair value with any material unrealized gains and losses, net of related tax, reported in accumulated other comprehensive (loss) income (AOCI). Adjustments to the fair value of investments classified as available-for-sale are recorded as an increase or decrease in AOCI, unless the adjustment is considered an other-than-temporary impairment, in which case the adjustment is recorded as a charge in the Consolidated Statements of Income. The Company reviews available-for-sale securities for impairment whenever the fair value of the security is less than its amortized cost. There were no impairments of investments in any of the fiscal years presented. Realized gains or losses on investments are determined based on the specific identification basis and are recognized in nonoperating (income) expense. There were no material net realized gains or losses from the sales of available-for-sale investments during any of the fiscal periods presented. The components of the Company’s cash and cash equivalents as of October 28, 2023 and October 29, 2022 were as follows:
See Note 2j, Fair Value, of the Notes to Consolidated Financial Statements for additional information on the Company’s cash equivalents. c.Supplemental Cash Flow Statement Information
d.Inventories Inventories are valued at the lower of cost (first-in, first-out method) or net realizable value. The valuation of inventory requires the Company to estimate obsolete or excess inventory as well as inventory that is not of saleable quality. The Company employs a variety of methodologies to determine the net realizable value of its inventory. While a portion of the calculation to record inventory at its net realizable value is based on the age of the inventory and lower of cost or net realizable value calculations, a key factor in estimating obsolete or excess inventory requires the Company to estimate the future demand for its products. If actual demand is less than the Company’s estimates, impairment charges, which are recorded to cost of sales, may need to be recorded in future periods. Inventory in excess of saleable amounts is not valued, and the remaining inventory is valued at the lower of cost or net realizable value. Inventories at October 28, 2023 and October 29, 2022 were as follows:
e.Property, Plant and Equipment The following table presents details of the Company's property, plant and equipment (PP&E), net of accumulated depreciation:
_________________________________ (1) Certain amounts previously reported between machinery and equipment and office equipment have been reclassified to conform to the presentation for fiscal 2023. PP&E is recorded at cost, less allowances for depreciation and amortization. The straight-line method of depreciation is used for all classes of assets for financial statement purposes while both straight-line and accelerated methods are used for income tax purposes. Leasehold improvements are depreciated over the lesser of the term of the lease or the useful life of the asset. Repairs and maintenance charges are expensed as incurred. Depreciation is based on the following ranges of estimated useful lives:
The Company reviews PP&E for impairment whenever events or changes in circumstances indicate that the carrying amount of assets may not be recoverable. Recoverability of these assets is determined by comparison of their carrying amount to the future undiscounted cash flows the assets are expected to generate over their remaining economic lives. If such assets are considered to be impaired, the impairment to be recognized in earnings equals the amount by which the carrying value of the assets exceeds their fair value determined by either a quoted market price, if any, or a value determined by utilizing a discounted cash flow technique. If such assets are not impaired, but their useful lives have decreased, the remaining net book value is depreciated over the revised useful life. PP&E is identified as held for sale when it meets the held for sale criteria of Accounting Standards Codification Topic 360, Property, Plant, and Equipment (ASC 360). Depreciation is not recorded for assets that are classified as held for sale. When an asset meets the held for sale criteria, the lower of its carrying value or fair value less costs to sell is reclassified from the relevant PP&E line items and into current assets on the balance sheet, where it remains until it is either sold or it no longer meets the held for sale criteria. If the assets held for sale were carried at fair value, it would be considered a Level 3 fair value measurement, and determined based on the use of appraisals and input from market participants. During fiscal 2023, the Company ceased usage of its campus facility located in Milpitas, California and determined that the facility met the held for sale criteria specified in Accounting Standards Codification (ASC) 360. No write-downs to fair value were required upon this determination as the fair value of the asset group, less costs to sell, was greater than the carrying value. As of October 28, 2023, prepaid expenses and other current assets includes the following assets held for sale:
f.Goodwill and Intangible Assets Goodwill The Company evaluates goodwill for impairment annually, as well as whenever events or changes in circumstances suggest that the carrying value of goodwill may not be recoverable, utilizing either the qualitative or quantitative method. The Company tests goodwill for impairment at the reporting unit level, which the Company has determined is consistent with its identified operating segments, on an annual basis on the first day of the fourth quarter (on or about July 30) or more frequently if indicators of impairment exist or the Company reorganizes its operating segments or reporting units. The Company has the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its net book value. When using the qualitative method, the Company considers several factors, including the following: –the amount by which the fair values of each reporting unit exceeded their carrying values as of the date of the most recent quantitative impairment analysis, which indicated there would need to be substantial negative developments in the markets in which these reporting units operate in order for there to be potential impairment; –the carrying values of these reporting units as of the assessment date compared to the previously calculated fair values as of the date of the most recent quantitative impairment analysis; –the Company's current forecasts as compared to the forecasts included in the most recent quantitative impairment analysis; –public information from competitors and other industry information to determine if there were any significant adverse trends in the Company's competitors' businesses; –changes in the value of major U.S. stock indices that could suggest declines in overall market stability that could impact the valuation of the Company's reporting units; –changes in the Company's market capitalization and overall enterprise valuation to determine if there were any significant decreases that could be an indication that the valuation of its reporting units had significantly decreased; and –whether there had been any significant increases to the weighted-average cost of capital rates for each reporting unit, which could materially lower the Company's prior valuation conclusions under a discounted cash flow approach. If the Company elects not to use this option, or it determines that it is more likely than not that the fair value of a reporting unit is less than its net book value, then the Company performs the quantitative goodwill impairment test. The quantitative goodwill impairment test requires an entity to compare the fair value of a reporting unit with its carrying amount. If fair value is determined to be less than carrying value, an impairment loss is recognized for the amount of the carrying value that exceeds the amount of the reporting unit's fair value, not to exceed the total amount of goodwill allocated to the reporting unit. Additionally, the Company considers income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. Management determines the fair values of the reporting units using a weighting of the income and market approaches. Under the income approach, it uses a discounted cash flow methodology, which requires management to make significant estimates and assumptions related to forecasted revenues, gross profit margins, operating income margins, working capital cash flow, perpetual growth rates and long-term discount rates, among others. For the market approach, it uses the guideline public company method. Under this method management utilizes information from comparable publicly traded companies with similar operating and investment characteristics as the reporting units, to create valuation multiples that are applied to the operating performance of the reporting unit being tested, in order to obtain its respective fair value. In order to assess the reasonableness of the calculated values, the aggregate fair values of the reporting units are reconciled to the Company's total market capitalization, allowing for a reasonable control premium. In fiscal 2023, the Company used the qualitative method of assessing goodwill for the Company's reporting units. In fiscal 2022, the Company used a combination of the qualitative and quantitative methods of assessing goodwill for the Company's reporting units. In all periods presented, management concluded the reporting units' fair values exceeded their carrying amounts as of the assessment dates and no risk of impairment existed. The Company’s next annual impairment assessment will be performed as of the first day of the fourth quarter of the fiscal year ending November 2, 2024 (fiscal 2024) unless indicators arise that would require the Company to reevaluate at an earlier date. The following table presents the changes in goodwill during fiscal 2023 and fiscal 2022:
_______________________ (1) See Note 6, Acquisitions, of the Notes to Consolidated Financial Statements for additional information. Intangible Assets The Company reviews finite-lived intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of assets may not be recoverable. If required, recoverability of these assets is determined by comparison of their carrying value to the estimated future undiscounted cash flows the assets are expected to generate over their remaining estimated useful lives. If such assets are considered to be impaired, the impairment to be recognized in earnings equals the amount by which the carrying value of the assets exceeds their estimated fair value determined by either a quoted market price, if any, or a value determined by utilizing a discounted cash flow technique. In-process research and development (IPR&D) assets are considered indefinite-lived intangible assets until completion or abandonment of the associated research and development (R&D) efforts. Upon completion of the projects, the IPR&D assets are reclassified to technology-based intangible assets and amortized over their estimated useful lives. As of October 28, 2023 and October 29, 2022, the Company’s intangible assets consisted of the following:
_______________________________________ (1) In fiscal 2022 foreign intangible asset carrying amounts were affected by foreign currency translation. Amortization expense related to intangible assets was $2.0 billion, $2.0 billion and $843.4 million in fiscal 2023, 2022 and 2021, respectively, and is recorded in cost of sales and amortization of intangibles on the Consolidated Statements of Income. The remaining amortization expense will be recognized over the remaining weighted average life of approximately 4.2 years. The Company expects annual amortization expense for intangible assets as follows:
g.Grant Accounting Certain of the Company’s subsidiaries have received grants from governmental agencies. These grants include capital, employment and research and development grants. Capital grants for the acquisition of property, plant and equipment are netted against the related capital expenditures and amortized as a credit to depreciation expense over the estimated useful life of the related asset. Employment grants, which relate to employee hiring and training, and research and development grants are recognized in earnings in the period in which the related expenditures are incurred by the Company. In August 2022, the U.S. government enacted the CHIPS and Science Act of 2022 (CHIPS Act), which provides funding for manufacturing grants and research investments and establishes a 25% investment tax credit for certain investments in U.S. semiconductor manufacturing. As of October 28, 2023 and October 29, 2022, the Company recognized $174.3 million and $16.6 million, respectively, in other assets with a corresponding reduction to the carrying amounts of the qualifying manufacturing assets on the Consolidated Balance Sheets. h.Translation of Foreign Currencies Generally, the functional currency of the Company’s foreign operations is the U.S. dollar. In certain entities where that is not the case, gains and losses resulting from translation of the foreign currencies into U.S. dollars are recorded in AOCI. Transaction gains and losses and re-measurement of foreign currency denominated assets and liabilities are included in income currently, including those at the Company’s principal foreign manufacturing operations where the functional currency is the U.S. dollar. Foreign currency transaction gains or losses are included in other, net in the Consolidated Statements of Income. i.Derivative Instruments and Hedging Agreements Foreign Exchange Exposure Management — The Company enters into forward foreign currency exchange contracts to offset certain operational and balance sheet exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company’s operations, assets and liabilities that are denominated in currencies other than the U.S. dollar, primarily the Euro; other significant exposures include the British Pound, Philippine Peso, Thai Baht, Malaysian Ringgit and the Japanese Yen. Derivative instruments are employed to eliminate or minimize certain foreign currency exposures that can be confidently identified and quantified. These foreign currency exchange contracts are entered into to support transactions made in the normal course of business, and accordingly, are not speculative in nature. The contracts are for periods consistent with the terms of the underlying transactions, generally one year or less. Hedges related to anticipated transactions are matched with the underlying exposures at inception and designated and documented as cash flow hedges. They are qualitatively evaluated for effectiveness on a quarterly basis. The gain or loss on the derivatives are reported as a component of AOCI in shareholders’ equity and reclassified into earnings in the same line item on the Consolidated Statements of Income as the impact of the hedged transaction in the same period during which the hedged transaction affects earnings. The total notional amounts of forward foreign currency derivative instruments designated as hedging instruments of cash flow hedges as of October 28, 2023 and October 29, 2022 was $322.6 million and $307.1 million, respectively. The fair values of forward foreign currency derivative instruments designated as hedging instruments in the Company’s Consolidated Balance Sheets as of October 28, 2023 and October 29, 2022 were as follows:
Additionally, the Company enters into forward foreign currency contracts that economically hedge the gains and losses generated by the re-measurement of certain recorded assets and liabilities in a non-functional currency. Changes in the fair value of these undesignated hedges are recognized in other (income) expense immediately as an offset to the changes in the fair value of the asset or liability being hedged. As of October 28, 2023 and October 29, 2022, the total notional amounts of undesignated hedges related to forward foreign currency exchange contracts were $334.7 million and $246.4 million, respectively. All of the Company’s derivative financial instruments are eligible for netting arrangements that allow the Company and its counterparties to net settle amounts owed to each other. As of October 28, 2023 and October 29, 2022, none of the netting arrangements involved collateral. As of October 28, 2023, none of the Company's forward foreign currency exchange contracts were netted in the Consolidated Balance Sheet. The following table presents the gross amounts of the Company's forward foreign currency exchange contracts and the net amounts recorded in the Company's Consolidated Balance Sheet as of October 29, 2022:
Interest Rate Exposure Management — The Company's current and future debt may be subject to interest rate risk. The Company utilizes interest rate derivatives to alter interest rate exposure in an attempt to reduce the effects of changes in interest rates. During fiscal 2019, the Company entered into an interest rate swap agreement which locked in the interest rate for up to $1 billion in future debt issuances. The interest rate swap was designated and qualified as a cash flow hedge. During fiscal 2021, the Company issued $1 billion of 2.100% Senior Notes due October 2031, and the swap was cash terminated in the amount of $153.2 million. During fiscal 2023, the Company entered into interest rate swap transactions related to its outstanding $1,000.0 million aggregate principal amount of 2.1% senior unsecured notes (the 2031 Notes) where the Company swapped the notional amount of its $1,000.0 million of fixed rate debt at 2.1% into floating interest rate debt through April 1, 2031. The fair value of the swaps at inception was zero and subsequent changes in the fair value of the interest rate swaps were reflected in the carrying value of the interest rate swaps on the balance sheet. The carrying value of the debt on the balance sheet was adjusted by an equal and offsetting amount. The interest rate swaps were designated and qualified as fair value hedges. The Company does not consider the risk of counterparty default to be significant. The gain or loss on the hedged item attributable to the hedged benchmark interest rate risk and the offsetting gain or loss on the related interest rate swaps were recorded as follows:
The market risk associated with the Company’s derivative instruments results from currency exchange rate or interest rate movements that are expected to offset the market risk of the underlying transactions, assets and liabilities being hedged. The counterparties to the agreements relating to the Company’s derivative instruments consist of a number of major international financial institutions with high credit ratings. Based on the credit ratings of the Company’s counterparties as of October 28, 2023 and October 29, 2022, nonperformance is not perceived to be a material risk. Furthermore, none of the Company’s derivatives are subject to collateral or other security arrangements and none contain provisions that are dependent on the Company’s credit ratings from any credit rating agency. While the contract or notional amounts of derivative financial instruments provide one measure of the volume of these transactions, they do not represent the amount of the Company’s exposure to credit risk. The amounts potentially subject to credit risk (arising from the possible inability of counterparties to meet the terms of their contracts) are generally limited to the amounts, if any, by which the counterparties’ obligations under the contracts exceed the obligations of the Company to the counterparties. As a result of the above considerations, the Company does not consider the risk of counterparty default to be significant. The Company records the fair value of its derivative financial instruments in its Consolidated Financial Statements in other current assets, other assets, accrued liabilities, other non-current liabilities and long-term debt, depending on their net position, regardless of the purpose or intent for holding the derivative contract. Changes in the fair value of cash flow hedges are recorded in AOCI and reclassified into earnings in the same line item on the Consolidated Statements of Income as the impact of the hedged transaction when the underlying contract matures. Changes in the fair value of designated fair value hedges are recorded on the Consolidated Balance Sheet as a swap asset or an accrued liability with an offsetting increment/decrement to the long-term debt balance, which is the underlying item being hedged. Changes in the fair values of derivatives not qualifying for hedge accounting are reported in earnings as they occur. For information on the unrealized holding gains (losses) on derivatives included in and reclassified out of AOCI into the Consolidated Statements of Income related to forward foreign currency exchange contracts, see Note 2o, Accumulated Other Comprehensive (Loss) Income, of the Notes to Consolidated Financial Statements. j.Fair Value The Company defines fair value as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Level 1 — Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 — Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified (contractual) term, a Level 2 input must be observable for substantially the full term of the asset or liability. Level 3 — Level 3 inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date. The tables below, set forth by level, presents the Company’s financial assets and liabilities, excluding accrued interest components, that were accounted for at fair value on a recurring basis as of October 28, 2023 and October 29, 2022. The tables exclude cash on hand and assets and liabilities that are measured at historical cost or any basis other than fair value. As of October 28, 2023 and October 29, 2022, the Company held $642.1 million and $1,016.0 million, respectively, of cash that was excluded from the tables below.
(1) The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 2i, Derivative Instruments and Hedging Agreements, of the Notes to Consolidated Financial Statements for more information related to the Company's master netting arrangements. (2) The carrying value of the related debt was adjusted by an equal and offsetting amount. See Note 2i, Derivative Instruments and Hedging Agreements, of the Notes to Consolidated Financial Statements.
(1) The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 2i, Derivative Instruments and Hedging Agreements, of the Notes to Consolidated Financial Statements for more information related to the Company's master netting arrangements. The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments: Cash equivalents — These investments are adjusted to fair value based on quoted market prices or are determined using a yield curve model based on current market rates. Deferred compensation plan investments — The fair value of these mutual fund, money market fund and equity investments are based on quoted market prices. Forward foreign currency exchange contracts — The estimated fair value of forward foreign currency exchange contracts, which includes derivatives that are accounted for as cash flow hedges and those that are not designated as cash flow hedges, is based on the estimated amount the Company would receive if it sold these agreements at the reporting date taking into consideration current exchange rates as well as the creditworthiness of the counterparty for assets and the Company’s creditworthiness for liabilities. The fair value of these instruments is based upon valuation models using current market information such as strike price, spot rate, forward points, and maturity date. Interest rate derivative — The fair value of interest rate derivatives is estimated using a discounted cash flow analysis based on the contractual terms of the derivatives. Financial Instruments Not Recorded at Fair Value on a Recurring Basis Santa Clara, California leased property asset group — As a result of a sublease transaction involving a leased property in Santa Clara, California during fiscal 2022, the Company estimated the fair value of the sublease assets using discounted cash flows from the estimated net sublease rental income discounted at a market rate and recorded an impairment charge which represented the excess carrying value of the asset group associated with the Santa Clara, California leased property over its estimated fair value. These assets are considered a Level 2 fair value measurement. See Note 5, Special Charges, Net, of the Notes to Consolidated Financial Statements for additional information. Held for sale assets — The Company has classified the assets held for sale at carrying value. However, if they were to be carried at fair value, they would be considered a Level 3 fair value measurement and would be determined based on the use of appraisals and input from market participants. Commercial paper notes — The fair values of commercial paper notes are obtained from indicative market prices and are classified as Level 2 measurements according to the fair value hierarchy. As of October 28, 2023, the fair value of the commercial paper notes was $547.2 million. Debt — The table below presents the estimated fair value of certain financial instruments not recorded at fair value on a recurring basis. As commercial paper issuances are at then current rates and with very short maturities, the carrying value will approximate fair value. The fair values of the senior unsecured notes are obtained from broker prices and are classified as Level 1 measurements according to the fair value hierarchy. See Note 14, Debt, of the Notes to Consolidated Financial Statements for further discussion related to outstanding debt.
k.Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates relate to the useful lives of fixed assets and identified intangible assets; allowances for doubtful accounts and customer returns; the net realizable value of inventory; potential reserves relating to litigation matters; accrued liabilities, including estimates of variable consideration related to distributor sales; accrued taxes; uncertain tax positions; deferred tax valuation allowances; assumptions pertaining to stock-based compensation payments and defined benefit plans; and fair value of acquired assets and liabilities, including inventory, property, plant and equipment, goodwill and acquired intangibles; and other reserves. Actual results could differ from those estimates and such differences may be material to the financial statements. l.Concentrations of Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of investments and trade accounts receivable. The Company maintains cash and cash equivalents with high credit quality counterparties, continuously monitors the amount of credit exposure to any one issuer and diversifies its investments in order to minimize its credit risk. The Company sells its products to distributors and original equipment manufacturers (OEMs) involved in a variety of industries including industrial, communications, automotive and consumer end markets. The Company has adopted credit policies and standards to accommodate growth in these markets. The Company performs continuing credit evaluations of its customers’ financial condition and although the Company generally does not require collateral, the Company may require letters of credit from customers in certain circumstances. The Company provides reserves for estimated amounts of accounts receivable that may not be collected. The Company's largest customer, which is a distributor rather than an end customer, accounted for approximately 25%, 22%, and 26% of net revenues in fiscal 2023, fiscal 2022 and fiscal 2021, respectively. The Company's next largest customer, which is also a distributor, accounted for approximately 10%, 10% and 11% of net revenues in fiscal 2023, fiscal 2022 and fiscal 2021, respectively. No other customer accounted for greater than 10% of revenue in any period presented. m.Concentration of Other Risks The semiconductor industry is characterized by rapid technological change, competitive pricing pressures and cyclical market patterns. The Company’s financial results are affected by a wide variety of factors, including general economic conditions worldwide, economic conditions specific to the semiconductor industry, the timely implementation of new manufacturing technologies, the ability to safeguard patents and intellectual property in a rapidly evolving market and reliance on assembly and test subcontractors, third-party wafer fabricators and independent distributors. In addition, the semiconductor market has historically been cyclical and subject to significant economic downturns at various times. The Company is exposed to the risk of obsolescence of its inventory depending on the mix of future business. Additionally, more than half of the Company’s purchases of external wafer and foundry services are from a limited number of suppliers, such as Taiwan Semiconductor Manufacturing Company (TSMC) and others. If these suppliers or any of the Company’s other key suppliers are unable or unwilling to manufacture and deliver sufficient quantities of components, on the time schedule and of the quality that the Company requires, the Company may be forced to engage additional or replacement suppliers, which could result in significant expenses and disruptions or delays in manufacturing, product development and shipment of product to the Company’s customers. n.Revenue Recognition Recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the providing entity expects to be entitled in exchange for those goods or services. The Company recognizes revenue upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. The Company recognizes revenue when all of the following criteria are met: (1) the Company has entered into a binding agreement, (2) the performance obligations have been identified, (3) the transaction price to the customer has been determined, (4) the transaction price has been allocated to the performance obligations in the contract, and (5) the performance obligations have been satisfied. The majority of the Company's shipping terms permit the Company to recognize revenue at point of shipment or delivery. Certain shipping terms require the goods to be through customs or be received by the customer before title passes. In those instances, the Company defers the revenue recognized until title and control of the promised goods have passed to the customer. Shipping costs are charged to selling, marketing, general and administrative expense as incurred. Sales taxes are excluded from revenue. Revenue from contracts with the United States government, government prime contractors and certain commercial customers is recorded over time using either units delivered or costs incurred as the measurement basis for progress toward completion. These measures are used to measure results directly and is generally the best measure of progress toward completion in circumstances in which a reliable measure of output can be established. Estimated revenue in excess of amounts billed is reported as unbilled receivables. Contract accounting requires judgment in estimating costs and assumptions related to technical issues and delivery schedule. Contract costs include material, subcontract costs, labor and an allocation of indirect costs. The estimation of costs at completion of a contract is subject to numerous variables involving contract costs and estimates as to the length of time to complete the contract. Changes in contract performance, estimated gross margin, including the impact of final contract settlements, and estimated losses are recognized in the period in which the changes or losses are determined. Performance Obligations: Substantially all of the Company’s contracts with customers contain a single performance obligation, the sale of mixed-signal integrated circuit products. Such sales represent a single performance obligation because the sale is one type of good or includes multiple goods that are neither capable of being distinct nor separable from the other promises in the contract. This performance obligation is satisfied when control of the product is transferred to the customer, which occurs upon shipment or delivery. Unsatisfied performance obligations primarily represent contracts for products with future delivery dates and with an original expected duration of one year or less. The Company generally offers a twelve-month warranty for its products. The Company’s warranty policy provides for replacement of defective products. Specific accruals are recorded for known product warranty issues. Product warranty expenses during fiscal 2023, fiscal 2022 and fiscal 2021 were not material. Transaction Price: The transaction price reflects the Company’s expectations about the consideration it will be entitled to receive from the customer and may include fixed or variable amounts. Fixed consideration primarily includes sales to direct customers and sales to distributors in which both the sale to the distributor and the sale to the end customer occur within the same reporting period. Variable consideration includes sales in which the amount of consideration that the Company will receive is unknown as of the end of a reporting period. The vast majority of such consideration are credits issued to the distributor due to price protection, but also include sales made to distributors under agreements that allow certain rights of return, referred to as stock rotation. Price protection represents price discounts granted to certain distributors to allow the distributor to earn an appropriate margin on sales negotiated with certain customers and in the event of a price decrease subsequent to the date the product was shipped and billed to the distributor. Stock rotation allows distributors limited levels of returns in order to reduce the amounts of slow-moving, discontinued or obsolete product from their inventory. A liability for distributor credits covering variable consideration is made based on the Company's estimate of historical experience rates as well as considering economic conditions and contractual terms. To date, actual distributor claims activity has been materially consistent with the provisions the Company has made based on its historical estimates. For fiscal 2023 and fiscal 2022, sales to distributors were approximately $7.5 billion and $7.5 billion, respectively, net of variable consideration for which the liability balances as of October 28, 2023 and October 29, 2022 were $525.4 million and $749.4 million, respectively, and were recorded in accrued liabilities on the Consolidated Balance Sheets. Contract Balances: Accounts receivable represents the Company’s unconditional right to receive consideration from its customers. Payments are typically due within 30 to 45 days of invoicing and do not include a significant financing component. To date, there have been no material credit losses on accounts receivable. There were no material contract assets or contract liabilities recorded on the Consolidated Balance Sheets in any of the periods presented. o.Accumulated Other Comprehensive (Loss) Income AOCI includes certain transactions that have generally been reported in the Consolidated Statement of Shareholders’ Equity. The changes in components of AOCI at October 28, 2023 and October 29, 2022 consisted of the following:
The amounts reclassified out of AOCI into the Consolidated Statements of Income, with presentation location during each period were as follows:
_______________________________________ (1)The amortization of pension components is included in the computation of net periodic benefit cost. See Note 11, Retirement Plans, of the Notes to Consolidated Financial Statements for further information. p.Income Taxes The Company makes certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of income tax credits, benefits, and deductions, and in the calculation of certain tax assets and liabilities, which arise from differences in the timing of the recognition of certain expenses for tax and financial statement purposes. The likelihood of the realization of deferred tax assets is assessed and a corresponding valuation allowance is recorded as necessary if management determines those deferred tax assets may not be realized due to the uncertainty of the timing and amount to be realized of certain state and international tax credit carryovers. In reaching this conclusion, the Company evaluates certain relevant criteria including the existence of deferred tax liabilities that can be used to realize deferred tax assets, the taxable income in prior carryback years in the impacted state and international jurisdictions that can be used to absorb net operating losses and taxable income in future years. Judgments regarding future profitability may change due to future market conditions, changes in U.S. or international tax laws and other factors. These changes, if any, may require material adjustments to these deferred tax assets, which may result in an increase or decrease to the income tax provision in future periods. The Company accounts for uncertain tax positions by first determining if it is “more likely than not” that a tax position will be sustained by the appropriate taxing authorities prior to recording any benefit in the Consolidated Financial Statements. An uncertain income tax position is not recognized if it has less than a 50% likelihood of being sustained. For those tax positions where it is more likely than not that a tax position will be sustained, the Company has recorded the largest amount of tax benefit with a greater than 50% likelihood of being realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where it is not more likely than not that a tax benefit will be sustained, no tax benefit has been recognized in the financial statements. Management classifies interest and penalties related to uncertain tax positions within the provision for (benefit from) income taxes line of the Consolidated Statements of Income. Management reevaluates these uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, changes in known facts or circumstances, changes in tax law, effectively settled issues under audit, and new guidance on legislative interpretations. A change in these factors could result in the recognition of an increase or decrease to the Company's income tax provision which could materially impact its consolidated financial position and results of operations. In the ordinary course of global business, there are many transactions and calculations where the ultimate tax outcome is uncertain. Some of these uncertainties arise as a consequence of cost reimbursement and royalty arrangements among related entities. Although the Company believes its estimates are reasonable, no assurance can be given that the final tax outcome of these matters will not be different than that which is reflected in the historical income tax provisions and income tax liabilities. In the event management's assumptions are incorrect, the differences could have a material impact on its income tax provision and operating results in the period in which such determination is made. In addition to the factors described above, the current and expected effective tax rate is based on then-current tax law. Significant changes in enacted tax law could affect these estimates. See Note 12, Income Taxes, of the Notes to Consolidated Financial Statements for further information related to income taxes. q.Earnings Per Share of Common Stock Basic earnings per share is computed based only on the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares outstanding during the period, plus the dilutive effect of potential future issuances of common stock relating to stock option programs and other potentially dilutive securities using the treasury stock method. In calculating diluted earnings per share, the dilutive effect of stock options and restricted stock units is computed using the average market price for the respective period. In addition, the assumed proceeds under the treasury stock method include the average unrecognized compensation expense of stock options that are in-the-money and restricted stock units. This results in the “assumed” buyback of additional shares, thereby reducing the dilutive impact of in-the-money stock options. Potential shares related to certain of the Company’s outstanding stock options and restricted stock units were excluded because they were anti-dilutive. Those potential shares, determined based on the weighted average exercise prices during the respective periods, could be dilutive in the future. In connection with the acquisition of Linear Technology Corporate (Linear), the Company granted restricted stock awards to replace outstanding restricted stock awards of Linear employees. These restricted stock awards entitle recipients to voting and nonforfeitable dividend rights from the date of grant. These unvested stock-based compensation awards are considered participating securities and the two-class method is used for purposes of calculating earnings per share. Under the two-class method, a portion of net income is allocated to these participating securities and therefore is excluded from the calculation of earnings per share allocated to common stock. The difference between the income allocated to participating securities under the basic and diluted two-class methods is not material. The following table sets forth the computation of basic and diluted earnings per share:
_______________________________________ (1)For all fiscal years presented, income allocated to participating securities, if any, is not material. r.Stock-Based Compensation Stock-based compensation is measured at the grant date based on the grant-date fair value of the awards ultimately expected to vest and is recognized as an expense on a straight-line basis over the vesting period, which is generally four years for stock options and restricted stock units, or in annual installments of 25% on each of the first, second, third and fourth anniversaries of the date of grant. Restricted stock units with service and performance or market conditions generally vest in one installment on the third anniversary of the date of grant. For grants issued prior to fiscal 2018, the vesting period was generally five years for stock options, or in annual installments of 20% on each of the first, second, third, fourth and fifth anniversaries of the date of grant and in one installment on the third anniversary of the date of grant for restricted stock units/awards. The maximum contractual term of all stock options is ten years. Determining the amount of stock-based compensation expense to be recorded requires the Company to develop estimates used in calculating the grant-date fair value of awards. These estimates may be based on different valuation models depending upon the type of award and may include assumptions, such as expected volatility, expected term, risk-free interest rate, expected dividend yield, forfeiture rate and others. The Company uses the Black-Scholes valuation model to calculate the grant-date fair value of stock option awards. The grant-date fair value of restricted stock units with a service condition and restricted stock units with both service and performance conditions is calculated using the value of the Company's common stock on the date of grant, reduced by the present value of dividends expected to be paid on the Company's common stock prior to vesting. For restricted stock units with both service and performance conditions, this grant-date fair value is also impacted by the number of units that are expected to vest during the performance period and is adjusted through the related stock-based compensation expense at each reporting period based on the probability of achievement of that performance condition. If the Company determines that an award is unlikely to vest, any previously recorded stock-based compensation expense is reversed in the period of that determination. The grant date fair value of restricted stock units and performance-based stock options with both service and market conditions is calculated using the Monte Carlo simulation model to estimate the probability of satisfying the performance condition stipulated in the award grant, including the possibility that the market condition may not be satisfied. The fair value of shares to be issued under the Company's employee stock purchase plan (ESPP) is computed using the Black-Scholes model at the commencement of an offering period in June and December of each year and the related expense is recorded over the offering period. See Note 3, Stock-Based Compensation and Shareholders' Equity, of the Notes to Consolidated Financial Statements for additional information relating to stock-based compensation. s.New Accounting Pronouncements Standards to Be Implemented Acquired Contract Assets and Contract Liabilities In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities. Under the new guidance (ASC 805-20-30-28), the acquirer should determine what contract assets and/or contract liabilities it would have recorded under ASC 606 (the revenue guidance) as of the acquisition date, as if the acquirer had entered into the original contract at the same date and on the same terms as the acquiree. The recognition and measurement of those contract assets and contract liabilities will likely be comparable to what the acquiree has recorded on its books under ASC 606 as of the acquisition date. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company will adopt this standard in the first quarter of fiscal 2024 and apply to any future business combinations.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-Based Compensation and Shareholders' Equity |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-Based Payment Arrangement [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock-Based Compensation and Shareholders' Equity | Stock-Based Compensation and Shareholders’ Equity Equity Compensation Plans The Company grants, or has granted, stock options and other stock and stock-based awards under the Company's 2020 Equity Incentive Plan (2020 Plan), which was approved by shareholders in March 2020. The 2020 Plan provides for the grant of up to 21.2 million shares of the Company’s common stock, which includes shares under the Company’s previous equity compensation plans, including the Amended and Restated 2006 Stock Incentive Plan and the Amended and Restated 2010 Equity Incentive Plan. The 2020 Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units and other stock-based awards. Employees, officers, directors, consultants and advisors of the Company and its subsidiaries are eligible to be granted awards under the 2020 Plan. No award may be made under the 2020 Plan after March 11, 2030, but awards previously granted may extend beyond that date. The Company does not intend to grant further equity awards under any previous legacy equity compensation plans. In connection with the Acquisition, the Company assumed the Maxim 1996 Stock Incentive Plan (1996 Plan) and may grant stock options and other stock and stock-based awards under the 1996 Plan. As of October 28, 2023, a total of 15.1 million common shares were available for future grant under the 2020 Plan and 8.5 million common shares were available for future grant under the 1996 Plan. Maxim Replacement Awards In connection with the Acquisition, the Company issued equity awards, consisting of restricted stock awards and restricted stock units (replacement awards), to certain Maxim employees in replacement of Maxim equity awards. The replacement awards consist of restricted stock and restricted stock unit awards for approximately 3.7 million shares of the Company's common stock with a weighted average grant date fair value of $161.63. The terms and intrinsic value of these replacement awards are substantially the same as the converted Maxim awards. The fair value of the replacement awards associated with services rendered through the Acquisition Date was recognized as a component of the total acquisition consideration, and the remaining fair value of the replacement awards associated with post-Acquisition services will be recognized as an expense on a straight-line basis over the remaining vesting period. Modification of Awards The Company has, from time to time, modified the terms of its equity awards to employees and directors. The modifications made to the Company’s equity awards in fiscal 2023, fiscal 2022 and fiscal 2021 did not result in significant incremental compensation costs, either individually or in the aggregate. Grant-Date Fair Value of Stock Options Information pertaining to the Company’s stock option awards and the related estimated weighted-average assumptions to calculate the fair value of stock options using the Black-Scholes valuation model granted in fiscal 2021 is below. The Company did not grant stock option awards in fiscal 2023 or fiscal 2022.
Expected volatility — The Company is responsible for estimating volatility and has considered a number of factors, including third-party estimates. The Company currently believes that the exclusive use of implied volatility results in the best estimate of the grant-date fair value of employee stock options because it reflects the market’s current expectations of future volatility. In evaluating the appropriateness of exclusively relying on implied volatility, the Company concluded that: (1) options in the Company’s common stock are actively traded with sufficient volume on several exchanges; (2) the market prices of both the traded options and the underlying shares are measured at a similar point in time to each other and on a date close to the grant date of the employee share options; (3) the traded options have exercise prices that are both near-the-money and close to the exercise price of the employee share options; and (4) the remaining maturities of the traded options used to estimate volatility are at least one year. Expected term — The Company uses historical employee exercise and option expiration data to estimate the expected term assumption for the Black-Scholes grant-date valuation. The Company believes that this historical data is currently the best estimate of the expected term of a new option, and that generally its employees exhibit similar exercise behavior. Risk-free interest rate — The yield on zero-coupon U.S. Treasury securities for a period that is commensurate with the expected term assumption is used as the risk-free interest rate. Expected dividend yield — Expected dividend yield is calculated by annualizing the cash dividend declared by the Company’s Board of Directors for the current quarter and dividing that result by the closing stock price on the date of grant. Until such time as the Company’s Board of Directors declares a cash dividend for an amount that is different from the current quarter’s cash dividend, the current dividend will be used in deriving this assumption. Cash dividends are not paid on options, restricted stock, replacement awards or restricted stock units. In connection with the acquisition of Linear, the Company granted restricted stock awards to replace outstanding restricted stock awards of Linear employees. These restricted stock awards specific to legacy Linear awards entitle recipients to voting and nonforfeitable dividend rights from the date of grant. Employee Stock Purchase Plan The Company offers an ESPP to eligible employees, providing the opportunity to purchase shares of the Company's common stock at a discount through payroll deductions. Offering periods begin in June and December each year. U.S. employees are allowed to purchase the Company's common stock at the lesser of 85% of the fair market value of the common stock at either the beginning or end of the offering period. Eligible employees outside of the U.S. are allowed to purchase the Company's common stock at the lesser of 80% of the fair market value of the common stock at either the beginning or end of the offering period. As of October 28, 2023, a total of 4.5 million shares of the Company's common stock were available for future grant under the ESPP. Stock-Based Compensation Expense The amount of stock-based compensation expense recognized during a period is based on the value of the awards that are ultimately expected to vest. Forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The term “forfeitures” is distinct from “cancellations” or “expirations” and represents only the unvested portion of the surrendered stock-based award. Based on an analysis of its historical forfeitures, the Company has applied an annual forfeiture rate of 5.0% to all unvested stock-based awards as of October 28, 2023. This analysis will be re-evaluated annually and the forfeiture rate will be adjusted as necessary. Ultimately, the actual expense recognized over the vesting period will only be for those awards that vest. Total stock-based compensation expense recognized is as follows:
As of October 28, 2023 and October 29, 2022, the Company capitalized $12.9 million and $13.1 million, respectively, of stock-based compensation in inventory. Stock-Based Compensation Activity A summary of the activity under the Company’s stock option plans as of October 28, 2023 and changes during the fiscal year then ended is presented below:
_______________________________________ (1)In addition to the vested options, the Company expects a portion of the unvested options to vest at some point in the future. The number of options expected to vest is calculated by applying an estimated forfeiture rate to the unvested options. The total intrinsic value of options exercised (i.e., the difference between the market price at exercise and the price paid by the employee to exercise the options) during fiscal 2023, fiscal 2022 and fiscal 2021 was $95.0 million, $56.2 million and $93.2 million, respectively. A summary of the Company’s restricted stock unit and award activity as of October 28, 2023 and changes during the fiscal year then ended is presented below:
As of October 28, 2023, there was $545.9 million of total unrecognized compensation cost related to unvested stock-based awards comprised of stock options, restricted stock awards and restricted stock unit awards. That cost is expected to be recognized over a weighted-average period of 1.4 years. The total grant-date fair value of awards that vested during fiscal 2023, fiscal 2022 and fiscal 2021 was approximately $298.2 million, $283.0 million and $207.0 million, respectively. Common Stock Repurchases In fiscal 2021, the Company entered into accelerated share repurchase agreements (ASR) with third party financial institutions, paid $2.5 billion and received an initial delivery of 12.3 million shares of common stock, which represented approximately 80% of the notional amount of the ASR. As of October 30, 2021, the Company recorded the remaining 20%, or $500.0 million, within Prepaid expenses and other current assets on the Consolidated Balance Sheet, which was utilized during the first quarter of fiscal 2022. During the first quarter of fiscal 2022, the ASR was completed and an additional 2.1 million shares of common stock were received as final settlement of the ASR. In total, the Company repurchased 14.4 million shares of common stock under the ASR at an average price per share of $173.77. The Company’s share repurchase program has been in place since August 2004. In the aggregate, the Board of Directors has authorized the Company to repurchase $16.7 billion of the Company’s common stock under the program, which includes the $8.5 billion authorization approved by the Board of Directors on August 25, 2021. The Company may repurchase outstanding shares of its common stock from time to time in the open market and through privately negotiated transactions. Unless terminated earlier by resolution of the Company’s Board of Directors, the repurchase program will expire when the Company has repurchased all shares authorized under the program. As of October 28, 2023, the Company had repurchased a total of approximately 205.3 million shares of its common stock for approximately $14.5 billion under this program. An additional $2.1 billion remains available for repurchase of shares under the current authorized program. The repurchased shares are held as authorized but unissued shares of common stock. Future repurchases of common stock will be dependent upon the Company's financial position, results of operations, outlook, liquidity, and other factors deemed relevant by the Company. The Company also, from time to time, repurchases shares in settlement of employee tax withholding obligations due upon the vesting of restricted stock units/awards or the exercise of stock options. The withholding amount is based on the employee's minimum statutory withholding requirement. Any future common stock repurchases will be dependent upon several factors, including the Company's financial performance, outlook, liquidity and the amount of cash the Company has available in the United States. Preferred Stock The Company has 471,934 authorized shares of $1.00 par value preferred stock, none of which is issued or outstanding. The Board of Directors is authorized to fix designations, relative rights, preferences and limitations on the preferred stock at the time of issuance.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Industry, Segment and Geographic Information |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Reporting [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Industry, Segment and Geographic Information | Industry, Segment and Geographic Information The Company operates and tracks its results in one reportable segment based on the aggregation of its operating segments. The Company designs, develops, manufactures and markets a broad range of integrated circuits (ICs). The Chief Executive Officer has been identified as the Company's Chief Operating Decision Maker. The Company has determined that all of the Company's operating segments share the following similar economic characteristics, and therefore meet the criteria established for operating segments to be aggregated into one reportable segment, namely: •The primary source of revenue for each operating segment is the sale of ICs. •The ICs sold by each of the Company's operating segments are manufactured using similar semiconductor manufacturing processes and raw materials in either the Company’s own production facilities or by third-party wafer fabricators using proprietary processes. •The Company sells its products to tens of thousands of customers worldwide. Many of these customers use products spanning all operating segments in a wide range of applications. •The ICs marketed by each of the Company's operating segments are sold globally through a direct sales force, third-party distributors, independent sales representatives and via the Company's website to the same types of customers. All of the Company's operating segments share a similar long-term financial model as they have similar economic characteristics. The causes for variation in operating and financial performance are the same among the Company's operating segments and include factors such as (i) life cycle and price and cost fluctuations, (ii) number of competitors, (iii) product differentiation and (iv) size of market opportunity. Additionally, each operating segment is subject to the overall cyclical nature of the semiconductor industry. Lastly, the number and composition of employees and the amounts and types of tools and materials required for production of products are proportionally similar for each operating segment. Revenue Trends by End Market The following table summarizes revenue by end market. The categorization of revenue by end market is determined using a variety of data points including the technical characteristics of the product, the “sold to” customer information, the "ship to" customer information and the end customer product or application into which the Company’s product will be incorporated. As data systems for capturing and tracking this data and the Company's methodology evolves and improves, the categorization of products by end market can vary over time. When this occurs, the Company reclassifies revenue by end market for prior periods. Such reclassifications typically do not materially change the sizing of, or the underlying trends of results within each end market.
_______________________________________ (1)The sum of the individual percentages may not equal the total due to rounding. Revenue by Sales Channel The following tables summarize revenue by sales channel. The Company sells its products globally through a direct sales force, third party distributors, independent sales representatives and via its website. Distributors are customers that buy products with the intention of reselling them. Direct customers are non-distributor customers and consist primarily of original equipment manufacturers (OEMs). Other customers include the U.S. government, government prime contractors and certain commercial customers for which revenue is recorded over time.
_______________________________________ (1)The sum of the individual percentages may not equal the total due to rounding. Geographic Information Geographic revenue information for fiscal 2023, fiscal 2022 and fiscal 2021 reflects the geographic location of the distributors or OEMs who purchased the Company's products. This may differ from the geographic location of the end customers. In all periods presented, the predominant regions comprising “Rest of North and South America” are Canada and Mexico; the predominant regions comprising “Europe” are Germany, Sweden and the Netherlands; and the predominant regions comprising “Rest of Asia” are Taiwan, Malaysia, South Korea and Singapore.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special Charges, Net |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and Related Activities [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special Charges, Net | Special Charges, NetThe Company monitors global macroeconomic conditions on an ongoing basis and continues to assess opportunities for improved operational effectiveness and efficiency, as well as a better alignment of expenses with revenues. As a result of these assessments, the Company has undertaken various actions resulting in special charges over the past several years. Liabilities related to special charges, net are presented in accrued liabilities and other non-current liabilities on the Consolidated Balance Sheets. The activity is detailed below:
Q4 2023 Plan In the fourth quarter of fiscal 2023, the Company committed to a plan to reorganize its business (the Q4 2023 Plan). The Q4 2023 Plan, consisting of voluntary and involuntary reductions-in-force and other cost-savings initiatives, was commenced to adjust the Company’s cost structure and business activities to better align with weaker market demand and continued economic uncertainty in its end markets, as well as to make certain strategic shifts in its workforce necessary to achieve its long-term vision. The reductions-in-force, which are subject to the laws and regulations of the countries in which the actions are planned, are expected to impact positions in manufacturing, engineering and selling, marketing, general and administrative functions. The Company recorded net special charges of $114.0 million during the fourth quarter of fiscal 2023 related to the Q4 2023 Plan. In connection with the Q4 2023 Plan, the Company expects to incur special charges, net of between $120.0 million and $140.0 million, primarily related to reductions-in-force. The Company expects that the majority of the actions under the Q4 2023 Plan will be completed by the second quarter of fiscal 2024 ending May 4, 2024. The Company expects to settle these charges with cash on hand, together with existing and anticipated available short-term financing. Global Repositioning Actions The Company recorded net special charges of $532.7 million on a cumulative basis through October 28, 2023, as part of the integration of the Acquisition and continued organizational initiatives to consolidate its global footprint related to certain manufacturing, engineering, sales, marketing and administrative offices and to better align its global workforce with the Company's long-term strategic plan. The special charges include severance and fringe benefit costs, in accordance with the Company's ongoing benefit plan or statutory requirements at foreign locations, and the write-off of acquired intellectual property due to the Company's decision to discontinue certain product development strategies. In connection with the Company’s decision during fiscal 2022 to transition its engineering, sales, marketing and administrative activities from its leased property in Santa Clara, California to its owned property in San Jose, California, the Company entered into a sublease agreement for a portion of the leased property and intends to sublease the remainder of this property. As a result of the sublease transaction, the Company recorded an impairment charge of $91.9 million in net special charges which represented the excess carrying value of the associated asset group over its estimated fair value. The Company estimated fair value using cash flows from the estimated net sublease rental income discounted at a market rate. The Company allocated $60.6 million, $28.1 million and $3.2 million of the impairment charge to right of use assets, leasehold improvements and office equipment, respectively. Closure of Manufacturing FacilitiesThe Company recorded net special charges of $63.8 million on a cumulative basis through October 28, 2023 as a result of its decision to consolidate certain wafer and test facility operations acquired as part of the acquisition of Linear. The net special charges included cumulative gains of $18.0 million related to net proceeds received of approximately $67.5 million for the sale of its Hillview wafer fabrication facility and certain equipment located in Milpitas, California as well as the sale of its facility and certain equipment in Singapore.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acquisitions |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Combination and Asset Acquisition [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Acquisitions | Acquisitions Maxim Integrated Products, Inc. On the Acquisition Date, the Company completed its acquisition of all of the voting interests of Maxim, an independent manufacturer of innovative analog and mixed-signal products and technologies. Under the terms of the agreement pursuant to which the Company acquired Maxim (Merger Agreement), Maxim stockholders received, for each outstanding share of Maxim common stock, 0.6300 of a share of the Company's common stock at the closing. The Company believes the combination creates an expanded suite of top-performing mixed-signal and power management technology offerings and complements the Company's legacy offerings. The results of operations of Maxim from the Acquisition Date are included in the Company’s Consolidated Statement of Income, Consolidated Balance Sheet, Consolidated Statement of Cash Flows and Consolidated Statement of Shareholders’ Equity for fiscal 2021. The amount of revenue attributable to Maxim included in the Company's Consolidated Statement of Income for fiscal 2021 was $558.8 million. The amount of Maxim's earnings included in the Consolidated Statement of Income for fiscal 2021 is impracticable to calculate. The Acquisition Date fair value of the consideration transferred in the Acquisition consisted of the following:
____________________ (a)This reflects the cash paid for fractional shares of the Company’s common stock in respect of shares of Maxim common stock outstanding. (b)The fair value is based on the issuance of approximately 169.2 million shares of the Company's common stock with a per share value of $164.00 on the Acquisition Date. (c)In connection with the Acquisition, the Company issued equity awards, consisting of restricted stock and restricted stock units, to certain Maxim employees in replacement of Maxim equity awards that were cancelled at closing. The replacement awards consist of restricted stock and restricted stock unit awards for approximately 3.7 million shares of the Company's common stock with a weighted average grant date fair value of $161.63. This amount represents the portion of the fair value of the replacement equity awards associated with services rendered through the Acquisition Date and has been included as a component of the total purchase consideration. During fiscal 2022, the Company completed the acquisition accounting for the Acquisition. The following is a summary of the amounts recognized in accounting for the Acquisition:
The acquired intangible assets consisted of the following, which are being amortized on a straight-line basis over their estimated useful lives or on an accelerated method of amortization that is expected to reflect the estimated pattern of economic use.
The goodwill recognized is attributable to synergies which are expected to enhance and expand the Company’s overall product portfolio and opportunities in new and existing markets, future technologies that have yet to be determined and Maxim’s assembled workforce. Future technologies do not meet the criteria for recognition separately from goodwill because they are part of future development and growth of the business. There were no significant contingencies assumed as part of the Acquisition. In aggregate, the Company recognized $174.0 million of transaction-related costs, including legal, accounting and other related fees that were expensed in fiscal 2023, fiscal 2022 and fiscal 2021. These costs are included in the Consolidated Statements of Income in operating expenses within selling, marketing, general and administrative expenses. The following unaudited pro forma consolidated financial information for the twelve months ended October 30, 2021 combines the results of the Company for fiscal 2021 and the unaudited results of Maxim for the corresponding period through the Acquisition Date. The unaudited pro forma consolidated financial information assumes that the Acquisition, which closed on August 26, 2021, was completed on November 3, 2019 (the first day of fiscal 2020). The pro forma consolidated financial information has been calculated after applying the Company’s accounting policies and includes adjustments for amortization expense of acquired intangible assets, fair value adjustments for acquired inventory, property, plant and equipment and long-term debt and compensation expense for ongoing share-based compensation arrangements that were replaced in conjunction with the Acquisition, together with the consequential tax effects. These pro forma results have been prepared for comparative purposes only and do not purport to be indicative of the operating results of the Company that would have been achieved had the Acquisition actually taken place on November 3, 2019. In addition, these results are not intended to be a projection of future results and do not reflect events that may occur after the Acquisition, including but not limited to revenue enhancements, cost savings or operating synergies that the combined Company may achieve as a result of the Acquisition.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Investments |
12 Months Ended |
|---|---|
Oct. 28, 2023 | |
| Investments, Debt and Equity Securities [Abstract] | |
| Other Investments | Other InvestmentsOther investments consist of interests in venture capital funds and other long-term investments. Investments are accounted for using the equity method of accounting or cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. For equity method investments, realized gains and losses are reflected in other, net based upon the Company's ownership share of the investee's financial results. |
Accrued Liabilities |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Payables and Accruals [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accrued Liabilities | Accrued LiabilitiesAccrued liabilities at October 28, 2023 and October 29, 2022 consisted of the following:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Leases [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Leases | LeasesThe Company enters into operating leases which primarily relate to certain facilities and, to a lesser extent, finance leases. Finance leases were not a material component of the Company's lease portfolio in the periods presented. The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. Lease assets represent the Company's right to use underlying assets for the lease term, and lease liabilities represent the obligation to make lease payments over the lease term. At lease commencement, leases are evaluated for classification, and assets and liabilities are recognized based on the present value of lease payments over the lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the appropriate incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. Certain adjustments to the right-of-use asset may be required for items such as initial direct costs paid or incentives received, such as construction allowances from landlords and/or rent abatements subsequent to taking possession of the leased property. The Company has agreements with lease and non-lease components, which are accounted for as a single lease component. Non-lease components may include real estate taxes, insurance, maintenance, parking and other operating costs. If these costs are variable costs they are not included in the measurement of the right-of-use assets and lease liabilities, but are expensed when the event determining the amount of variable consideration to be paid occurs. The Company’s leases have remaining lease terms of less than one year to approximately twenty-two years, some of which may include options to extend the initial term of the lease. These options are included in determining the initial lease term at lease commencement only if the Company is reasonably certain to exercise the option. Lease costs are recognized on a straight-line basis as lease expense over the lease term. For leases with terms of twelve months or less the Company recognizes the related lease payments as expense either on a straight-line basis over the lease term or as incurred depending on whether the lease payments are fixed or variable. The Company subleases certain properties that are not used in its core business operations (See Note 5, Special Charges, Net, of the Notes to Consolidated Financial Statements). Sublease income for fiscal 2023 was $12.9 million. The following table presents supplemental balance sheet information related to the Company's operating leases:
Details of the Company's operating leases are as follows:
The following table presents the maturities of the Company's operating lease liabilities as of October 28, 2023:
The following table presents the future minimum cash receipts as a result of subleases as of October 28, 2023:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Leases | LeasesThe Company enters into operating leases which primarily relate to certain facilities and, to a lesser extent, finance leases. Finance leases were not a material component of the Company's lease portfolio in the periods presented. The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances present at the inception of an arrangement. Lease assets represent the Company's right to use underlying assets for the lease term, and lease liabilities represent the obligation to make lease payments over the lease term. At lease commencement, leases are evaluated for classification, and assets and liabilities are recognized based on the present value of lease payments over the lease term. The interest rate implicit in lease contracts is typically not readily determinable. As such, the Company utilizes the appropriate incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. Certain adjustments to the right-of-use asset may be required for items such as initial direct costs paid or incentives received, such as construction allowances from landlords and/or rent abatements subsequent to taking possession of the leased property. The Company has agreements with lease and non-lease components, which are accounted for as a single lease component. Non-lease components may include real estate taxes, insurance, maintenance, parking and other operating costs. If these costs are variable costs they are not included in the measurement of the right-of-use assets and lease liabilities, but are expensed when the event determining the amount of variable consideration to be paid occurs. The Company’s leases have remaining lease terms of less than one year to approximately twenty-two years, some of which may include options to extend the initial term of the lease. These options are included in determining the initial lease term at lease commencement only if the Company is reasonably certain to exercise the option. Lease costs are recognized on a straight-line basis as lease expense over the lease term. For leases with terms of twelve months or less the Company recognizes the related lease payments as expense either on a straight-line basis over the lease term or as incurred depending on whether the lease payments are fixed or variable. The Company subleases certain properties that are not used in its core business operations (See Note 5, Special Charges, Net, of the Notes to Consolidated Financial Statements). Sublease income for fiscal 2023 was $12.9 million. The following table presents supplemental balance sheet information related to the Company's operating leases:
Details of the Company's operating leases are as follows:
The following table presents the maturities of the Company's operating lease liabilities as of October 28, 2023:
The following table presents the future minimum cash receipts as a result of subleases as of October 28, 2023:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies |
12 Months Ended |
|---|---|
Oct. 28, 2023 | |
| Commitments and Contingencies Disclosure [Abstract] | |
| Commitments and Contingencies | Commitments and Contingencies From time to time, in the ordinary course of the Company’s business, various claims, charges and litigation are asserted or commenced against the Company arising from, or related to, among other things, contractual matters, acquisitions, patents, trademarks, personal injury, environmental matters, product liability, insurance coverage, employment or employment benefits. As to such claims and litigation, the Company can give no assurance that it will prevail. On March 17, 2022, Walter E. Ryan and Ryan Asset Management, LLC, purported stockholders of Maxim Integrated Products, Inc. (Maxim), filed a putative class action in the Court of Chancery of the State of Delaware (C.A. No. 2022—0255) against the Company and the former directors of Maxim. The complaint alleges breaches of fiduciary duties by the individual defendants in connection with Maxim’s agreement, as part of the merger negotiations with the Company, to suspend Maxim dividends for up to four quarters prior to the closing of the Acquisition. The complaint further alleges that the Company aided and abetted those alleged breaches of fiduciary duties. The plaintiffs seek damages in an amount to be determined at trial, plaintiffs’ costs and disbursements, including reasonable attorneys’ and experts’ fees, costs and other expenses. On May 2, 2023, the Court of Chancery entered an order dismissing the action in its entirety and with prejudice. On May 9, 2023, the plaintiffs filed a Motion for Reargument, which the Court denied on May 30, 2023. On June 21, 2023, the plaintiffs filed a Notice of Appeal to the Delaware Supreme Court. The appeal is fully briefed and remains pending. The Company believes that it and the other defendants have meritorious arguments in response to the appeal and defenses to the underlying allegations; however, the Company is currently unable to determine the ultimate outcome of this matter or determine an estimate, or a range of estimates, of potential losses, if any.The Company has supplier commitments of approximately $705.6 million for the purchase of materials and supplies in advance or with minimum purchase quantities through 2031.
|
Retirement Plans |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Retirement Plans | Retirement Plans The Company and its subsidiaries have various savings and retirement plans covering substantially all employees. Defined Contribution Plans The Company maintains a defined contribution plan for the benefit of its eligible U.S. employees. This plan provides for Company contributions of up to 5% of each participant’s total eligible compensation. In addition, the Company contributes an amount equal to each participant’s pre-tax contribution, if any, up to a maximum of 3% of each participant’s total eligible compensation. The total expense related to the defined contribution plans for all eligible U.S. employees was $76.0 million in fiscal 2023, $65.2 million in fiscal 2022 and $52.1 million in fiscal 2021. Non-Qualified Deferred Compensation Plan The Deferred Compensation Plan (DCP) allows certain members of management and other highly-compensated employees and non-employee directors to defer receipt of all or any portion of their compensation. The DCP was established to provide participants with the opportunity to defer receiving all or a portion of their compensation, which includes salary, bonus, commissions and director fees. Under the DCP, the Company provides all participants (other than non-employee directors) with Company contributions equal to 8% of eligible deferred contributions. The DCP is a non-qualified plan that is maintained in a rabbi trust. The fair value of the investments held in the rabbi trust are included within other investments, with the current portion of the investment included in prepaid expenses and other current assets in the Consolidated Balance Sheets. See Note 2j, Fair Value, of the Notes to Consolidated Financial Statements for further information on these investments. The deferred compensation obligation represents DCP participant accumulated deferrals and earnings thereon since the inception of the DCP net of withdrawals. The deferred compensation obligation is included within other non-current liabilities, with the current portion of the obligation in accrued liabilities in the Consolidated Balance Sheets. The Company’s liability under the DCP is an unsecured general obligation of the Company. Defined Benefit Pension and Post Retirement Benefit Plans The Company also has various defined benefit pension and other retirement plans for certain non-U.S. employees that are consistent with local statutory requirements and practices. The total expense related to the various defined benefit pension, contribution and other retirement plans for certain non-U.S. employees was $55.3 million in fiscal 2023, $51.4 million in fiscal 2022 and $45.9 million in fiscal 2021. The Company’s funding policy for its foreign defined benefit pension plans is consistent with the local requirements of each country. The plans’ assets consist primarily of U.S. and non-U.S. equity securities, bonds, property and cash. The Company has elected to measure defined benefit plan assets and obligations as of October 31, which is the month-end that is closest to its fiscal year-ends, which were October 28, 2023 for fiscal 2023 and October 29, 2022 for fiscal 2022. As a result of the Acquisition, the Company acquired a postretirement plan that provides postretirement medical expenses to certain former employees of a Maxim acquired company and certain former Maxim executives in the U.S. Components of Net Periodic Benefit Cost Net annual periodic benefit cost of the Company’s pension and postretirement benefit plans for fiscal 2023, fiscal 2022 and fiscal 2021 is presented in the following table:
The service cost component of net periodic benefit cost above is recorded in Cost of sales, Research and development, Selling, marketing, general and administrative expenses within the Consolidated Statements of Income, while the remaining components are recorded to . Benefit Obligations and Plan Assets Obligation and asset data of the Company’s pension and postretirement benefit plans at October 28, 2023 and October 29, 2022 is presented in the following table:
The accumulated benefit obligation for the Company’s pension and postretirement benefit plans was $120.1 million and $111.3 million at October 28, 2023 and October 29, 2022, respectively. Information relating to the Company’s pension and postretirement benefit plans with projected benefit obligations in excess of plan assets and accumulated benefit obligations in excess of plan assets at October 28, 2023 and October 29, 2022 is presented in the following table:
Assumptions The range of assumptions used for the Company’s pension and postretirement benefit plans reflects the different economic environments within the various countries as well as the differences in the attributes of the participants. The projected benefit obligation was determined using the following weighted-average assumptions:
Net annual periodic benefit cost was determined using the following weighted average assumptions:
The expected long-term rate of return on assets is a weighted-average of the long-term rates of return selected for the various countries where the Company has funded pension plans. The expected long-term rate of return on assets assumption is selected based on the facts and circumstances that exist as of the measurement date and the specific portfolio mix of plan assets. Management, in conjunction with its actuaries, reviewed anticipated future long-term performance of individual asset categories and considered the asset allocation strategy adopted by the Company and/or the trustees of the plans. While the review considered recent fund performance and historical returns, the assumption is primarily a long-term prospective rate. The Company’s investment strategy is based on an expectation that equity securities will outperform debt securities over the long term. Investments within each asset class are diversified to reduce the impact of losses in single investments. The use of derivative instruments is permitted where appropriate and necessary to achieve overall investment policy objectives and asset class targets. The Company establishes strategic asset allocation percentage targets and appropriate benchmarks for each significant asset class to obtain a prudent balance between return and risk. The interaction between plan assets and benefit obligations is periodically studied by the Company and its actuaries to assist in the establishment of strategic asset allocation targets. Fair value of plan assets The following table presents plan assets measured at fair value on a recurring basis by investment categories as of October 28, 2023 and October 29, 2022 using the same three-level hierarchy described in Note 2j, Fair Value, of the Notes to Consolidated Financial Statements:
_______________________________________ (1)The majority of the assets in these categories are invested in a mix of equities, including those from North America, Europe and Asia. The funds are valued using the net asset value method in which an average of the market prices for underlying investments is used to value the fund. Due to the nature of the underlying assets of these funds, changes in market conditions and the economic environment may significantly impact the net asset value of these investments and, consequently, the fair value of the investments. These investments are redeemable at net asset value to the extent provided in the documentation governing the investments. However, these redemption rights may be restricted in accordance with governing documents. Publicly traded securities are valued at the last trade or closing price reported in the active market in which the individual securities are traded. (2)Consists of funds primarily concentrated in non-U.S. debt instruments. The funds are valued using the net asset value method in which an average of the market prices for underlying investments is used to value the fund. (3)Consists of funds that primarily invest in global real estate and infrastructure funds. The funds are valued using the net asset value method in which an average of the market prices for underlying investments is used to value the fund. (4)Consists of liability driven investment funds that may hold a range of low-risk hedging instruments including but not limited to government bonds, interest rate and inflation swaps, physical inflation-linked and nominal gilts, synthetic gilts, cash and money market instruments. The investment funds are valued at the closing price reported if traded on an active market or at yields currently available on comparable securities of issuers with similar credit ratings. Estimated future cash flows Expected fiscal 2024 Company contributions and estimated future benefit payments are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Taxes |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Taxes | Income Taxes The Company's effective tax rate reflects the applicable tax rate in effect in the various tax jurisdictions around the world where the Company's income is earned. The reconciliation of income tax computed at the U.S. federal statutory rates to income tax expense for fiscal 2023, fiscal 2022 and fiscal 2021 is as follows:
Income before income taxes for fiscal 2023, fiscal 2022 and fiscal 2021 includes the following components:
_______________________________________ (1)Income before income taxes reflects deemed intercompany royalties in all periods presented. The components of the provision for (benefit from) income taxes for fiscal 2023, fiscal 2022 and fiscal 2021 are as follows:
The Company’s effective tax rate for fiscal 2023 was impacted by a discrete income tax benefit recorded of $81.7 million resulting from the approval granted by the Joint Committee on Taxation of its federal corporate income tax relief claim which reduced the amount of transition tax owed under the Tax Cuts and Jobs Act. U.S. tax legislation subjects a U.S. shareholder to tax on global intangible low-taxed income (GILTI). Under U.S. GAAP, an accounting policy election can be made to either treat taxes due on the GILTI inclusion as a current period expense or to recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years. The Company elected the deferral method and recorded the corresponding GILTI deferred tax assets and liabilities on its Consolidated Balance Sheets. The Company carries other outside basis differences in its subsidiaries, primarily arising from acquisition accounting adjustments and certain undistributed earnings that are considered indefinitely reinvested. As of October 28, 2023, the Company has not recognized deferred income tax on $33.6 billion of outside basis differences because of its intent and ability to indefinitely reinvest these basis differences. These basis differences could be reversed through a sale of the subsidiaries or the receipt of dividends from the subsidiaries, as well as various other events, none of which are considered probable at this time. Determination of the amount of unrecognized deferred income tax liability related to these outside basis differences is not practicable. The significant components of the Company’s deferred tax assets and liabilities for fiscal 2023 and fiscal 2022 are as follows:
_______________________________________________ (1) As of October 28, 2023, the Company included the effects of the mandatory capitalization and amortization of research and development expenses which began in fiscal 2023 under the Tax Cuts and Jobs Act. The valuation allowances of $332.5 million and $339.1 million as of October 28, 2023 and October 29, 2022, respectively, are primarily for the Company’s state R&D credit carryforwards, foreign net operating losses and international credit carryforwards. The Company believes that it is more-likely-than-not that these credit carryovers will not be realized and as a result has recorded a partial valuation allowance. The federal and state net operating losses of $89.9 million will begin to expire in fiscal 2035 while foreign net operating loss carryovers of $145.2 million have no expiration date. There are also $299.7 million of federal and state credit carryovers and $14.2 million of foreign investment tax credit carryovers that begin to expire in the fiscal year ending November 1, 2025. As of October 28, 2023 and October 29, 2022, the Company had unrealized tax benefits, net of indirect tax benefits, of $187.4 million and $165.3 million, respectively, which if settled in the Company's favor, would lower the Company's effective tax rate in the period recorded. Liabilities for unrealized tax benefits are primarily classified as non-current because the Company believes that the ultimate payment or settlement of these liabilities will not occur within the next twelve months. As of October 28, 2023 and October 29, 2022, the Company had liabilities of approximately $70.7 million and $45.5 million, respectively, for interest and penalties, which is included within the provision for (benefit from) income taxes in the Consolidated Statements of Income. The following table summarizes the changes in the total amounts of unrealized tax benefits for fiscal 2021 through fiscal 2023:
In fiscal 2021, the Company acquired $125.5 million in reserves as part of the Acquisition consisting of $91.2 million in tax and $34.3 million in accrued interest. In fiscal 2023, the Company continued to engage in discussions and negotiations with tax authorities regarding tax matters in various jurisdictions. It is reasonably possible that the balance of unrealized tax benefits, including accrued interest and penalties, could decrease by up to $160.0 million within the next twelve months due to the completion of federal tax audits, including any administrative appeals. The $160.0 million primarily relates to matters involving federal taxation of international income and cross-border transactions. The Company has numerous audits ongoing at any time throughout the world including: an IRS income tax audit for fiscal year ended November 2, 2019 (fiscal 2019) and fiscal year ended November 3, 2018 (fiscal 2018), a pre-Acquisition IRS income tax audit for Maxim's fiscal years ended June 27, 2015 through August 26, 2021, and various U.S. state and local tax audits and international audits, including an Irish corporate tax audit for fiscal 2019. The Company’s U.S. federal tax returns prior to fiscal 2018 are no longer subject to examination, except for the applicable Maxim pre-Acquisition fiscal years noted above.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revolving Credit Facility |
12 Months Ended |
|---|---|
Oct. 28, 2023 | |
| Line of Credit Facility [Abstract] | |
| Revolving Credit Facility | Revolving Credit Facility On June 23, 2021, the Company entered into a Third Amended and Restated Credit Agreement with Bank of America, N.A. as administrative agent and the other banks identified therein as lenders, which was subsequently amended on December 20, 2022 and July 24, 2023 (as amended, the Revolving Credit Agreement). The Revolving Credit Agreement provides for a five year, unsecured, revolving credit facility in an aggregate principal amount not to exceed $2.5 billion (subject to certain terms and conditions). In the first quarter of fiscal 2023, the Company amended the Revolving Credit Agreement, replacing the LIBOR interest rate provisions with interest rate provisions based on a forward-looking term rate based on the Secured Overnight Financing Rate (SOFR) plus a 10 basis point credit spread adjustment. After the amendment, revolving loans under the Revolving Credit Agreement can be Term SOFR Loans or Base Rate Loans (each as defined in the Revolving Credit Agreement) at the Company's option. Each Term SOFR Loan will bear interest at a rate per annum equal to the applicable adjusted term SOFR plus a margin based on the Company's Debt Ratings (as defined in the Revolving Credit Agreement) from time to time of between 0.690% and 1.175%. As of October 28, 2023, the Company had no outstanding borrowings under this revolving credit facility but may borrow in the future and use the proceeds for repayment of existing indebtedness, stock repurchases, acquisitions, capital expenditures, working capital and other lawful corporate purposes. In addition, the Company has agreed to pay a facility fee based on the Company's Debt Ratings from time to time of between 0.060% and 0.200% multiplied by the actual daily amount of the Commitments (as defined in the Revolving Credit Agreement) in effect. The Revolving Credit Agreement also contains a sustainability-linked pricing component which provides for interest rate and facility fee reductions or increases based on the Company meeting or missing targets related to environmental sustainability, specifically greenhouse gas emissions and renewable energy usage. For calendar year 2022, the Company was within its target threshold range for greenhouse gas emission which resulted in no pricing adjustment. The Company exceeded the target threshold for renewable energy usage, which resulted in a modest pricing benefit on its commitment fee and any future borrowings. This adjustment did not have a material impact on the Company's business, net income or financing costs. The Revolving Credit Agreement includes a multicurrency borrowing feature for certain specified foreign currencies. The Company will guarantee the obligations of each subsidiary that is named a Designated Borrower under the Revolving Credit Agreement. The Revolving Credit Agreement contains customary representations and warranties, and affirmative and negative covenants and events of default applicable to the Company and its subsidiaries. As of October 28, 2023, the Company was in compliance with these covenants.
|
Debt |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt | Debt On December 14, 2015, the Company issued $850.0 million aggregate principal amount of 3.9% senior unsecured notes due December 15, 2025 (the December 2025 Notes) and $400.0 million aggregate principal amount of 5.3% senior unsecured notes due December 15, 2045 (the 2045 Notes) with semi-annual fixed interest payments due on June 15 and December 15 of each year, commencing June 15, 2016. The net proceeds of the offering were $1.2 billion, after discounts and issuance costs. On October 5, 2021 and October 7, 2021, $325.5 million, or 38.3%, of the $850.0 million aggregate principal amount of the December 2025 Notes at a price of $1,112.13 for each $1,000 principal amount of December 2025 Notes, and $67.4 million, or 16.85%, of the $400.0 million aggregate principal amount of the 2045 Notes at a price of $1,400.67 for each $1,000 principal amount of 2045 Notes, were tendered for repurchase and canceled. On October 20, 2021, the remaining December 2025 Notes were redeemed for cash at a redemption price equal to $1,103.81 for each $1,000 principal amount of the December 2025 Notes. Debt discounts and issuance costs will be amortized through interest expense over the term of the 2045 Notes. The 2045 Notes are subordinated to any future secured debt and to the other liabilities of the Company's subsidiaries. The 2045 Notes were issued pursuant to a base indenture (the ADI Base Indenture) between the Company and The Bank of New York Mellon Trust Company as trustee, as supplemented by a supplemental indenture, which contain certain covenants, events of default and other customary provisions. The covenants applicable to the 2045 Notes limit the Company's ability to incur, create, assume or guarantee any debt secured by a lien upon a principal property; enter into sale and lease-back transactions with respect to a principal property; and consolidate with or merge into, or transfer or lease all or substantially all of its assets to, any other party. As of October 28, 2023, the Company was in compliance with these covenants. On December 5, 2016, the Company issued $400.0 million aggregate principal amount of 2.5% senior unsecured notes due December 5, 2021 (the 2021 Notes), $550.0 million aggregate principal amount of 3.125% senior unsecured notes due December 5, 2023 (the December 2023 Notes), $900.0 million aggregate principal amount of 3.5% senior unsecured notes due December 5, 2026 (the 2026 Notes) and $250.0 million aggregate principal amount of 4.5% senior unsecured notes due December 5, 2036 (the 2036 Notes) with semi-annual fixed interest payments due on June 5 and December 5 of each year, commencing June 5, 2017. The net proceeds of the offering were $2.1 billion, after discounts and issuance costs. On October 5, 2021, (i) $71.2 million, or 17.80%, of the $400.0 million aggregate principal amount of the 2021 Notes at a price of $1,001.77 for each $1,000 principal amount of 2021 Notes, (ii) $282.7 million, or 51.41%, of the $550.0 million aggregate principal amount of the December 2023 Notes at a price of $1,053.78 for each $1,000 principal amount of December 2023 Notes and (iii) $105.7 million, or 42.29%, of the $250.0 million aggregate principal amount of the 2036 Notes at a price of $1,239.96 for each $1,000 principal amount of 2036 Notes were tendered for redemption. On October 20, 2021, the remaining 2021 Notes and December 2023 Notes were redeemed for cash at a redemption price equal to $1,000.98 for each $1,000 principal amount of 2021 Notes and $1,050.17 for each $1,000 principal amount of December 2023 Notes. Debt discounts and issuance costs will be amortized through interest expense over the term of the respective notes. The 2026 Notes and 2036 Notes rank without preference or priority among themselves and equally in right of payment with all other existing and future senior unsecured debt and senior in right of payment to all of the Company's future subordinated debt. The 2026 Notes and 2036 Notes were issued pursuant to the ADI Base Indenture, as supplemented by a supplemental indenture, which contain covenants similar to those applicable to the 2045 Notes, events of default and other customary provisions. As of October 28, 2023, the Company was in compliance with these covenants. On April 8, 2020, in an underwritten public offering of green bonds, the Company issued $400.0 million aggregate principal amount of 2.95% senior unsecured notes due April 1, 2025 (the April 2025 Notes), with semi-annual fixed interest payments due on April 1 and October 1 of each year, commencing on October 1, 2020. The Company used the net proceeds of $395.6 million from the green bond offering to finance or refinance new and existing eligible projects involving renewable energy, green buildings, and eco-efficient products, production technologies and processes. Debt discounts and underwriting fees will be amortized through interest expense over the term of the April 2025 Notes. At any time prior to March 1, 2025, the Company may, at its option, redeem some or all of the April 2025 Notes at a redemption price equal to the greater of 100% of the principal amount of the April 2025 Notes being redeemed and the make-whole premium, plus accrued and unpaid interest on the April 2025 Notes being redeemed, if any, to but excluding the date of redemption. The April 2025 Notes are unsecured and rank equally in right of payment with all of the Company's other existing and future unsecured senior indebtedness. The April 2025 Notes were issued pursuant to the ADI Base Indenture, as supplemented by a supplemental indenture, which contain covenants similar to those applicable to the 2045 Notes, events of default and other customary provisions. As of October 28, 2023, the Company was in compliance with these covenants. In conjunction with the Acquisition, the Company recognized $500.0 million aggregate principal amount of Maxim’s 3.375% senior unsecured and unsubordinated notes due March 15, 2023 (the Maxim 2023 Notes) and $500.0 million aggregate principal amount of Maxim’s 3.45% senior unsecured and unsubordinated notes due June 15, 2027 (the Maxim 2027 Notes), which were recognized at fair value as of the Acquisition Date. On October 5, 2021, Maxim gave notice that it would redeem the Maxim 2023 Notes, and in November 2021 (fiscal 2022), the Maxim 2023 Notes were redeemed for cash. On October 5, 2021, in an underwritten public offering, the Company issued $500.0 million aggregate principal amount of floating rate senior notes due October 1, 2024 (the Floating Rate Notes), $750.0 million aggregate principal amount of 1.7% sustainability-linked senior notes due October 1, 2028 (the Sustainability-Linked Senior Notes), $1.0 billion aggregate principal amount of 2.1% senior notes due October 1, 2031 (the 2031 Notes), $750.0 million aggregate principal amount of 2.8% senior notes due October 1, 2041 (the 2041 Notes), and $1.0 billion aggregate principal amount of 2.95% senior notes due October 1, 2051 (the 2051 Notes, and, together with the Floating Rate Notes, the Sustainability-Linked Senior Notes, the 2031 Notes and the 2041 Notes, the Notes). The Floating Rate Notes bear interest at a floating annual rate equal to a benchmark rate, which initially is Compounded SOFR (as defined in the Supplemental Indenture) plus 25 basis points. As of October 28, 2023, the interest rate on the Floating Rate Notes was 0.3% per annum. Interest payments on the Floating Rate Notes are due on January 1, April 1, July 1 and October 1 of each year, beginning on January 1, 2022. The Sustainability-Linked Senior Notes initially bear interest at a rate of 1.7% per annum and are subject to an increase of an additional 30 basis points from April 1, 2026 to the maturity date unless the Sustainability Performance Target (as defined in the Sustainability-Linked Senior Notes) has been satisfied. Semi-annual fixed interest payments on the Sustainability-Linked Senior Notes, the 2031 Notes, the 2041 Notes and the 2051 Notes are due on April 1 and October 1 of each year, beginning on April 1, 2022. At any time prior to August 1, 2028 in the case of the Sustainability-Linked Senior Notes, July 1, 2031 in the case of the 2031 Notes, April 1, 2041 in the case of the 2041 Notes and April 1, 2051 in the case of the 2051 Notes (each, a Par Call Date), the Company may, at its option, redeem some or all of the applicable series of Notes at a redemption price equal to the greater of (i) 100% of the principal amount of such series of Notes being redeemed and (ii) the make-whole redemption price (as described in the Supplemental Indenture). On and after the applicable Par Call Date, the Company may, at its option, redeem some or all of the applicable series of Notes at a redemption price equal to 100% of the principal amount of the Notes being redeemed. In each case, the Company will also pay the accrued and unpaid interest on the Notes being redeemed to, but excluding, the date of redemption. The Company may not redeem the Floating Rate Notes prior to their maturity. The Notes are unsecured and rank equally in right of payment with all of the Company’s other existing and future unsecured senior indebtedness. Debt discounts and issuance costs will be amortized through interest expense over the term of the respective Notes. The Notes were issued pursuant to an indenture, as supplemented by a supplemental indenture, and the indenture and supplemental indenture contain certain covenants, events of default and other customary provisions. As of October 28, 2023, the Company was in compliance with these covenants. On September 15, 2022, in an underwritten public offering, the Company issued $300.0 million aggregate principal amount of 4.250% senior notes due October 1, 2032 (the 2032 Notes) with semi-annual fixed interest payments due on April 1 and October 1 of each year, commencing April 1, 2023. The net proceeds of the offering were $296.1 million, after discounts and issuance costs. Prior to July 1, 2032 (three months prior to the maturity date), the Company may, at its option, redeem the 2032 Notes, in whole or in part, at any time and from time to time, at a redemption price equal to the greater of: (1) (a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the redemption date (assuming the notes matured on July 1, 2032) on a semi-annual basis at the Treasury Rate plus 20 basis points less (b) interest accrued to the date of redemption, and (2) 100% of the principal amount of the notes to be redeemed, plus, in either case, accrued and unpaid interest thereon to the redemption date. On or after July 1, 2032, the Company may, at its option, redeem the 2032 Notes, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of the 2032 Notes being redeemed plus accrued and unpaid interest thereon to the redemption date. The 2032 Notes are unsecured and rank equally in right of payment with all of the Company’s other existing and future unsecured senior indebtedness. The 2032 Notes were issued pursuant to the ADI Base Indenture, as supplemented by a supplemental indenture, which contain covenants similar to those applicable to the 2045 Notes, events of default and other customary provisions. As of October 28, 2023, the Company was in compliance with these covenants. On October 7, 2022, the Company completed an offer to exchange any and all outstanding Maxim 2027 Notes, for new 3.450% Senior Notes due June 15, 2027 to be issued by the Company (the Unregistered 2027 Notes) and cash. Pursuant to the exchange offer, $440.2 million aggregate principal amount of the Maxim 2027 Notes were tendered and subsequently accepted for exchange, and the Company retired and canceled all Maxim 2027 Notes accepted for exchange. In exchange for the tendered Maxim 2027 Notes, the Company issued approximately $440.2 million aggregate principal amount of Unregistered 2027 Notes pursuant to a private exchange offer exempt from, or not subject to, registration under the Securities Act of 1933, as amended (the Securities Act) and $0.5 million in cash. Following settlement of the exchange offer, $59.8 million aggregate principal amount of the Maxim 2027 Notes remained outstanding, The Unregistered 2027 Notes were issued pursuant to the ADI Base Indenture, as supplemented by a supplemental indenture, which contain certain covenants similar to those applicable to the 2045 Notes, events of default and other customary provisions. The Unregistered 2027 Notes bear interest at a rate of 3.450% per annum, with semi-annual fixed interest payments due on June 15 and December 15 of each year, commencing on December 15, 2022 and will mature on June 15, 2027. On April 26,2023, the Company redeemed for cash all of the outstanding $59.8 million aggregate principal amount of Maxim 2027 Notes in accordance with the terms of the indenture governing the Maxim 2027 Notes. The Maxim 2027 Notes were redeemed for cash at a redemption price equal to $1,012.55 for each $1,000 principal of the Maxim 2027 Notes and included accrued interest. As of April 27, 2023, there were no Maxim 2027 Notes outstanding. On September 19, 2023, the Company completed an offer to exchange in which the Company exchanged Unregistered 2027 Notes for a like principal amount of new notes that are identical in all material respects to the terms of the Unregistered 2027 Notes, except that the new notes have been registered under the Securities Act and the transfer restrictions, registration rights and additional interest provisions relating to the Unregistered 2027 Notes do not apply to the new notes (the 2027 Notes). As of October 28, 2023, the Company was in compliance with the covenants contained in the indenture and supplemental indenture governing the 2027 Notes. On April 14, 2023, the Company established a commercial paper program under which the Company may issue short-term, unsecured commercial paper notes (CP Notes) in amounts up to a maximum aggregate face amount of $2.5 billion outstanding at any time, with maturities up to 397 days from the date of issuance. The CP Notes will be sold under customary market terms in the U.S. commercial paper market at a discount from par or at par and bear interest at rates determined at the time of issuance. The Company intends to use the net proceeds of the CP Notes for general corporate purposes, including without limitation, repayment of indebtedness, stock repurchases, acquisitions, capital expenditures and working capital. As of October 28, 2023, the Company had $547.2 million of outstanding borrowings under the commercial paper program recorded in the Consolidated Balance Sheet. The carrying value of the outstanding CP Notes approximated fair value at October 28, 2023. The Company’s debt consisted of the following as of October 28, 2023 and October 29, 2022:
_________________________________ (1) Includes fair value adjustment related to interest rate swap related to outstanding debt. See Note 2i, Derivative Instruments and Hedge Agreements, for more information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subsequent Events |
12 Months Ended |
|---|---|
Oct. 28, 2023 | |
| Subsequent Events [Abstract] | |
| Subsequent Events | Subsequent EventsOn November 20, 2023, the Board of Directors of the Company declared a cash dividend of $0.86 per outstanding share of common stock. The dividend will be paid on December 14, 2023 to all shareholders of record at the close of business on December 4, 2023 and is expected to total approximately $426.8 million. |
Valuation and Qualifying Accounts |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Valuation and Qualifying Accounts | SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS Years ended October 28, 2023, October 29, 2022 and October 30, 2021 (dollar amounts in thousands)
_______________________________________ (1)Represents balances assumed as part of the Acquisition.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pay vs Performance Disclosure - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Pay vs Performance Disclosure | |||
| Net Income (Loss) | $ 3,314,579 | $ 2,748,561 | $ 1,390,422 |
Insider Trading Arrangements |
3 Months Ended |
|---|---|
Oct. 28, 2023 | |
| Trading Arrangements, by Individual | |
| Rule 10b5-1 Arrangement Adopted | false |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
Summary of Significant Accounting Policies (Policies) |
12 Months Ended | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | |||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||
| Principles of Consolidation | Principles of Consolidation The Consolidated Financial Statements include the accounts of the Company and all of its subsidiaries. Upon consolidation, all intercompany accounts and transactions are eliminated. Certain amounts reported in previous years have been reclassified to conform to the presentation for the fiscal year ended October 28, 2023 (fiscal 2023). Such reclassified amounts are immaterial. The Company’s fiscal year is the 52-week or 53-week period ending on the Saturday closest to the last day in October. Fiscal 2023, the fiscal year ended October 29, 2022 (fiscal 2022) and the fiscal year ended October 30, 2021 (fiscal 2021) were 52-week fiscal periods. On August 26, 2021 (Acquisition Date), the Company completed the acquisition of Maxim Integrated Products, Inc. (Maxim), an independent manufacturer of innovative analog and mixed-signal products and technologies. Pursuant to the Agreement and Plan of Merger, dated as of July 12, 2020 (the Merger Agreement), Maxim stockholders received, for each outstanding share of Maxim common stock, 0.6300 of a share of the Company’s common stock as of the Acquisition Date for total consideration of approximately $28.0 billion of the Company's common stock. The acquisition of Maxim is referred to as the Acquisition. The consolidated financial statements included in this Annual Report on Form 10-K include the financial results of Maxim prospectively from the Acquisition Date. See Note 6, Acquisitions, of the Notes to Consolidated Financial Statements for additional information.
|
||||||||||||||||||||||||||||||
| Cash and Cash Equivalents | Cash and Cash Equivalents Cash and cash equivalents are highly liquid investments with insignificant interest rate risk and maturities of ninety days or less at the time of acquisition. Cash and cash equivalents consist primarily of government and institutional money market funds, corporate obligations such as commercial paper and floating rate notes, bonds, demand deposit accounts, money market deposit accounts, and bank time deposits. The Company classifies its investments in readily marketable debt and equity securities as “held-to-maturity,” “available-for-sale” or “trading” at the time of purchase. There were no transfers between investment classifications in any of the fiscal years presented. Held-to-maturity securities, which are carried at amortized cost, include only those securities the Company has the positive intent and ability to hold to maturity. Securities such as bank time deposits, which by their nature are typically held to maturity, are classified as such. The Company’s other readily marketable cash equivalents are classified as available-for-sale. Available-for-sale securities are carried at fair value with any material unrealized gains and losses, net of related tax, reported in accumulated other comprehensive (loss) income (AOCI). Adjustments to the fair value of investments classified as available-for-sale are recorded as an increase or decrease in AOCI, unless the adjustment is considered an other-than-temporary impairment, in which case the adjustment is recorded as a charge in the Consolidated Statements of Income. The Company reviews available-for-sale securities for impairment whenever the fair value of the security is less than its amortized cost. There were no impairments of investments in any of the fiscal years presented. Realized gains or losses on investments are determined based on the specific identification basis and are recognized in nonoperating (income) expense. There were no material net realized gains or losses from the sales of available-for-sale investments during any of the fiscal periods presented.
|
||||||||||||||||||||||||||||||
| Inventories | InventoriesInventories are valued at the lower of cost (first-in, first-out method) or net realizable value. The valuation of inventory requires the Company to estimate obsolete or excess inventory as well as inventory that is not of saleable quality. The Company employs a variety of methodologies to determine the net realizable value of its inventory. While a portion of the calculation to record inventory at its net realizable value is based on the age of the inventory and lower of cost or net realizable value calculations, a key factor in estimating obsolete or excess inventory requires the Company to estimate the future demand for its products. If actual demand is less than the Company’s estimates, impairment charges, which are recorded to cost of sales, may need to be recorded in future periods. Inventory in excess of saleable amounts is not valued, and the remaining inventory is valued at the lower of cost or net realizable value. | ||||||||||||||||||||||||||||||
| Property, Plant and Equipment | Property, Plant and Equipment PP&E is recorded at cost, less allowances for depreciation and amortization. The straight-line method of depreciation is used for all classes of assets for financial statement purposes while both straight-line and accelerated methods are used for income tax purposes. Leasehold improvements are depreciated over the lesser of the term of the lease or the useful life of the asset. Repairs and maintenance charges are expensed as incurred. Depreciation is based on the following ranges of estimated useful lives:
The Company reviews PP&E for impairment whenever events or changes in circumstances indicate that the carrying amount of assets may not be recoverable. Recoverability of these assets is determined by comparison of their carrying amount to the future undiscounted cash flows the assets are expected to generate over their remaining economic lives. If such assets are considered to be impaired, the impairment to be recognized in earnings equals the amount by which the carrying value of the assets exceeds their fair value determined by either a quoted market price, if any, or a value determined by utilizing a discounted cash flow technique. If such assets are not impaired, but their useful lives have decreased, the remaining net book value is depreciated over the revised useful life. PP&E is identified as held for sale when it meets the held for sale criteria of Accounting Standards Codification Topic 360, Property, Plant, and Equipment (ASC 360). Depreciation is not recorded for assets that are classified as held for sale. When an asset meets the held for sale criteria, the lower of its carrying value or fair value less costs to sell is reclassified from the relevant PP&E line items and into current assets on the balance sheet, where it remains until it is either sold or it no longer meets the held for sale criteria. If the assets held for sale were carried at fair value, it would be considered a Level 3 fair value measurement, and determined based on the use of appraisals and input from market participants.
|
||||||||||||||||||||||||||||||
| Goodwill | Goodwill The Company evaluates goodwill for impairment annually, as well as whenever events or changes in circumstances suggest that the carrying value of goodwill may not be recoverable, utilizing either the qualitative or quantitative method. The Company tests goodwill for impairment at the reporting unit level, which the Company has determined is consistent with its identified operating segments, on an annual basis on the first day of the fourth quarter (on or about July 30) or more frequently if indicators of impairment exist or the Company reorganizes its operating segments or reporting units. The Company has the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its net book value. When using the qualitative method, the Company considers several factors, including the following: –the amount by which the fair values of each reporting unit exceeded their carrying values as of the date of the most recent quantitative impairment analysis, which indicated there would need to be substantial negative developments in the markets in which these reporting units operate in order for there to be potential impairment; –the carrying values of these reporting units as of the assessment date compared to the previously calculated fair values as of the date of the most recent quantitative impairment analysis; –the Company's current forecasts as compared to the forecasts included in the most recent quantitative impairment analysis; –public information from competitors and other industry information to determine if there were any significant adverse trends in the Company's competitors' businesses; –changes in the value of major U.S. stock indices that could suggest declines in overall market stability that could impact the valuation of the Company's reporting units; –changes in the Company's market capitalization and overall enterprise valuation to determine if there were any significant decreases that could be an indication that the valuation of its reporting units had significantly decreased; and –whether there had been any significant increases to the weighted-average cost of capital rates for each reporting unit, which could materially lower the Company's prior valuation conclusions under a discounted cash flow approach. If the Company elects not to use this option, or it determines that it is more likely than not that the fair value of a reporting unit is less than its net book value, then the Company performs the quantitative goodwill impairment test. The quantitative goodwill impairment test requires an entity to compare the fair value of a reporting unit with its carrying amount. If fair value is determined to be less than carrying value, an impairment loss is recognized for the amount of the carrying value that exceeds the amount of the reporting unit's fair value, not to exceed the total amount of goodwill allocated to the reporting unit. Additionally, the Company considers income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. Management determines the fair values of the reporting units using a weighting of the income and market approaches. Under the income approach, it uses a discounted cash flow methodology, which requires management to make significant estimates and assumptions related to forecasted revenues, gross profit margins, operating income margins, working capital cash flow, perpetual growth rates and long-term discount rates, among others. For the market approach, it uses the guideline public company method. Under this method management utilizes information from comparable publicly traded companies with similar operating and investment characteristics as the reporting units, to create valuation multiples that are applied to the operating performance of the reporting unit being tested, in order to obtain its respective fair value. In order to assess the reasonableness of the calculated values, the aggregate fair values of the reporting units are reconciled to the Company's total market capitalization, allowing for a reasonable control premium. In fiscal 2023, the Company used the qualitative method of assessing goodwill for the Company's reporting units. In fiscal 2022, the Company used a combination of the qualitative and quantitative methods of assessing goodwill for the Company's reporting units. In all periods presented, management concluded the reporting units' fair values exceeded their carrying amounts as of the assessment dates and no risk of impairment existed. The Company’s next annual impairment assessment will be performed as of the first day of the fourth quarter of the fiscal year ending November 2, 2024 (fiscal 2024) unless indicators arise that would require the Company to reevaluate at an earlier date.
|
||||||||||||||||||||||||||||||
| Intangible Assets | Intangible Assets The Company reviews finite-lived intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of assets may not be recoverable. If required, recoverability of these assets is determined by comparison of their carrying value to the estimated future undiscounted cash flows the assets are expected to generate over their remaining estimated useful lives. If such assets are considered to be impaired, the impairment to be recognized in earnings equals the amount by which the carrying value of the assets exceeds their estimated fair value determined by either a quoted market price, if any, or a value determined by utilizing a discounted cash flow technique. In-process research and development (IPR&D) assets are considered indefinite-lived intangible assets until completion or abandonment of the associated research and development (R&D) efforts. Upon completion of the projects, the IPR&D assets are reclassified to technology-based intangible assets and amortized over their estimated useful lives.
|
||||||||||||||||||||||||||||||
| Grant Accounting | Grant AccountingCertain of the Company’s subsidiaries have received grants from governmental agencies. These grants include capital, employment and research and development grants. Capital grants for the acquisition of property, plant and equipment are netted against the related capital expenditures and amortized as a credit to depreciation expense over the estimated useful life of the related asset. Employment grants, which relate to employee hiring and training, and research and development grants are recognized in earnings in the period in which the related expenditures are incurred by the Company. In August 2022, the U.S. government enacted the CHIPS and Science Act of 2022 (CHIPS Act), which provides funding for manufacturing grants and research investments and establishes a 25% investment tax credit for certain investments in U.S. semiconductor manufacturing. As of October 28, 2023 and October 29, 2022, the Company recognized $174.3 million and $16.6 million, respectively, in other assets with a corresponding reduction to the carrying amounts of the qualifying manufacturing assets on the Consolidated Balance Sheets. | ||||||||||||||||||||||||||||||
| Translation of Foreign Currencies | Translation of Foreign CurrenciesGenerally, the functional currency of the Company’s foreign operations is the U.S. dollar. In certain entities where that is not the case, gains and losses resulting from translation of the foreign currencies into U.S. dollars are recorded in AOCI. Transaction gains and losses and re-measurement of foreign currency denominated assets and liabilities are included in income currently, including those at the Company’s principal foreign manufacturing operations where the functional currency is the U.S. dollar. Foreign currency transaction gains or losses are included in other, net in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||||
| Foreign Exchange Exposure Management | Foreign Exchange Exposure Management — The Company enters into forward foreign currency exchange contracts to offset certain operational and balance sheet exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company’s operations, assets and liabilities that are denominated in currencies other than the U.S. dollar, primarily the Euro; other significant exposures include the British Pound, Philippine Peso, Thai Baht, Malaysian Ringgit and the Japanese Yen. Derivative instruments are employed to eliminate or minimize certain foreign currency exposures that can be confidently identified and quantified. These foreign currency exchange contracts are entered into to support transactions made in the normal course of business, and accordingly, are not speculative in nature. The contracts are for periods consistent with the terms of the underlying transactions, generally one year or less. Hedges related to anticipated transactions are matched with the underlying exposures at inception and designated and documented as cash flow hedges. They are qualitatively evaluated for effectiveness on a quarterly basis. The gain or loss on the derivatives are reported as a component of AOCI in shareholders’ equity and reclassified into earnings in the same line item on the Consolidated Statements of Income as the impact of the hedged transaction in the same period during which the hedged transaction affects earnings. | ||||||||||||||||||||||||||||||
| Interest Rate Exposure Management | Interest Rate Exposure Management — The Company's current and future debt may be subject to interest rate risk. The Company utilizes interest rate derivatives to alter interest rate exposure in an attempt to reduce the effects of changes in interest rates. During fiscal 2019, the Company entered into an interest rate swap agreement which locked in the interest rate for up to $1 billion in future debt issuances. The interest rate swap was designated and qualified as a cash flow hedge. During fiscal 2021, the Company issued $1 billion of 2.100% Senior Notes due October 2031, and the swap was cash terminated in the amount of $153.2 million. During fiscal 2023, the Company entered into interest rate swap transactions related to its outstanding $1,000.0 million aggregate principal amount of 2.1% senior unsecured notes (the 2031 Notes) where the Company swapped the notional amount of its $1,000.0 million of fixed rate debt at 2.1% into floating interest rate debt through April 1, 2031. The fair value of the swaps at inception was zero and subsequent changes in the fair value of the interest rate swaps were reflected in the carrying value of the interest rate swaps on the balance sheet. The carrying value of the debt on the balance sheet was adjusted by an equal and offsetting amount. The interest rate swaps were designated and qualified as fair value hedges. The Company does not consider the risk of counterparty default to be significant. | ||||||||||||||||||||||||||||||
| Derivative Instruments and Hedging Agreements | The market risk associated with the Company’s derivative instruments results from currency exchange rate or interest rate movements that are expected to offset the market risk of the underlying transactions, assets and liabilities being hedged. The counterparties to the agreements relating to the Company’s derivative instruments consist of a number of major international financial institutions with high credit ratings. Based on the credit ratings of the Company’s counterparties as of October 28, 2023 and October 29, 2022, nonperformance is not perceived to be a material risk. Furthermore, none of the Company’s derivatives are subject to collateral or other security arrangements and none contain provisions that are dependent on the Company’s credit ratings from any credit rating agency. While the contract or notional amounts of derivative financial instruments provide one measure of the volume of these transactions, they do not represent the amount of the Company’s exposure to credit risk. The amounts potentially subject to credit risk (arising from the possible inability of counterparties to meet the terms of their contracts) are generally limited to the amounts, if any, by which the counterparties’ obligations under the contracts exceed the obligations of the Company to the counterparties. As a result of the above considerations, the Company does not consider the risk of counterparty default to be significant. The Company records the fair value of its derivative financial instruments in its Consolidated Financial Statements in other current assets, other assets, accrued liabilities, other non-current liabilities and long-term debt, depending on their net position, regardless of the purpose or intent for holding the derivative contract. Changes in the fair value of cash flow hedges are recorded in AOCI and reclassified into earnings in the same line item on the Consolidated Statements of Income as the impact of the hedged transaction when the underlying contract matures. Changes in the fair value of designated fair value hedges are recorded on the Consolidated Balance Sheet as a swap asset or an accrued liability with an offsetting increment/decrement to the long-term debt balance, which is the underlying item being hedged. Changes in the fair values of derivatives not qualifying for hedge accounting are reported in earnings as they occur. For information on the unrealized holding gains (losses) on derivatives included in and reclassified out of AOCI into the Consolidated Statements of Income related to forward foreign currency exchange contracts, see Note 2o, Accumulated Other Comprehensive (Loss) Income, of the Notes to Consolidated Financial Statements.
|
||||||||||||||||||||||||||||||
| Fair Value | Fair Value The Company defines fair value as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Level 1 — Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 — Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified (contractual) term, a Level 2 input must be observable for substantially the full term of the asset or liability. Level 3 — Level 3 inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date. The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments: Cash equivalents — These investments are adjusted to fair value based on quoted market prices or are determined using a yield curve model based on current market rates. Deferred compensation plan investments — The fair value of these mutual fund, money market fund and equity investments are based on quoted market prices. Forward foreign currency exchange contracts — The estimated fair value of forward foreign currency exchange contracts, which includes derivatives that are accounted for as cash flow hedges and those that are not designated as cash flow hedges, is based on the estimated amount the Company would receive if it sold these agreements at the reporting date taking into consideration current exchange rates as well as the creditworthiness of the counterparty for assets and the Company’s creditworthiness for liabilities. The fair value of these instruments is based upon valuation models using current market information such as strike price, spot rate, forward points, and maturity date. Interest rate derivative — The fair value of interest rate derivatives is estimated using a discounted cash flow analysis based on the contractual terms of the derivatives. Financial Instruments Not Recorded at Fair Value on a Recurring Basis Santa Clara, California leased property asset group — As a result of a sublease transaction involving a leased property in Santa Clara, California during fiscal 2022, the Company estimated the fair value of the sublease assets using discounted cash flows from the estimated net sublease rental income discounted at a market rate and recorded an impairment charge which represented the excess carrying value of the asset group associated with the Santa Clara, California leased property over its estimated fair value. These assets are considered a Level 2 fair value measurement. See Note 5, Special Charges, Net, of the Notes to Consolidated Financial Statements for additional information. Held for sale assets — The Company has classified the assets held for sale at carrying value. However, if they were to be carried at fair value, they would be considered a Level 3 fair value measurement and would be determined based on the use of appraisals and input from market participants. Commercial paper notes — The fair values of commercial paper notes are obtained from indicative market prices and are classified as Level 2 measurements according to the fair value hierarchy. As of October 28, 2023, the fair value of the commercial paper notes was $547.2 million.
|
||||||||||||||||||||||||||||||
| Use of Estimates | Use of EstimatesThe preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Such estimates relate to the useful lives of fixed assets and identified intangible assets; allowances for doubtful accounts and customer returns; the net realizable value of inventory; potential reserves relating to litigation matters; accrued liabilities, including estimates of variable consideration related to distributor sales; accrued taxes; uncertain tax positions; deferred tax valuation allowances; assumptions pertaining to stock-based compensation payments and defined benefit plans; and fair value of acquired assets and liabilities, including inventory, property, plant and equipment, goodwill and acquired intangibles; and other reserves. Actual results could differ from those estimates and such differences may be material to the financial statements. | ||||||||||||||||||||||||||||||
| Concentrations of Risk | Concentrations of Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of investments and trade accounts receivable. The Company maintains cash and cash equivalents with high credit quality counterparties, continuously monitors the amount of credit exposure to any one issuer and diversifies its investments in order to minimize its credit risk. The Company sells its products to distributors and original equipment manufacturers (OEMs) involved in a variety of industries including industrial, communications, automotive and consumer end markets. The Company has adopted credit policies and standards to accommodate growth in these markets. The Company performs continuing credit evaluations of its customers’ financial condition and although the Company generally does not require collateral, the Company may require letters of credit from customers in certain circumstances. The Company provides reserves for estimated amounts of accounts receivable that may not be collected.
|
||||||||||||||||||||||||||||||
| Concentration of Other Risks | Concentration of Other RisksThe semiconductor industry is characterized by rapid technological change, competitive pricing pressures and cyclical market patterns. The Company’s financial results are affected by a wide variety of factors, including general economic conditions worldwide, economic conditions specific to the semiconductor industry, the timely implementation of new manufacturing technologies, the ability to safeguard patents and intellectual property in a rapidly evolving market and reliance on assembly and test subcontractors, third-party wafer fabricators and independent distributors. In addition, the semiconductor market has historically been cyclical and subject to significant economic downturns at various times. The Company is exposed to the risk of obsolescence of its inventory depending on the mix of future business. Additionally, more than half of the Company’s purchases of external wafer and foundry services are from a limited number of suppliers, such as Taiwan Semiconductor Manufacturing Company (TSMC) and others. If these suppliers or any of the Company’s other key suppliers are unable or unwilling to manufacture and deliver sufficient quantities of components, on the time schedule and of the quality that the Company requires, the Company may be forced to engage additional or replacement suppliers, which could result in significant expenses and disruptions or delays in manufacturing, product development and shipment of product to the Company’s customers. | ||||||||||||||||||||||||||||||
| Revenue Recognition | Revenue Recognition Recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the providing entity expects to be entitled in exchange for those goods or services. The Company recognizes revenue upon transfer of control of promised products or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. The Company recognizes revenue when all of the following criteria are met: (1) the Company has entered into a binding agreement, (2) the performance obligations have been identified, (3) the transaction price to the customer has been determined, (4) the transaction price has been allocated to the performance obligations in the contract, and (5) the performance obligations have been satisfied. The majority of the Company's shipping terms permit the Company to recognize revenue at point of shipment or delivery. Certain shipping terms require the goods to be through customs or be received by the customer before title passes. In those instances, the Company defers the revenue recognized until title and control of the promised goods have passed to the customer. Shipping costs are charged to selling, marketing, general and administrative expense as incurred. Sales taxes are excluded from revenue. Revenue from contracts with the United States government, government prime contractors and certain commercial customers is recorded over time using either units delivered or costs incurred as the measurement basis for progress toward completion. These measures are used to measure results directly and is generally the best measure of progress toward completion in circumstances in which a reliable measure of output can be established. Estimated revenue in excess of amounts billed is reported as unbilled receivables. Contract accounting requires judgment in estimating costs and assumptions related to technical issues and delivery schedule. Contract costs include material, subcontract costs, labor and an allocation of indirect costs. The estimation of costs at completion of a contract is subject to numerous variables involving contract costs and estimates as to the length of time to complete the contract. Changes in contract performance, estimated gross margin, including the impact of final contract settlements, and estimated losses are recognized in the period in which the changes or losses are determined. Performance Obligations: Substantially all of the Company’s contracts with customers contain a single performance obligation, the sale of mixed-signal integrated circuit products. Such sales represent a single performance obligation because the sale is one type of good or includes multiple goods that are neither capable of being distinct nor separable from the other promises in the contract. This performance obligation is satisfied when control of the product is transferred to the customer, which occurs upon shipment or delivery. Unsatisfied performance obligations primarily represent contracts for products with future delivery dates and with an original expected duration of one year or less. The Company generally offers a twelve-month warranty for its products. The Company’s warranty policy provides for replacement of defective products. Specific accruals are recorded for known product warranty issues. Product warranty expenses during fiscal 2023, fiscal 2022 and fiscal 2021 were not material. Transaction Price: The transaction price reflects the Company’s expectations about the consideration it will be entitled to receive from the customer and may include fixed or variable amounts. Fixed consideration primarily includes sales to direct customers and sales to distributors in which both the sale to the distributor and the sale to the end customer occur within the same reporting period. Variable consideration includes sales in which the amount of consideration that the Company will receive is unknown as of the end of a reporting period. The vast majority of such consideration are credits issued to the distributor due to price protection, but also include sales made to distributors under agreements that allow certain rights of return, referred to as stock rotation. Price protection represents price discounts granted to certain distributors to allow the distributor to earn an appropriate margin on sales negotiated with certain customers and in the event of a price decrease subsequent to the date the product was shipped and billed to the distributor. Stock rotation allows distributors limited levels of returns in order to reduce the amounts of slow-moving, discontinued or obsolete product from their inventory. A liability for distributor credits covering variable consideration is made based on the Company's estimate of historical experience rates as well as considering economic conditions and contractual terms. To date, actual distributor claims activity has been materially consistent with the provisions the Company has made based on its historical estimates. For fiscal 2023 and fiscal 2022, sales to distributors were approximately $7.5 billion and $7.5 billion, respectively, net of variable consideration for which the liability balances as of October 28, 2023 and October 29, 2022 were $525.4 million and $749.4 million, respectively, and were recorded in accrued liabilities on the Consolidated Balance Sheets.Contract Balances: Accounts receivable represents the Company’s unconditional right to receive consideration from its customers. Payments are typically due within 30 to 45 days of invoicing and do not include a significant financing component. To date, there have been no material credit losses on accounts receivable. There were no material contract assets or contract liabilities recorded on the Consolidated Balance Sheets in any of the periods presented.
|
||||||||||||||||||||||||||||||
| Income Taxes | Income Taxes The Company makes certain estimates and judgments in determining income tax expense for financial statement purposes. These estimates and judgments occur in the calculation of income tax credits, benefits, and deductions, and in the calculation of certain tax assets and liabilities, which arise from differences in the timing of the recognition of certain expenses for tax and financial statement purposes. The likelihood of the realization of deferred tax assets is assessed and a corresponding valuation allowance is recorded as necessary if management determines those deferred tax assets may not be realized due to the uncertainty of the timing and amount to be realized of certain state and international tax credit carryovers. In reaching this conclusion, the Company evaluates certain relevant criteria including the existence of deferred tax liabilities that can be used to realize deferred tax assets, the taxable income in prior carryback years in the impacted state and international jurisdictions that can be used to absorb net operating losses and taxable income in future years. Judgments regarding future profitability may change due to future market conditions, changes in U.S. or international tax laws and other factors. These changes, if any, may require material adjustments to these deferred tax assets, which may result in an increase or decrease to the income tax provision in future periods. The Company accounts for uncertain tax positions by first determining if it is “more likely than not” that a tax position will be sustained by the appropriate taxing authorities prior to recording any benefit in the Consolidated Financial Statements. An uncertain income tax position is not recognized if it has less than a 50% likelihood of being sustained. For those tax positions where it is more likely than not that a tax position will be sustained, the Company has recorded the largest amount of tax benefit with a greater than 50% likelihood of being realized upon ultimate settlement with a taxing authority that has full knowledge of all relevant information. For those income tax positions where it is not more likely than not that a tax benefit will be sustained, no tax benefit has been recognized in the financial statements. Management classifies interest and penalties related to uncertain tax positions within the provision for (benefit from) income taxes line of the Consolidated Statements of Income. Management reevaluates these uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, changes in known facts or circumstances, changes in tax law, effectively settled issues under audit, and new guidance on legislative interpretations. A change in these factors could result in the recognition of an increase or decrease to the Company's income tax provision which could materially impact its consolidated financial position and results of operations. In the ordinary course of global business, there are many transactions and calculations where the ultimate tax outcome is uncertain. Some of these uncertainties arise as a consequence of cost reimbursement and royalty arrangements among related entities. Although the Company believes its estimates are reasonable, no assurance can be given that the final tax outcome of these matters will not be different than that which is reflected in the historical income tax provisions and income tax liabilities. In the event management's assumptions are incorrect, the differences could have a material impact on its income tax provision and operating results in the period in which such determination is made. In addition to the factors described above, the current and expected effective tax rate is based on then-current tax law. Significant changes in enacted tax law could affect these estimates. See Note 12, Income Taxes, of the Notes to Consolidated Financial Statements for further information related to income taxes.
|
||||||||||||||||||||||||||||||
| Earnings Per Share of Common Stock | Earnings Per Share of Common Stock Basic earnings per share is computed based only on the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares outstanding during the period, plus the dilutive effect of potential future issuances of common stock relating to stock option programs and other potentially dilutive securities using the treasury stock method. In calculating diluted earnings per share, the dilutive effect of stock options and restricted stock units is computed using the average market price for the respective period. In addition, the assumed proceeds under the treasury stock method include the average unrecognized compensation expense of stock options that are in-the-money and restricted stock units. This results in the “assumed” buyback of additional shares, thereby reducing the dilutive impact of in-the-money stock options. Potential shares related to certain of the Company’s outstanding stock options and restricted stock units were excluded because they were anti-dilutive. Those potential shares, determined based on the weighted average exercise prices during the respective periods, could be dilutive in the future. In connection with the acquisition of Linear Technology Corporate (Linear), the Company granted restricted stock awards to replace outstanding restricted stock awards of Linear employees. These restricted stock awards entitle recipients to voting and nonforfeitable dividend rights from the date of grant. These unvested stock-based compensation awards are considered participating securities and the two-class method is used for purposes of calculating earnings per share. Under the two-class method, a portion of net income is allocated to these participating securities and therefore is excluded from the calculation of earnings per share allocated to common stock. The difference between the income allocated to participating securities under the basic and diluted two-class methods is not material.
|
||||||||||||||||||||||||||||||
| Share-Based Compensation | Stock-Based Compensation Stock-based compensation is measured at the grant date based on the grant-date fair value of the awards ultimately expected to vest and is recognized as an expense on a straight-line basis over the vesting period, which is generally four years for stock options and restricted stock units, or in annual installments of 25% on each of the first, second, third and fourth anniversaries of the date of grant. Restricted stock units with service and performance or market conditions generally vest in one installment on the third anniversary of the date of grant. For grants issued prior to fiscal 2018, the vesting period was generally five years for stock options, or in annual installments of 20% on each of the first, second, third, fourth and fifth anniversaries of the date of grant and in one installment on the third anniversary of the date of grant for restricted stock units/awards. The maximum contractual term of all stock options is ten years. Determining the amount of stock-based compensation expense to be recorded requires the Company to develop estimates used in calculating the grant-date fair value of awards. These estimates may be based on different valuation models depending upon the type of award and may include assumptions, such as expected volatility, expected term, risk-free interest rate, expected dividend yield, forfeiture rate and others. The Company uses the Black-Scholes valuation model to calculate the grant-date fair value of stock option awards. The grant-date fair value of restricted stock units with a service condition and restricted stock units with both service and performance conditions is calculated using the value of the Company's common stock on the date of grant, reduced by the present value of dividends expected to be paid on the Company's common stock prior to vesting. For restricted stock units with both service and performance conditions, this grant-date fair value is also impacted by the number of units that are expected to vest during the performance period and is adjusted through the related stock-based compensation expense at each reporting period based on the probability of achievement of that performance condition. If the Company determines that an award is unlikely to vest, any previously recorded stock-based compensation expense is reversed in the period of that determination. The grant date fair value of restricted stock units and performance-based stock options with both service and market conditions is calculated using the Monte Carlo simulation model to estimate the probability of satisfying the performance condition stipulated in the award grant, including the possibility that the market condition may not be satisfied. The fair value of shares to be issued under the Company's employee stock purchase plan (ESPP) is computed using the Black-Scholes model at the commencement of an offering period in June and December of each year and the related expense is recorded over the offering period. See Note 3, Stock-Based Compensation and Shareholders' Equity, of the Notes to Consolidated Financial Statements for additional information relating to stock-based compensation.
|
||||||||||||||||||||||||||||||
| New Accounting Pronouncements | New Accounting Pronouncements Standards to Be Implemented Acquired Contract Assets and Contract Liabilities In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities. Under the new guidance (ASC 805-20-30-28), the acquirer should determine what contract assets and/or contract liabilities it would have recorded under ASC 606 (the revenue guidance) as of the acquisition date, as if the acquirer had entered into the original contract at the same date and on the same terms as the acquiree. The recognition and measurement of those contract assets and contract liabilities will likely be comparable to what the acquiree has recorded on its books under ASC 606 as of the acquisition date. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company will adopt this standard in the first quarter of fiscal 2024 and apply to any future business combinations.
|
||||||||||||||||||||||||||||||
Summary of Significant Accounting Policies (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of cash and cash equivalents and short term investments | The components of the Company’s cash and cash equivalents as of October 28, 2023 and October 29, 2022 were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of supplemental cash flow statement information |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of inventories | Inventories at October 28, 2023 and October 29, 2022 were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of property, plant and equipment | The following table presents details of the Company's property, plant and equipment (PP&E), net of accumulated depreciation:
_________________________________ (1) Certain amounts previously reported between machinery and equipment and office equipment have been reclassified to conform to the presentation for fiscal 2023. Depreciation is based on the following ranges of estimated useful lives:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of reclassification from properly, plant and equipment | As of October 28, 2023, prepaid expenses and other current assets includes the following assets held for sale:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of changes in goodwill | The following table presents the changes in goodwill during fiscal 2023 and fiscal 2022:
_______________________ (1) See Note 6, Acquisitions, of the Notes to Consolidated Financial Statements for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of intangible assets | As of October 28, 2023 and October 29, 2022, the Company’s intangible assets consisted of the following:
_______________________________________ (1) In fiscal 2022 foreign intangible asset carrying amounts were affected by foreign currency translation.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of expected annual amortization expense | The Company expects annual amortization expense for intangible assets as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of fair value of hedging instruments | The fair values of forward foreign currency derivative instruments designated as hedging instruments in the Company’s Consolidated Balance Sheets as of October 28, 2023 and October 29, 2022 were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of offsetting assets liabilities | The following table presents the gross amounts of the Company's forward foreign currency exchange contracts and the net amounts recorded in the Company's Consolidated Balance Sheet as of October 29, 2022:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of interest rate derivatives | The gain or loss on the hedged item attributable to the hedged benchmark interest rate risk and the offsetting gain or loss on the related interest rate swaps were recorded as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of fair value of financial assets and liabilities | The tables below, set forth by level, presents the Company’s financial assets and liabilities, excluding accrued interest components, that were accounted for at fair value on a recurring basis as of October 28, 2023 and October 29, 2022. The tables exclude cash on hand and assets and liabilities that are measured at historical cost or any basis other than fair value. As of October 28, 2023 and October 29, 2022, the Company held $642.1 million and $1,016.0 million, respectively, of cash that was excluded from the tables below.
(1) The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 2i, Derivative Instruments and Hedging Agreements, of the Notes to Consolidated Financial Statements for more information related to the Company's master netting arrangements. (2) The carrying value of the related debt was adjusted by an equal and offsetting amount. See Note 2i, Derivative Instruments and Hedging Agreements, of the Notes to Consolidated Financial Statements.
(1) The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 2i, Derivative Instruments and Hedging Agreements, of the Notes to Consolidated Financial Statements for more information related to the Company's master netting arrangements.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of debt | The table below presents the estimated fair value of certain financial instruments not recorded at fair value on a recurring basis. As commercial paper issuances are at then current rates and with very short maturities, the carrying value will approximate fair value. The fair values of the senior unsecured notes are obtained from broker prices and are classified as Level 1 measurements according to the fair value hierarchy. See Note 14, Debt, of the Notes to Consolidated Financial Statements for further discussion related to outstanding debt.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of components of accumulated other comprehensive (loss) income | The changes in components of AOCI at October 28, 2023 and October 29, 2022 consisted of the following:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of reclassification out of accumulated other comprehensive income | The amounts reclassified out of AOCI into the Consolidated Statements of Income, with presentation location during each period were as follows:
_______________________________________ (1)The amortization of pension components is included in the computation of net periodic benefit cost. See Note 11, Retirement Plans, of the Notes to Consolidated Financial Statements for further information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of computation of basic and diluted earnings per share | The following table sets forth the computation of basic and diluted earnings per share:
_______________________________________ (1)For all fiscal years presented, income allocated to participating securities, if any, is not material.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-Based Compensation and Shareholders' Equity (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-Based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Company's stock option awards and the related estimated weighted-average assumptions used to calculate the fair value of stock options granted | Information pertaining to the Company’s stock option awards and the related estimated weighted-average assumptions to calculate the fair value of stock options using the Black-Scholes valuation model granted in fiscal 2021 is below. The Company did not grant stock option awards in fiscal 2023 or fiscal 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of share-based payment arrangement, expensed amount | Total stock-based compensation expense recognized is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of the activity under the Company's stock option plans | A summary of the activity under the Company’s stock option plans as of October 28, 2023 and changes during the fiscal year then ended is presented below:
_______________________________________ (1)In addition to the vested options, the Company expects a portion of the unvested options to vest at some point in the future. The number of options expected to vest is calculated by applying an estimated forfeiture rate to the unvested options.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of the company's restricted stock unit award activity | A summary of the Company’s restricted stock unit and award activity as of October 28, 2023 and changes during the fiscal year then ended is presented below:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Industry, Segment And Geographic Information (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of revenue trends by end market | The following table summarizes revenue by end market. The categorization of revenue by end market is determined using a variety of data points including the technical characteristics of the product, the “sold to” customer information, the "ship to" customer information and the end customer product or application into which the Company’s product will be incorporated. As data systems for capturing and tracking this data and the Company's methodology evolves and improves, the categorization of products by end market can vary over time. When this occurs, the Company reclassifies revenue by end market for prior periods. Such reclassifications typically do not materially change the sizing of, or the underlying trends of results within each end market.
_______________________________________ (1)The sum of the individual percentages may not equal the total due to rounding.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of revenue trends by sales channel | The following tables summarize revenue by sales channel. The Company sells its products globally through a direct sales force, third party distributors, independent sales representatives and via its website. Distributors are customers that buy products with the intention of reselling them. Direct customers are non-distributor customers and consist primarily of original equipment manufacturers (OEMs). Other customers include the U.S. government, government prime contractors and certain commercial customers for which revenue is recorded over time.
_______________________________________ (1)The sum of the individual percentages may not equal the total due to rounding.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of revenue trends and property, plant and equipment by geographic region | Geographic revenue information for fiscal 2023, fiscal 2022 and fiscal 2021 reflects the geographic location of the distributors or OEMs who purchased the Company's products. This may differ from the geographic location of the end customers. In all periods presented, the predominant regions comprising “Rest of North and South America” are Canada and Mexico; the predominant regions comprising “Europe” are Germany, Sweden and the Netherlands; and the predominant regions comprising “Rest of Asia” are Taiwan, Malaysia, South Korea and Singapore.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special Charges, Net (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Restructuring and Related Activities [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of the company's accrued restructuring | The activity is detailed below:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acquisitions (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Combination and Asset Acquisition [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of business acquisitions, by acquisition | The Acquisition Date fair value of the consideration transferred in the Acquisition consisted of the following:
____________________ (a)This reflects the cash paid for fractional shares of the Company’s common stock in respect of shares of Maxim common stock outstanding. (b)The fair value is based on the issuance of approximately 169.2 million shares of the Company's common stock with a per share value of $164.00 on the Acquisition Date. (c)In connection with the Acquisition, the Company issued equity awards, consisting of restricted stock and restricted stock units, to certain Maxim employees in replacement of Maxim equity awards that were cancelled at closing. The replacement awards consist of restricted stock and restricted stock unit awards for approximately 3.7 million shares of the Company's common stock with a weighted average grant date fair value of $161.63. This amount represents the portion of the fair value of the replacement equity awards associated with services rendered through the Acquisition Date and has been included as a component of the total purchase consideration.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of recognized identified assets acquired and liabilities assumed | During fiscal 2022, the Company completed the acquisition accounting for the Acquisition. The following is a summary of the amounts recognized in accounting for the Acquisition:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of finite-lived intangible assets acquired as part of business combination | The acquired intangible assets consisted of the following, which are being amortized on a straight-line basis over their estimated useful lives or on an accelerated method of amortization that is expected to reflect the estimated pattern of economic use.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of business acquisitions, pro forma information | The following unaudited pro forma consolidated financial information for the twelve months ended October 30, 2021 combines the results of the Company for fiscal 2021 and the unaudited results of Maxim for the corresponding period through the Acquisition Date. The unaudited pro forma consolidated financial information assumes that the Acquisition, which closed on August 26, 2021, was completed on November 3, 2019 (the first day of fiscal 2020). The pro forma consolidated financial information has been calculated after applying the Company’s accounting policies and includes adjustments for amortization expense of acquired intangible assets, fair value adjustments for acquired inventory, property, plant and equipment and long-term debt and compensation expense for ongoing share-based compensation arrangements that were replaced in conjunction with the Acquisition, together with the consequential tax effects. These pro forma results have been prepared for comparative purposes only and do not purport to be indicative of the operating results of the Company that would have been achieved had the Acquisition actually taken place on November 3, 2019. In addition, these results are not intended to be a projection of future results and do not reflect events that may occur after the Acquisition, including but not limited to revenue enhancements, cost savings or operating synergies that the combined Company may achieve as a result of the Acquisition.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accrued Liabilities (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Payables and Accruals [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of accrued liabilities | Accrued liabilities at October 28, 2023 and October 29, 2022 consisted of the following:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Leases [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of assets and liabilities, lessee | The following table presents supplemental balance sheet information related to the Company's operating leases:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of lease, cost | Details of the Company's operating leases are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of lessee, operating lease, liability, maturity | The following table presents the maturities of the Company's operating lease liabilities as of October 28, 2023:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Lessor, operating lease, payment to be received, maturity | The following table presents the future minimum cash receipts as a result of subleases as of October 28, 2023:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Plans (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of net periodic pension cost of non-U.S. plans | Net annual periodic benefit cost of the Company’s pension and postretirement benefit plans for fiscal 2023, fiscal 2022 and fiscal 2021 is presented in the following table:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of obligation and asset data of the company's non-US plans | Obligation and asset data of the Company’s pension and postretirement benefit plans at October 28, 2023 and October 29, 2022 is presented in the following table:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of accumulated and projected benefit obligation in excess of plan assets | Information relating to the Company’s pension and postretirement benefit plans with projected benefit obligations in excess of plan assets and accumulated benefit obligations in excess of plan assets at October 28, 2023 and October 29, 2022 is presented in the following table:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of weighted average assumptions used | The projected benefit obligation was determined using the following weighted-average assumptions:
Net annual periodic benefit cost was determined using the following weighted average assumptions:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of plan assets measured at fair value on a recurring basis by investment categories | The following table presents plan assets measured at fair value on a recurring basis by investment categories as of October 28, 2023 and October 29, 2022 using the same three-level hierarchy described in Note 2j, Fair Value, of the Notes to Consolidated Financial Statements:
_______________________________________ (1)The majority of the assets in these categories are invested in a mix of equities, including those from North America, Europe and Asia. The funds are valued using the net asset value method in which an average of the market prices for underlying investments is used to value the fund. Due to the nature of the underlying assets of these funds, changes in market conditions and the economic environment may significantly impact the net asset value of these investments and, consequently, the fair value of the investments. These investments are redeemable at net asset value to the extent provided in the documentation governing the investments. However, these redemption rights may be restricted in accordance with governing documents. Publicly traded securities are valued at the last trade or closing price reported in the active market in which the individual securities are traded. (2)Consists of funds primarily concentrated in non-U.S. debt instruments. The funds are valued using the net asset value method in which an average of the market prices for underlying investments is used to value the fund. (3)Consists of funds that primarily invest in global real estate and infrastructure funds. The funds are valued using the net asset value method in which an average of the market prices for underlying investments is used to value the fund. (4)Consists of liability driven investment funds that may hold a range of low-risk hedging instruments including but not limited to government bonds, interest rate and inflation swaps, physical inflation-linked and nominal gilts, synthetic gilts, cash and money market instruments. The investment funds are valued at the closing price reported if traded on an active market or at yields currently available on comparable securities of issuers with similar credit ratings.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of expected company contributions and estimated future benefit payments | Expected fiscal 2024 Company contributions and estimated future benefit payments are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Taxes (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of income tax provision reconciliation | The reconciliation of income tax computed at the U.S. federal statutory rates to income tax expense for fiscal 2023, fiscal 2022 and fiscal 2021 is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of income before income tax domestic and foreign | Income before income taxes for fiscal 2023, fiscal 2022 and fiscal 2021 includes the following components:
_______________________________________ (1)Income before income taxes reflects deemed intercompany royalties in all periods presented.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of components of the provision for (benefit from) income taxes | The components of the provision for (benefit from) income taxes for fiscal 2023, fiscal 2022 and fiscal 2021 are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of deferred tax assets and liabilities | The significant components of the Company’s deferred tax assets and liabilities for fiscal 2023 and fiscal 2022 are as follows:
_______________________________________________ (1) As of October 28, 2023, the Company included the effects of the mandatory capitalization and amortization of research and development expenses which began in fiscal 2023 under the Tax Cuts and Jobs Act.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of changes in unrealized tax benefits | The following table summarizes the changes in the total amounts of unrealized tax benefits for fiscal 2021 through fiscal 2023:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of debt | The Company’s debt consisted of the following as of October 28, 2023 and October 29, 2022:
_________________________________ (1) Includes fair value adjustment related to interest rate swap related to outstanding debt. See Note 2i, Derivative Instruments and Hedge Agreements, for more information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Significant Accounting Policies - Principles of Consolidation (Details) $ in Thousands |
12 Months Ended | |||
|---|---|---|---|---|
|
Aug. 26, 2021
USD ($)
|
Oct. 28, 2023
week
|
Oct. 29, 2022
week
|
Oct. 31, 2020
week
|
|
| Accounting Policies [Line Items] | ||||
| Fiscal year term | 52 | 52 | 52 | |
| Maxim | ||||
| Accounting Policies [Line Items] | ||||
| Conversion of company common stock | 0.6300 | |||
| Consideration transferred, equity interests issued and issuable | $ | $ 27,754,161 | |||
| Minimum | ||||
| Accounting Policies [Line Items] | ||||
| Fiscal year term | 52 | |||
| Maximum | ||||
| Accounting Policies [Line Items] | ||||
| Fiscal year term | 53 | |||
| Maximum | Maxim | ||||
| Accounting Policies [Line Items] | ||||
| Consideration transferred, equity interests issued and issuable | $ | $ 28,000,000 | |||
Summary of Significant Accounting Policies - Cash, Cash Equivalents and Short-Term Investments (Details) - USD ($) $ in Thousands |
Oct. 28, 2023 |
Oct. 29, 2022 |
|---|---|---|
| Cash and cash equivalents: | ||
| Cash | $ 642,081 | $ 1,016,027 |
| Available-for-sale securities | 315,980 | 454,545 |
| Total cash and cash equivalents | $ 958,061 | $ 1,470,572 |
Summary of Significant Accounting Policies - Supplemental Cash Flow Statement Information (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Cash paid during the fiscal year for: | |||
| Income taxes | $ 987,225 | $ 821,683 | $ 388,115 |
| Interest | 206,415 | 172,957 | 197,841 |
| Noncash issuance of common stock for the Acquisition | 0 | 0 | 27,754,161 |
| Fair value of partially vested equity replacement awards issued for the Acquisition | $ 0 | $ 0 | $ 194,890 |
Summary of Significant Accounting Policies - Inventories (Details) - USD ($) $ in Thousands |
Oct. 28, 2023 |
Oct. 29, 2022 |
|---|---|---|
| Inventories | ||
| Raw materials | $ 128,142 | $ 110,908 |
| Work in process | 1,125,819 | 904,648 |
| Finished goods | 388,253 | 384,358 |
| Total inventories | $ 1,642,214 | $ 1,399,914 |
Summary of Significant Accounting Policies - Property, Plant and Equipment (Details) - USD ($) $ in Thousands |
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|---|---|---|---|
| Accounting Policies [Abstract] | |||
| Land and buildings | $ 1,715,572 | $ 1,459,981 | |
| Machinery and equipment | 4,377,921 | 3,648,256 | |
| Office equipment | 373,126 | 322,414 | |
| Leasehold improvements | 177,313 | 118,856 | |
| Property, plant and equipment, gross | 6,643,932 | 5,549,507 | |
| Less accumulated depreciation and amortization | 3,424,775 | 3,148,203 | |
| Net property, plant and equipment | $ 3,219,157 | $ 2,401,304 | $ 1,979,051 |
Summary of Significant Accounting Policies - Useful Live of Property, Plant and Equipment (Details) |
Oct. 28, 2023 |
|---|---|
| Buildings | |
| Property Plant And Equipment [Line Items] | |
| Property, plant and equipment, useful life (in years) | 30 years |
| Machinery & equipment | Minimum | |
| Property Plant And Equipment [Line Items] | |
| Property, plant and equipment, useful life (in years) | 4 years |
| Machinery & equipment | Maximum | |
| Property Plant And Equipment [Line Items] | |
| Property, plant and equipment, useful life (in years) | 10 years |
| Office equipment | Minimum | |
| Property Plant And Equipment [Line Items] | |
| Property, plant and equipment, useful life (in years) | 2 years |
| Office equipment | Maximum | |
| Property Plant And Equipment [Line Items] | |
| Property, plant and equipment, useful life (in years) | 10 years |
| Leasehold improvements | Minimum | |
| Property Plant And Equipment [Line Items] | |
| Property, plant and equipment, useful life (in years) | 5 years |
| Leasehold improvements | Maximum | |
| Property Plant And Equipment [Line Items] | |
| Property, plant and equipment, useful life (in years) | 20 years |
Summary of Significant Accounting Policies - Prepaid Expenses and Other Current Assets (Details) $ in Thousands |
Oct. 28, 2023
USD ($)
|
|---|---|
| Long Lived Assets Held-for-sale [Line Items] | |
| Less accumulated depreciation and amortization | $ (20,604) |
| Net property, plant and equipment reclassified to Prepaid expenses and other current assets | 41,120 |
| Land and Buildings | |
| Long Lived Assets Held-for-sale [Line Items] | |
| Land and buildings | $ 61,724 |
Summary of Significant Accounting Policies - Goodwill (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
|
| Changes in goodwill | ||
| Balance at beginning of year | $ 26,913,134 | $ 26,918,470 |
| Foreign currency translation adjustment and other adjustments | 0 | (20,603) |
| Balance at end of year | 26,913,134 | 26,913,134 |
| Maxim | ||
| Changes in goodwill | ||
| Acquisition of Maxim | $ 0 | $ 15,267 |
Summary of Significant Accounting Policies - Intangible Assets (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] | |||
| Gross Carrying Amount | $ 18,360,130 | $ 18,355,033 | |
| Accumulated Amortization | 7,048,173 | 5,089,627 | |
| Amortization of intangibles | $ 1,958,399 | 2,014,161 | $ 843,359 |
| Weighted average useful lives (in years) | 4 years 2 months 12 days | ||
| Finite-Lived Intangible Assets, Future Amortization Expense [Abstract] | |||
| 2024 | $ 1,739,964 | ||
| 2025 | 1,579,260 | ||
| 2026 | 1,529,468 | ||
| 2027 | 1,526,093 | ||
| 2028 | 1,462,929 | ||
| IPR&D | |||
| Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] | |||
| Gross Carrying Amount | 0 | 28,222 | |
| Customer relationships | |||
| Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] | |||
| Gross Carrying Amount | 10,335,903 | 10,335,903 | |
| Accumulated Amortization | 3,811,865 | 3,011,889 | |
| Technology-based | |||
| Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] | |||
| Gross Carrying Amount | 7,589,027 | 7,555,708 | |
| Accumulated Amortization | 2,804,876 | 1,804,596 | |
| Trade-name | |||
| Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] | |||
| Gross Carrying Amount | 72,200 | 72,200 | |
| Accumulated Amortization | 68,432 | 58,117 | |
| Backlog | |||
| Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] | |||
| Gross Carrying Amount | 361,200 | 361,200 | |
| Accumulated Amortization | 361,200 | 213,346 | |
| Assembled workforce | |||
| Finite-Lived and Indefinite-Lived Intangible Assets [Line Items] | |||
| Gross Carrying Amount | 1,800 | 1,800 | |
| Accumulated Amortization | $ 1,800 | $ 1,679 | |
Summary of Significant Accounting Policies - Grant Accounting (Details) - USD ($) $ in Millions |
Oct. 28, 2023 |
Oct. 29, 2022 |
|---|---|---|
| Accounting Policies [Abstract] | ||
| Grant receivable | $ 174.3 | $ 16.6 |
Summary of Significant Accounting Policies - Derivatives Textual (Details) - USD ($) |
12 Months Ended | ||||
|---|---|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
Oct. 05, 2021 |
Nov. 02, 2019 |
|
| Derivative [Line Items] | |||||
| Principal | $ 7,064,301,000 | $ 6,576,865,000 | |||
| 2031 Notes, due October 2031 | Senior Notes | |||||
| Derivative [Line Items] | |||||
| Principal | $ 1,000,000,000 | 1,000,000,000 | $ 1,000,000,000 | $ 1,000,000,000 | |
| Interest rate (as a percent) | 2.10% | 2.10% | |||
| Forward Contracts | |||||
| Derivative [Line Items] | |||||
| Term of contract | 1 year | ||||
| Notional amount of cash flow hedges | $ 322,600,000 | 307,100,000 | |||
| Derivative, notional amount | 334,700,000 | $ 246,400,000 | |||
| Interest Rate Swap | |||||
| Derivative [Line Items] | |||||
| Derivative, notional amount | $ 1,000,000,000 | ||||
| Derivative, cash terminated amount | $ 153,200,000 | ||||
| Interest Rate Swap | 2031 Notes, due October 2031 | Senior Notes | |||||
| Derivative [Line Items] | |||||
| Principal | $ 1,000,000,000 | ||||
| Interest rate (as a percent) | 2.10% | ||||
| Interest rate derivatives, fair value | $ 0 |
Summary of Significant Accounting Policies - Derivative Instruments Designated as Cash Flow Hedges (Details) - USD ($) $ in Thousands |
Oct. 28, 2023 |
Oct. 29, 2022 |
|---|---|---|
| Accrued liabilities | Forward foreign currency exchange contracts | ||
| Derivative Instruments, Gain (Loss) [Line Items] | ||
| Forward foreign currency exchange contracts, liability | $ 9,426 | $ 18,050 |
Summary of Significant Accounting Policies - Derivative Fair Value of Hedging Instruments (Details) $ in Thousands |
Oct. 29, 2022
USD ($)
|
|---|---|
| Accounting Policies [Abstract] | |
| Gross amount of recognized liabilities | $ (19,846) |
| Gross amounts of recognized assets | 2,862 |
| Net liabilities offset and presented in the Consolidated Balance Sheets | $ (16,984) |
| Net liabilities offset and presented in the Consolidated Balance Sheets [Extensible Enumeration] | Accrued Liabilities, Current |
Summary of Significant Accounting Policies - Interest Rate Derivatives (Details) - Interest Rate Swap $ in Thousands |
12 Months Ended |
|---|---|
|
Oct. 28, 2023
USD ($)
| |
| Accrued liabilities | |
| Derivatives, Fair Value [Line Items] | |
| Loss on Swaps | $ 81,602 |
| Gain on Note | 0 |
| Long-term debt | |
| Derivatives, Fair Value [Line Items] | |
| Loss on Swaps | 0 |
| Gain on Note | $ 81,602 |
Summary of Significant Accounting Policies - Fair Value Textual (Details) - USD ($) $ in Thousands |
Oct. 28, 2023 |
Oct. 29, 2022 |
|---|---|---|
| Accounting Policies [Abstract] | ||
| Cash and held to maturity investments | $ 642,100 | $ 1,016,000 |
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Commercial paper notes | 547,224 | $ 0 |
| Fair Value, Inputs, Level 2 [Member] | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Commercial paper notes | $ 547,200 |
Summary of Significant Accounting Policies - Fair Value Financial Assets and Liabilities (Details) - USD ($) $ in Thousands |
Oct. 28, 2023 |
Oct. 29, 2022 |
|---|---|---|
| Liabilities | ||
| Interest rate derivatives | $ 81,602 | $ 0 |
| Recurring | ||
| Other assets: | ||
| Forward foreign currency exchange contracts | 1,940 | |
| Deferred compensation investments | 78,246 | 63,211 |
| Total assets measured at fair value | 396,166 | 517,756 |
| Liabilities | ||
| Forward foreign currency exchange contracts | 13,515 | 16,984 |
| Interest rate derivatives | 81,602 | |
| Total liabilities measured at fair value | 95,117 | 16,984 |
| Recurring | Government and institutional money market funds | ||
| Available-for-sale: | ||
| Cash equivalents | 315,980 | 454,545 |
| Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
| Other assets: | ||
| Forward foreign currency exchange contracts | 0 | |
| Deferred compensation investments | 78,246 | 63,211 |
| Total assets measured at fair value | 394,226 | 517,756 |
| Liabilities | ||
| Forward foreign currency exchange contracts | 0 | 0 |
| Interest rate derivatives | 0 | |
| Total liabilities measured at fair value | 0 | 0 |
| Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Government and institutional money market funds | ||
| Available-for-sale: | ||
| Cash equivalents | 315,980 | 454,545 |
| Recurring | Significant Other Observable Inputs (Level 2) | ||
| Other assets: | ||
| Forward foreign currency exchange contracts | 1,940 | |
| Deferred compensation investments | 0 | 0 |
| Total assets measured at fair value | 1,940 | 0 |
| Liabilities | ||
| Forward foreign currency exchange contracts | 13,515 | 16,984 |
| Interest rate derivatives | 81,602 | |
| Total liabilities measured at fair value | 95,117 | 16,984 |
| Recurring | Significant Other Observable Inputs (Level 2) | Government and institutional money market funds | ||
| Available-for-sale: | ||
| Cash equivalents | $ 0 | $ 0 |
Summary of Significant Accounting Policies - Fair Value Outstanding Debt (Details) - USD ($) |
Oct. 28, 2023 |
Apr. 27, 2023 |
Oct. 29, 2022 |
Oct. 08, 2022 |
Oct. 07, 2022 |
Sep. 15, 2022 |
Oct. 30, 2021 |
Oct. 05, 2021 |
Aug. 26, 2021 |
Apr. 08, 2020 |
Dec. 05, 2016 |
Dec. 14, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Instrument [Line Items] | ||||||||||||
| Principal | $ 7,064,301,000 | $ 6,576,865,000 | ||||||||||
| Fair Value | 5,844,284,000 | 5,472,605,000 | ||||||||||
| Commercial Paper | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 547,224,000 | 0 | ||||||||||
| Fair Value | 547,185,000 | 0 | ||||||||||
| Senior Notes | 2024 Notes, due October 2024 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 500,000,000 | 500,000,000 | $ 500,000,000 | |||||||||
| Fair Value | 499,473,000 | 491,982,000 | ||||||||||
| Senior Notes | 2025 Notes, due April 2025 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 400,000,000 | 400,000,000 | $ 400,000,000 | |||||||||
| Fair Value | 385,231,000 | 383,378,000 | ||||||||||
| Senior Notes | 2026 Notes, due December 2026 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 900,000,000 | 900,000,000 | $ 900,000,000 | |||||||||
| Fair Value | 851,023,000 | 851,479,000 | ||||||||||
| Senior Notes | Maxim 2027 Notes, due June 2027 | Maxim | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 0 | $ 0 | 59,788,000 | $ 59,800,000 | $ 440,200,000 | $ 500,000,000 | ||||||
| Fair Value | 0 | 54,771,000 | ||||||||||
| Senior Notes | 2027 Notes, due June 2027 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 440,212,000 | 440,212,000 | ||||||||||
| Fair Value | 408,595,000 | 410,091,000 | ||||||||||
| Senior Notes | 2028 Notes, due October 2028 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 750,000,000 | 750,000,000 | 750,000,000 | |||||||||
| Fair Value | 628,999,000 | 621,093,000 | ||||||||||
| Senior Notes | 2031 Notes, due October 2031 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 1,000,000,000 | 1,000,000,000 | $ 1,000,000,000 | 1,000,000,000 | ||||||||
| Fair Value | 773,404,000 | 786,772,000 | ||||||||||
| Senior Notes | 2032 Notes, due October 2032 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 300,000,000 | 300,000,000 | $ 300,000,000 | |||||||||
| Fair Value | 269,828,000 | 278,359,000 | ||||||||||
| Senior Notes | 2036 Notes, due December 2036 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 144,278,000 | 144,278,000 | $ 250,000,000 | |||||||||
| Fair Value | 118,554,000 | 126,274,000 | ||||||||||
| Senior Notes | 2041 Notes, due October 2041 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 750,000,000 | 750,000,000 | 750,000,000 | |||||||||
| Fair Value | 479,078,000 | 513,709,000 | ||||||||||
| Senior Notes | 2045 Notes, due December 2045 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 332,587,000 | 332,587,000 | $ 400,000,000 | |||||||||
| Fair Value | 292,248,000 | 313,931,000 | ||||||||||
| Senior Notes | 2051 Notes, due October 2051 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 1,000,000,000 | 1,000,000,000 | $ 1,000,000,000 | |||||||||
| Fair Value | $ 590,666,000 | $ 640,766,000 |
Summary of Significant Accounting Policies - Concentrations of Risk and Revenue Recognition (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Product Information [Line Items] | |||
| Standard product warranty term (in months) | 12 months | ||
| Revenue | $ 12,305,539 | $ 12,013,953 | $ 7,318,286 |
| Distributors | |||
| Product Information [Line Items] | |||
| Revenue | 7,534,894 | 7,458,478 | $ 4,589,944 |
| Liability | $ 525,400 | $ 749,400 | |
| Largest Customer | Revenue Benchmark | Customer Concentration Risk | |||
| Product Information [Line Items] | |||
| Concentration risk (as a percent) | 25.00% | 22.00% | 26.00% |
| Next Largest Customer | Revenue Benchmark | Customer Concentration Risk | |||
| Product Information [Line Items] | |||
| Concentration risk (as a percent) | 10.00% | 10.00% | 11.00% |
Summary of Significant Accounting Policies - Accumulated Other Comprehensive (Loss) Income (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| AOCI Attribute to Parent, Net of Tax [Roll Forward] | |||
| Beginning balance | $ 36,465,323 | ||
| Other comprehensive income before reclassifications | (488) | ||
| Amounts reclassified out of other comprehensive loss | 14,446 | ||
| Tax | (4,108) | ||
| Other comprehensive income (loss) | 9,850 | $ (11,587) | $ 62,896 |
| Ending balance | 35,565,122 | 36,465,323 | |
| Foreign currency translation adjustment | |||
| AOCI Attribute to Parent, Net of Tax [Roll Forward] | |||
| Beginning balance | (72,136) | ||
| Other comprehensive income before reclassifications | (408) | ||
| Amounts reclassified out of other comprehensive loss | 0 | ||
| Tax | 0 | ||
| Other comprehensive income (loss) | (408) | ||
| Ending balance | (72,544) | (72,136) | |
| Unrealized holding gains/losses on derivatives | |||
| AOCI Attribute to Parent, Net of Tax [Roll Forward] | |||
| Beginning balance | (119,613) | ||
| Other comprehensive income before reclassifications | 8,433 | ||
| Amounts reclassified out of other comprehensive loss | 12,933 | ||
| Tax | (3,796) | ||
| Other comprehensive income (loss) | 17,570 | ||
| Ending balance | (102,043) | (119,613) | |
| Pension plans | |||
| AOCI Attribute to Parent, Net of Tax [Roll Forward] | |||
| Beginning balance | (6,403) | ||
| Other comprehensive income before reclassifications | (8,513) | ||
| Amounts reclassified out of other comprehensive loss | 1,513 | ||
| Tax | (312) | ||
| Other comprehensive income (loss) | (7,312) | ||
| Ending balance | (13,715) | (6,403) | |
| Total | |||
| AOCI Attribute to Parent, Net of Tax [Roll Forward] | |||
| Beginning balance | (198,152) | (186,565) | (249,461) |
| Ending balance | $ (188,302) | $ (198,152) | $ (186,565) |
Summary of Significant Accounting Policies - Accumulated Other Comprehensive (Loss) Income - Reclassified Amounts (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
| Cost of sales | $ 4,428,321 | $ 4,481,479 | $ 2,793,274 |
| Research and development | 1,660,194 | 1,700,518 | 1,296,126 |
| Selling, marketing, general and administrative | 1,273,584 | 1,266,175 | 915,418 |
| Interest expense | 264,641 | 200,408 | 184,825 |
| Income before income taxes | (3,608,003) | (3,098,749) | (1,328,714) |
| Tax | 293,424 | 350,188 | (61,708) |
| Net income | (3,314,579) | (2,748,561) | $ (1,390,422) |
| Reclassification out of Accumulated Other Comprehensive Income | |||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
| Net income | 11,135 | 36,445 | |
| Reclassification out of Accumulated Other Comprehensive Income | Unrealized holding gains/losses on derivatives | |||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
| Net income | 9,622 | 34,472 | |
| Reclassification out of Accumulated Other Comprehensive Income | Pension plans | |||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
| Net income | 1,513 | 1,973 | |
| Reclassification out of Accumulated Other Comprehensive Income | Currency forwards | Unrealized holding gains/losses on derivatives | |||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
| Cost of sales | 213 | 9,474 | |
| Research and development | 538 | 5,637 | |
| Selling, marketing, general and administrative | (2,738) | 9,492 | |
| Reclassification out of Accumulated Other Comprehensive Income | Interest rate derivatives | Unrealized holding gains/losses on derivatives | |||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
| Interest expense | 14,920 | 14,923 | |
| Income before income taxes | 12,933 | 39,526 | |
| Tax | $ (3,311) | $ (5,054) | |
Summary of Significant Accounting Policies - Earnings Per Share of Common Stock (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Earnings per share | |||
| Net income | $ 3,314,579 | $ 2,748,561 | $ 1,390,422 |
| Basic shares: | |||
| Weighted-average shares outstanding (in shares) | 502,232 | 519,226 | 397,462 |
| Earnings per common share basic (in dollars per share) | $ 6.60 | $ 5.29 | $ 3.50 |
| Diluted shares: | |||
| Weighted-average shares outstanding (in shares) | 502,232 | 519,226 | 397,462 |
| Assumed exercise of common stock equivalents (in shares) | 3,727 | 3,952 | 3,826 |
| Weighted-average common and common equivalent shares (in shares) | 505,959 | 523,178 | 401,288 |
| Diluted earnings per common share (in dollars per share) | $ 6.55 | $ 5.25 | $ 3.46 |
| Outstanding stock options (in shares) | 253 | 608 | 424 |
Summary of Significant Accounting Policies - Stock-Based Compensation (Details) - installment |
12 Months Ended | |
|---|---|---|
Oct. 28, 2023 |
Nov. 03, 2018 |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
| Number of installment | 1 | |
| Options | ||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
| Award vesting period (in years) | 4 years | 5 years |
| Award vesting rights (as a percent) | 25.00% | 20.00% |
| Award contractual term (in years) | 10 years | |
| Restricted Stock Units (RSUs) | ||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
| Number of installment | 1 | |
Stock-Based Compensation and Shareholders' Equity - Textual (Details) - USD ($) |
3 Months Ended | 12 Months Ended | 231 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|
Aug. 26, 2021 |
Jan. 29, 2022 |
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
Oct. 28, 2023 |
Aug. 25, 2021 |
Mar. 31, 2020 |
Aug. 31, 2004 |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
| Units/Awards granted (in dollars per share) | $ 180.18 | ||||||||
| Options granted (in shares) | 0 | 0 | 644,000 | ||||||
| Minimum maturity of traded options used to estimate volatility (in years) | 1 year | ||||||||
| Annual forfeiture rate (as a percent) | 5.00% | 5.00% | |||||||
| Share-based payment arrangement, amount capitalized | $ 12,900,000 | $ 13,100,000 | |||||||
| Total intrinsic value of options exercised | 95,000,000 | 56,200,000 | $ 93,200,000 | ||||||
| Total unrecognized compensation cost related to unvested share-based awards, before tax consideration | $ 545,900,000 | $ 545,900,000 | |||||||
| Weighted-average period for recognition of compensation cost (in years) | 1 year 4 months 24 days | ||||||||
| Total grant-date fair value of vested stock options | $ 298,200,000 | $ 283,000,000 | 207,000,000 | ||||||
| Amount authorized to repurchase company common stock | $ 8,500,000,000 | $ 16,700,000,000 | |||||||
| Repurchase of common stock | $ 2,100,000,000 | 2,100,000,000 | |||||||
| Repurchased common stock, shares (in shares) | 205,300,000 | ||||||||
| Repurchase of common stock, cumulative | $ 14,500,000,000 | ||||||||
| Preferred stock, shares authorized (in shares) | 471,934 | 471,934 | 471,934 | ||||||
| Preferred stock, par value (in dollars per share) | $ 1.00 | $ 1.00 | $ 1.00 | ||||||
| Preferred stock, shares issued (in shares) | 0 | 0 | |||||||
| Preferred stock, shares outstanding (in shares) | 0 | 0 | 0 | ||||||
| Share Repurchase Program, Fiscal 2021 | |||||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
| Amount authorized to repurchase company common stock | $ 2,500,000,000 | ||||||||
| Initial delivery (in shares) | 12,300,000 | ||||||||
| Initial purchase, percentage of common stock underlying agreement (as a percent) | 80.00% | ||||||||
| Remaining purchase, percentage of common stock underlying agreement (as a percent) | 20.00% | ||||||||
| Repurchase of common stock | $ 500,000,000 | ||||||||
| Repurchased common stock, shares (in shares) | 2,100,000 | ||||||||
| Repurchase of common stock, cumulative | $ 14,400,000 | ||||||||
| Shares delivered (in dollars per share) | $ 173.77 | ||||||||
| ESPP | |||||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
| Total number of common shares available for grant Units/Awards granted (in shares) | 4,500,000 | 4,500,000 | |||||||
| ESPP | US | |||||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
| ESPP purchase price of common stock, percent of market price (as a percent) | 85.00% | ||||||||
| ESPP | Outside US | |||||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
| ESPP purchase price of common stock, percent of market price (as a percent) | 80.00% | ||||||||
| Maxim | Replacement Awards | |||||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
| Total number of common shares available for grant Units/Awards granted (in shares) | 3,700,000 | ||||||||
| Units/Awards granted (in dollars per share) | $ 161.63 | ||||||||
| 2020 Stock Incentive Plan | |||||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
| Maximum common stock granted (in shares) | 21,200,000 | ||||||||
| Total number of common shares available for grant Units/Awards granted (in shares) | 15,100,000 | 15,100,000 | |||||||
| 1996 Stock Incentive Plan | |||||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
| Total number of common shares available for grant Units/Awards granted (in shares) | 8,500,000 | 8,500,000 | |||||||
Stock-Based Compensation and Shareholders' Equity - Stock Option Awards (Details) - $ / shares |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Share-Based Payment Arrangement [Abstract] | |||
| Options granted (in shares) | 0 | 0 | 644,000 |
| Weighted-average exercise price (in dollars per share) | $ 145.04 | ||
| Weighted-average grant-date fair value (in dollars per share) | $ 33.35 | ||
| Assumptions: | |||
| Weighted-average expected volatility | 35.30% | ||
| Weighted-average expected term (in years) | 5 years | ||
| Weighted-average risk-free interest rate | 0.80% | ||
| Weighted-average expected dividend yield | 1.90% | ||
Stock-Based Compensation and Shareholders' Equity - Share-Based Compensation (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Stock-based compensation expense | $ 299,823 | $ 323,487 | $ 243,611 |
| Cost of sales | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Stock-based compensation expense | 36,703 | 36,773 | 22,028 |
| Research and development | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Stock-based compensation expense | 116,354 | 121,298 | 86,820 |
| Selling, marketing, general and administrative | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Stock-based compensation expense | 143,789 | 133,900 | 80,099 |
| Special charges, net | |||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
| Stock-based compensation expense | $ 2,977 | $ 31,516 | $ 54,664 |
Stock-Based Compensation and Shareholders' Equity - Stock Options Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands |
12 Months Ended |
|---|---|
|
Oct. 28, 2023
USD ($)
$ / shares
shares
| |
| Options Outstanding (in shares) | |
| Options outstanding, beginning balance (in shares) | shares | 3,194 |
| Options exercised (in shares) | shares | (823) |
| Options forfeited (in shares) | shares | (4) |
| Options outstanding, ending balance (in shares) | shares | 2,367 |
| Options exercisable (in shares) | shares | 1,735 |
| Options vested or expected to vest (in shares) | shares | 2,361 |
| Weighted-Average Exercise Price Per Share (in dollars per share) | |
| Options outstanding, beginning balance (in dollars per share) | $ / shares | $ 89.13 |
| Options exercised (in dollars per share) | $ / shares | 68.50 |
| Options forfeited (in dollars per share) | $ / shares | 74.45 |
| Options outstanding, ending balance (in dollars per share) | $ / shares | 96.33 |
| Options exercisable (in dollars per share) | $ / shares | 81.04 |
| Options vested or expected to vest (in dollars per share) | $ / shares | $ 96.23 |
| Options outstanding, weighted-average remaining contractual term in years | 4 years 6 months |
| Options exercisable, weighted-average remaining contractual term in years | 3 years 7 months 6 days |
| Options vested or expected to vest, weighted-average remaining contractual term in years | 4 years 6 months |
| Options outstanding, aggregate intrinsic value | $ | $ 152,060 |
| Options exercisable, aggregate intrinsic value | $ | 137,960 |
| Options vested or expected to vest, aggregate intrinsic value | $ | $ 151,904 |
Stock-Based Compensation and Shareholders' Equity - Restricted Stock Unit Award Activity (Details) shares in Thousands |
12 Months Ended |
|---|---|
|
Oct. 28, 2023
$ / shares
shares
| |
| Restricted Stock Units Outstanding (in shares) | |
| Restricted stock units/awards outstanding, beginning balance (in shares) | shares | 5,322 |
| Units/Awards granted (in shares) | shares | 2,149 |
| Restrictions lapsed (in shares) | shares | (2,166) |
| Forfeited (in shares) | shares | (258) |
| Restricted stock units/awards outstanding, ending balance (in shares) | shares | 5,047 |
| Weighted Average Grant-Date Fair Value Per Share (USD per share) | |
| Restricted stock units/awards outstanding, beginning balance (in dollars per share) | $ / shares | $ 142.54 |
| Units/Awards granted (in dollars per share) | $ / shares | 180.18 |
| Restrictions lapsed (in dollars per share) | $ / shares | 132.49 |
| Forfeited (in dollars per share) | $ / shares | 155.78 |
| Restricted stock units/awards outstanding, beginning balance (in dollars per share) | $ / shares | $ 162.20 |
Industry, Segment and Geographic Information - Textual (Details) |
12 Months Ended |
|---|---|
|
Oct. 28, 2023
segment
| |
| Segment Reporting [Abstract] | |
| Number of reportable segments | 1 |
| Number of operating segments | 1 |
Industry, Segment and Geographic Information - Revenue Trends by End Market (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Segment Reporting Information [Line Items] | |||
| Revenue | $ 12,305,539 | $ 12,013,953 | $ 7,318,286 |
| % of Total Revenue | 100.00% | 100.00% | 100.00% |
| Industrial | |||
| Segment Reporting Information [Line Items] | |||
| Revenue | $ 6,555,222 | $ 6,186,114 | $ 4,021,105 |
| % of Total Revenue | 53.00% | 51.00% | 55.00% |
| Automotive | |||
| Segment Reporting Information [Line Items] | |||
| Revenue | $ 2,915,199 | $ 2,442,705 | $ 1,245,605 |
| % of Total Revenue | 24.00% | 20.00% | 17.00% |
| Communications | |||
| Segment Reporting Information [Line Items] | |||
| Revenue | $ 1,619,517 | $ 1,863,156 | $ 1,215,516 |
| % of Total Revenue | 13.00% | 16.00% | 17.00% |
| Consumer | |||
| Segment Reporting Information [Line Items] | |||
| Revenue | $ 1,215,601 | $ 1,521,978 | $ 836,060 |
| % of Total Revenue | 10.00% | 13.00% | 11.00% |
Industry, Segment and Geographic Information - Revenue by Sales Channel (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Disaggregation of Revenue [Line Items] | |||
| Revenue | $ 12,305,539 | $ 12,013,953 | $ 7,318,286 |
| % of Total Revenue | 100.00% | 100.00% | 100.00% |
| Distributors | |||
| Disaggregation of Revenue [Line Items] | |||
| Revenue | $ 7,534,894 | $ 7,458,478 | $ 4,589,944 |
| % of Total Revenue | 61.00% | 62.00% | 63.00% |
| Direct customers | |||
| Disaggregation of Revenue [Line Items] | |||
| Revenue | $ 4,603,166 | $ 4,423,883 | $ 2,600,353 |
| % of Total Revenue | 37.00% | 37.00% | 36.00% |
| Other | |||
| Disaggregation of Revenue [Line Items] | |||
| Revenue | $ 167,479 | $ 131,592 | $ 127,989 |
| % of Total Revenue | 1.00% | 1.00% | 2.00% |
Industry, Segment and Geographic Information - Revenue Trends and Property, Plant and Equipment by Geographic Region (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Revenues from External Customers and Long-Lived Assets [Line Items] | |||
| Revenue | $ 12,305,539 | $ 12,013,953 | $ 7,318,286 |
| Property, plant and equipment | 3,219,157 | 2,401,304 | 1,979,051 |
| United States | |||
| Revenues from External Customers and Long-Lived Assets [Line Items] | |||
| Revenue | 4,165,296 | 4,025,398 | 2,389,439 |
| Property, plant and equipment | 1,577,914 | 1,117,404 | 956,624 |
| Rest of North and South America | |||
| Revenues from External Customers and Long-Lived Assets [Line Items] | |||
| Revenue | 88,579 | 72,497 | 42,830 |
| Europe | |||
| Revenues from External Customers and Long-Lived Assets [Line Items] | |||
| Revenue | 3,001,871 | 2,534,423 | 1,592,989 |
| Japan | |||
| Revenues from External Customers and Long-Lived Assets [Line Items] | |||
| Revenue | 1,397,119 | 1,221,549 | 787,966 |
| China | |||
| Revenues from External Customers and Long-Lived Assets [Line Items] | |||
| Revenue | 2,229,631 | 2,563,536 | 1,614,396 |
| Rest of Asia | |||
| Revenues from External Customers and Long-Lived Assets [Line Items] | |||
| Revenue | 1,423,043 | 1,596,550 | 890,666 |
| Subtotal all foreign regions | |||
| Revenues from External Customers and Long-Lived Assets [Line Items] | |||
| Revenue | 8,140,243 | 7,988,555 | 4,928,847 |
| Property, plant and equipment | 1,641,243 | 1,283,900 | 1,022,427 |
| Ireland | |||
| Revenues from External Customers and Long-Lived Assets [Line Items] | |||
| Property, plant and equipment | 573,684 | 343,728 | 206,353 |
| Philippines | |||
| Revenues from External Customers and Long-Lived Assets [Line Items] | |||
| Property, plant and equipment | 620,453 | 608,474 | 524,128 |
| Thailand | |||
| Revenues from External Customers and Long-Lived Assets [Line Items] | |||
| Property, plant and equipment | 209,660 | 143,558 | 126,040 |
| Malaysia | |||
| Revenues from External Customers and Long-Lived Assets [Line Items] | |||
| Property, plant and equipment | 123,574 | 119,670 | 84,971 |
| All other regions | |||
| Revenues from External Customers and Long-Lived Assets [Line Items] | |||
| Property, plant and equipment | $ 113,872 | $ 68,470 | $ 80,935 |
Special Charges, Net - Balance Sheet Impact (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Closure of Manufacturing Facilities | |||
| Restructuring Reserve [Roll Forward] | |||
| Beginning balance | $ 2,629 | $ 25,774 | $ 45,176 |
| Employee severance and benefit costs | 0 | 75 | 200 |
| Facility closure costs | 12,076 | 11,880 | |
| Severance and benefit payments | (2,629) | (22,805) | (19,602) |
| Facility closure cost payments | (12,491) | (11,880) | |
| Effect of foreign currency on accrual | 0 | 0 | |
| Ending balance | 0 | 2,629 | 25,774 |
| Accrued liabilities | 0 | ||
| Other non-current liabilities | 0 | ||
| Global Repositioning Actions | |||
| Restructuring Reserve [Roll Forward] | |||
| Beginning balance | 52,070 | 21,065 | 20,774 |
| Employee severance and benefit costs | 45,064 | 149,853 | 28,731 |
| Facility closure costs | 0 | 0 | |
| Severance and benefit payments | (60,153) | (118,567) | (28,604) |
| Facility closure cost payments | 0 | 0 | |
| Effect of foreign currency on accrual | (281) | 164 | |
| Ending balance | 36,981 | 52,070 | 21,065 |
| Accrued liabilities | 13,845 | ||
| Other non-current liabilities | 23,136 | ||
| Q4 2023 Plan | |||
| Restructuring Reserve [Roll Forward] | |||
| Beginning balance | 0 | 0 | 0 |
| Employee severance and benefit costs | 113,995 | 0 | 0 |
| Facility closure costs | 0 | 0 | |
| Severance and benefit payments | (3,549) | 0 | 0 |
| Facility closure cost payments | 0 | 0 | |
| Effect of foreign currency on accrual | 0 | 0 | |
| Ending balance | 110,446 | $ 0 | $ 0 |
| Accrued liabilities | 110,446 | ||
| Other non-current liabilities | $ 0 | ||
Special Charges, Net - Textual (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Restructuring Cost and Reserve [Line Items] | |||
| Non-cash impairment charge | $ 0 | $ 91,953 | $ 0 |
| Q4 2023 Plan | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Special charges, cumulative | 114,000 | ||
| Q4 2023 Plan | Minimum | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Expected cost | 120,000 | ||
| Q4 2023 Plan | Maximum | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Expected cost | 140,000 | ||
| Global Repositioning Actions | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Special charges, cumulative | 532,700 | ||
| Operating lease, impairment loss | 60,600 | ||
| Non-cash impairment charge | 91,900 | ||
| Global Repositioning Actions | Leasehold Improvements | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Non-cash impairment charge | 28,100 | ||
| Global Repositioning Actions | Office Equipment | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Non-cash impairment charge | $ 3,200 | ||
| Closure of Manufacturing Facilities | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Special charges, cumulative | 63,800 | ||
| Closure of Manufacturing Facilities | Discontinued Operations, Disposed of by Sale | Testing Facility | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Gain on sale of facility | 18,000 | ||
| Consideration from sale of facility | $ 67,500 | ||
Acquisitions - Textual (Details) - Maxim $ in Millions |
12 Months Ended | 36 Months Ended | |
|---|---|---|---|
|
Oct. 30, 2021
USD ($)
|
Oct. 28, 2023
USD ($)
|
Aug. 26, 2021 |
|
| Business Acquisition [Line Items] | |||
| Conversion of company common stock | 0.6300 | ||
| Revenue of acquiree since acquisition date | $ 558.8 | ||
| Transaction costs | $ 174.0 |
Acquisitions - Purchase Price Consideration (Details) - USD ($) $ / shares in Units, $ in Thousands, shares in Millions |
12 Months Ended | |||
|---|---|---|---|---|
Aug. 26, 2021 |
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Business Acquisition [Line Items] | ||||
| Fair value of partially vested restricted stock and restricted stock unit replacement awards | $ 0 | $ 0 | $ 194,890 | |
| Units/Awards granted (in dollars per share) | $ 180.18 | |||
| Maxim | ||||
| Business Acquisition [Line Items] | ||||
| Cash consideration | $ 47 | |||
| Issuance of common stock | 27,754,161 | |||
| Fair value of partially vested restricted stock and restricted stock unit replacement awards | 194,890 | |||
| Total purchase consideration | $ 27,949,098 | |||
| Maxim | Replacement Awards | ||||
| Business Acquisition [Line Items] | ||||
| Units/Awards available for grant (in shares) | 3.7 | |||
| Units/Awards granted (in dollars per share) | $ 161.63 | |||
| Maxim | Common Stock | ||||
| Business Acquisition [Line Items] | ||||
| Number of shares issued (in shares) | 169.2 | |||
| Share price (in dollars per share) | $ 164.00 | |||
Acquisitions - Allocation of Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands |
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
Aug. 26, 2021 |
|---|---|---|---|---|
| Business Acquisition [Line Items] | ||||
| Goodwill | $ 26,913,134 | $ 26,913,134 | $ 26,918,470 | |
| Maxim | ||||
| Business Acquisition [Line Items] | ||||
| Cash and cash equivalents | $ 2,450,597 | |||
| Accounts receivable | 609,245 | |||
| Inventories | 858,300 | |||
| Prepaid expenses and other current assets | 59,310 | |||
| Property, plant and equipment | 759,544 | |||
| Intangible assets | 12,429,100 | |||
| Goodwill | 14,660,343 | |||
| Other long-term assets | 80,373 | |||
| Total assets | 31,906,812 | |||
| Accounts payable | 112,828 | |||
| Income taxes payable | 156,592 | |||
| Accrued liabilities | 592,432 | |||
| Long-term debt | 1,072,150 | |||
| Deferred income taxes | 1,661,907 | |||
| Other non-current liabilities | 361,805 | |||
| Total liabilities | 3,957,714 | |||
| Total purchase consideration | $ 27,949,098 |
Acquisitions - Intangible Assets Acquired (Details) - Maxim $ in Thousands |
Aug. 26, 2021
USD ($)
|
|---|---|
| Acquired Finite-Lived Intangible Assets [Line Items] | |
| Fair Value | $ 12,429,100 |
| Weighted Average Useful Life (in Years) | 10 years |
| Customer relationships | |
| Acquired Finite-Lived Intangible Assets [Line Items] | |
| Fair Value | $ 5,642,100 |
| Weighted Average Useful Life (in Years) | 14 years |
| Developed technology | |
| Acquired Finite-Lived Intangible Assets [Line Items] | |
| Fair Value | $ 6,425,800 |
| Weighted Average Useful Life (in Years) | 8 years |
| Backlog | |
| Acquired Finite-Lived Intangible Assets [Line Items] | |
| Fair Value | $ 361,200 |
| Weighted Average Useful Life (in Years) | 2 years |
Acquisitions - Pro Forma Financial Information (Details) - Maxim $ / shares in Units, $ in Thousands |
12 Months Ended |
|---|---|
|
Oct. 30, 2021
USD ($)
$ / shares
| |
| Business Acquisition [Line Items] | |
| Revenue | $ | $ 9,541,488 |
| Net income | $ | $ 1,578,274 |
| Basic net income per common share (in dollars per share) | $ / shares | $ 2.94 |
| Diluted net income per common share (in dollars per share) | $ / shares | $ 2.91 |
Accrued Liabilities (Details) - USD ($) $ in Thousands |
Oct. 28, 2023 |
Oct. 29, 2022 |
|---|---|---|
| Payables and Accruals [Abstract] | ||
| Distributor price adjustments and other revenue reserves | $ 525,405 | $ 749,402 |
| Accrued compensation and benefits | 308,001 | 465,536 |
| Accrued special charges | 124,291 | 54,699 |
| Interest rate swap | 81,602 | 0 |
| Lease liabilities | 64,745 | 53,628 |
| Accrued interest | 40,412 | 33,298 |
| Accrued taxes | 36,649 | 22,815 |
| Accrued withholdings related to ESPP | 32,441 | 28,131 |
| Other | 139,062 | 187,141 |
| Total accrued liabilities | $ 1,352,608 | $ 1,594,650 |
Leases - Textual (Details) $ in Millions |
12 Months Ended |
|---|---|
|
Oct. 28, 2023
USD ($)
| |
| Lessee, Lease, Description [Line Items] | |
| Sublease income | $ 12.9 |
| Minimum | |
| Lessee, Lease, Description [Line Items] | |
| Lessee, operating lease, remaining lease contract (in years) | 1 year |
| Maximum | |
| Lessee, Lease, Description [Line Items] | |
| Lessee, operating lease, remaining lease contract (in years) | 22 years |
Leases - Cost (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
|
| Leases [Abstract] | ||
| Operating lease right-of-use assets in Other assets | $ 277,220 | $ 262,997 |
| Operating lease right-of-use assets in Other assets [Extensible Enumeration] | Other assets | Other assets |
| Operating lease liabilities in Accrued liabilities | $ 64,745 | $ 53,628 |
| Operating lease liabilities in Accrued liabilities [Extensible Enumeration] | Accrued Liabilities, Current | Accrued Liabilities, Current |
| Operating lease liabilities in Other non-current liabilities | $ 360,460 | $ 337,279 |
| Operating lease liabilities in Other non-current liabilities [Extensible Enumeration] | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent |
| Lease expense | $ 66,818 | $ 60,660 |
| Cash flows from operating leases | 68,759 | 61,915 |
| Lease assets obtained in exchange for new lease liabilities | $ 66,760 | $ 107,631 |
| Weighted average remaining lease term | 7 years 1 month 6 days | 7 years 7 months 6 days |
| Weighted average discount rate | 3.60% | 3.30% |
Leases - Maturity (Details) $ in Thousands |
Oct. 28, 2023
USD ($)
|
|---|---|
| Leases [Abstract] | |
| 2024 | $ 80,998 |
| 2025 | 76,815 |
| 2026 | 71,750 |
| 2027 | 65,278 |
| 2028 | 52,925 |
| Thereafter | 146,896 |
| Total future minimum operating lease payments | 494,662 |
| Less: imputed interest | (69,457) |
| Present value of operating lease liabilities | $ 425,205 |
Leases - Future Minimum Cash Receipts (Details) $ in Thousands |
Oct. 28, 2023
USD ($)
|
|---|---|
| Operating Leases, Future Minimum Payments Receivable [Abstract] | |
| 2024 | $ 13,287 |
| 2025 | 15,231 |
| 2026 | 15,683 |
| 2027 | 16,153 |
| 2028 | 16,635 |
| Thereafter | 29,365 |
| Total future minimum cash receipts | $ 106,354 |
Commitments and Contingencies (Details) $ in Millions |
Oct. 28, 2023
USD ($)
|
|---|---|
| Commitments and Contingencies Disclosure [Abstract] | |
| Supplier commitment | $ 705.6 |
Retirement Plans - Textual (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Retirement Benefits [Abstract] | |||
| Employer matching contribution, percent of employees' gross pay (as a percent) | 5.00% | ||
| Employer matching contribution, percent of match (as a percent) | 3.00% | ||
| Total expense related to the defined contribution plan for U.S. employees | $ 76.0 | $ 65.2 | $ 52.1 |
| Maximum of each participants eligible deferred contributions (as a percent) | 8.00% | ||
| Total expense related to the defined benefit pension and other retirement plans for certain non-U.S. employees | $ 55.3 | 51.4 | $ 45.9 |
| Accumulated benefit obligation for pension and postretirement benefit plans | $ 120.1 | $ 111.3 | |
Retirement Plans - Net Periodic Benefit Cost (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Net periodic pension cost | |||
| Service cost | $ 7,728 | $ 10,914 | $ 9,207 |
| Interest cost | 8,773 | 6,148 | 4,071 |
| Expected return on plan assets | (5,236) | (4,540) | (3,759) |
| Recognized actuarial loss | 1,168 | 2,299 | 2,973 |
| Subtotal | 12,433 | 14,821 | 12,492 |
| Settlement impact | 173 | (35) | (6) |
| Net periodic benefit cost | $ 12,606 | $ 14,786 | $ 12,486 |
| Net periodic benefit cost excluding service cost [Extensible Enumeration] | Other Nonoperating Income (Expense) | Other Nonoperating Income (Expense) | Other Nonoperating Income (Expense) |
Retirement Plans - Obligation and Asset Data (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Change in Benefit Obligation | |||
| Benefit obligation at beginning of year | $ 157,730 | $ 242,593 | |
| Service cost | 7,728 | 10,914 | $ 9,207 |
| Interest cost | 8,773 | 6,148 | 4,071 |
| Acquisition of Maxim benefit obligation | (3,880) | 0 | |
| Settlement | (1,887) | (1,052) | |
| Actuarial gain | 574 | (68,806) | |
| Benefits paid | (6,352) | (3,596) | |
| Exchange rate adjustment | 5,182 | (28,471) | |
| Benefit obligation at end of year | 167,868 | 157,730 | 242,593 |
| Change in Plan Assets | |||
| Fair value of plan assets at beginning of year | 84,029 | 128,283 | |
| Actual return on plan assets | (2,831) | (34,231) | |
| Employer contributions | 10,811 | 11,344 | |
| Settlements | (1,887) | (1,052) | |
| Benefits paid | (6,352) | (3,596) | |
| Exchange rate adjustment | 3,836 | (16,719) | |
| Fair value of plan assets at end of year | 87,606 | 84,029 | $ 128,283 |
| Reconciliation of Funded Status | |||
| Funded status | (80,262) | (73,701) | |
| Amounts Recognized in the Balance Sheet | |||
| Non-current assets | 0 | 1,185 | |
| Current liabilities | (4,222) | (2,638) | |
| Non-current liabilities | (76,040) | (72,248) | |
| Net amount recognized | (80,262) | (73,701) | |
| Reconciliation of Amounts Recognized in the Statement of Financial Position | |||
| Prior service credit | (27) | (29) | |
| Net loss | (12,304) | (5,302) | |
| Accumulated other comprehensive loss | (12,331) | (5,331) | |
| Accumulated contributions less than net periodic benefit cost | (67,931) | (68,370) | |
| Net amount recognized | (80,262) | (73,701) | |
| Changes in plan assets and benefit obligations recognized in other comprehensive income (loss) | |||
| Net gain/loss arising during the year | 8,876 | (31,223) | |
| Effect of exchange rates on amounts included in AOCI | (536) | (4,882) | |
| Amounts recognized as a component of net periodic benefit cost | |||
| Amortization or settlement recognition of net loss | (1,340) | (2,264) | |
| Total recognized in other comprehensive gain/loss | 7,000 | (38,369) | |
| Total recognized in net periodic cost and other comprehensive loss | 19,606 | (23,583) | |
| Estimated amounts that will be amortized from AOCI over the next fiscal year | |||
| Net loss | $ (1,281) | $ (1,067) | |
Retirement Plans - Accumulated and Projected Benefit Obligation in Excess of Plan Assets (Details) - USD ($) $ in Thousands |
Oct. 28, 2023 |
Oct. 29, 2022 |
|---|---|---|
| Plans with projected benefit obligations in excess of plan assets: | ||
| Projected benefit obligation | $ 169,356 | $ 120,763 |
| Fair value of plan assets | 87,606 | 45,879 |
| Plans with accumulated benefit obligations in excess of plan assets: | ||
| Projected benefit obligation | 112,200 | 62,980 |
| Accumulated benefit obligation | 98,477 | 49,429 |
| Fair value of plan assets | $ 45,555 | $ 2,573 |
Retirement Plans - Weighted Average Assumptions (Details) |
12 Months Ended | |
|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
|
| Projected benefit obligation | ||
| Discount rate | 5.73% | 5.44% |
| Rate of increase in compensation levels | 4.34% | 4.08% |
| Net annual periodic pension cost was determined using the following weighted average assumptions | ||
| Discount rate | 5.44% | 2.77% |
| Expected long-term return on plan assets | 5.84% | 3.73% |
| Rate of increase in compensation levels | 4.08% | 3.70% |
Retirement Plans - Plan Assets Measured at Fair Value (Details) - USD ($) $ in Thousands |
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|---|---|---|---|
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | $ 87,606 | $ 84,029 | $ 128,283 |
| Unit trust funds | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 4,803 | 3,625 | |
| Equities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 16,226 | 14,467 | |
| Fixed income securities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 29,020 | 28,214 | |
| Property | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 4,624 | 4,773 | |
| Investment Funds | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 22,933 | 29,760 | |
| Cash and cash equivalents | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 10,000 | 3,190 | |
| Quoted Prices in Active Markets for Identical Assets (Level 1) | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 17,851 | 9,890 | |
| Quoted Prices in Active Markets for Identical Assets (Level 1) | Unit trust funds | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 0 | 0 | |
| Quoted Prices in Active Markets for Identical Assets (Level 1) | Equities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 7,851 | 6,700 | |
| Quoted Prices in Active Markets for Identical Assets (Level 1) | Fixed income securities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 0 | 0 | |
| Quoted Prices in Active Markets for Identical Assets (Level 1) | Property | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 0 | 0 | |
| Quoted Prices in Active Markets for Identical Assets (Level 1) | Investment Funds | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 0 | 0 | |
| Quoted Prices in Active Markets for Identical Assets (Level 1) | Cash and cash equivalents | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 10,000 | 3,190 | |
| Significant Other Observable Inputs (Level 2) | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 69,755 | 74,139 | |
| Significant Other Observable Inputs (Level 2) | Unit trust funds | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 4,803 | 3,625 | |
| Significant Other Observable Inputs (Level 2) | Equities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 8,375 | 7,767 | |
| Significant Other Observable Inputs (Level 2) | Fixed income securities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 29,020 | 28,214 | |
| Significant Other Observable Inputs (Level 2) | Property | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 4,624 | 4,773 | |
| Significant Other Observable Inputs (Level 2) | Investment Funds | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | 22,933 | 29,760 | |
| Significant Other Observable Inputs (Level 2) | Cash and cash equivalents | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Total assets measured at fair value | $ 0 | $ 0 |
Retirement Plans - Schedule of Expected Benefit Payments (Details) $ in Thousands |
Oct. 28, 2023
USD ($)
|
|---|---|
| Expected Company Contributions | |
| 2024 | $ 8,779 |
| Expected Benefit Payments | |
| 2024 | 7,470 |
| 2025 | 6,481 |
| 2026 | 6,719 |
| 2027 | 7,481 |
| 2028 | 8,618 |
| 2029 through 2033 | $ 60,534 |
Income Taxes - Income Tax Provision Reconciliation (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Income Tax Disclosure [Abstract] | |||
| U.S. federal statutory tax rate | 21.00% | 21.00% | 21.00% |
| Income tax provision reconciliation: | |||
| Tax at statutory rate | $ 757,681 | $ 650,737 | $ 279,030 |
| Net foreign income subject to lower tax rate | (358,944) | (358,725) | (227,470) |
| State income taxes, net of federal benefit | 4,453 | (15,615) | (28,052) |
| Valuation allowance | (6,641) | 29,737 | 13,263 |
| Federal research and development tax credits | (65,391) | (58,625) | (37,902) |
| Change in uncertain tax positions | 17,985 | 19,394 | (1,061) |
| Amortization of purchased intangibles | 142,358 | 142,375 | 146,094 |
| Acquisition and integration costs | 0 | 0 | 11,367 |
| Taxes attributable to the Tax Cuts and Jobs Act of 2017 | (81,695) | 0 | 0 |
| U.S. effects of international operations | (98,286) | (47,665) | (24,624) |
| Windfalls (under ASU 2016-09) | (24,211) | (16,717) | (26,365) |
| Intra-entity transfer of intangible assets | 0 | 0 | (188,804) |
| Other, net | 6,115 | 5,292 | 22,816 |
| Total income tax provision (benefit) | $ 293,424 | $ 350,188 | $ (61,708) |
Income Taxes - Income Before Income Taxes Domestic and Foreign (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Income Tax Disclosure [Abstract] | |||
| Domestic | $ 846,592 | $ 958,465 | $ 508,100 |
| Foreign | 2,761,411 | 2,140,284 | 820,614 |
| Income before income taxes | $ 3,608,003 | $ 3,098,749 | $ 1,328,714 |
Income Taxes - Components of the Provision for Income Taxes (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Current: | |||
| Federal tax | $ 303,146 | $ 304,556 | $ 134,652 |
| State | 11,772 | 13,214 | 7,772 |
| Foreign | 431,452 | 359,173 | 202,790 |
| Total current | 746,370 | 676,943 | 345,214 |
| Deferred: | |||
| Federal | (508,741) | (341,777) | 515,541 |
| State | 2,063 | (612) | (12,444) |
| Foreign | 53,732 | 15,634 | (910,019) |
| Total deferred | (452,946) | (326,755) | (406,922) |
| Total income tax provision (benefit) | $ 293,424 | $ 350,188 | $ (61,708) |
Income Taxes - Textual (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 29, 2022 |
Oct. 30, 2021 |
Oct. 28, 2023 |
|
| Operating Loss Carryforwards [Line Items] | |||
| Income tax expense (benefit), discrete | $ 81,700 | ||
| Unrecognized income tax, other outside basis differences | 33,600,000 | ||
| Valuation allowance | $ 339,105 | 332,464 | |
| Federal and state net operating losses, subject to expiration | 89,900 | ||
| Foreign operating loss carryforwards, not subject to expiration | 145,200 | ||
| State credit carryover, subject to expiration | 299,700 | ||
| Foreign investment tax credit carryover, subject to expiration | 14,200 | ||
| Liability for unrealized tax benefits | 165,300 | 187,400 | |
| Liability for interest and penalties | 45,500 | 70,700 | |
| Unrecognized tax benefits, increase resulting from acquisition | $ 15,267 | $ 91,179 | |
| Settlement with Taxing Authority | |||
| Operating Loss Carryforwards [Line Items] | |||
| Decrease in unrecognized tax benefits is reasonably possible | $ 160,000 | ||
| Maxim | |||
| Operating Loss Carryforwards [Line Items] | |||
| Unrecognized tax benefits, increase resulting from acquisition | 125,500 | ||
| Unrecognized tax benefits with tax | 91,200 | ||
| Unrecognized tax benefits with interest | $ 34,300 | ||
Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands |
Oct. 28, 2023 |
Oct. 29, 2022 |
|---|---|---|
| Deferred tax assets: | ||
| Inventory reserves | $ 20,159 | $ 16,584 |
| Reserves for compensation and benefits | 57,603 | 60,871 |
| Tax credit carryovers | 313,891 | 327,671 |
| Stock-based compensation | 10,734 | 25,059 |
| Net operating losses | 42,825 | 43,696 |
| Intangible assets | 1,955,752 | 1,975,096 |
| Lease liability | 82,305 | 76,709 |
| Capitalization of R&D expenses | 421,485 | 155,099 |
| Other | 88,164 | 93,697 |
| Total gross deferred tax assets | 2,992,918 | 2,774,482 |
| Valuation allowance | (332,464) | (339,105) |
| Total deferred tax assets | 2,660,454 | 2,435,377 |
| Deferred tax liabilities: | ||
| Depreciation | (122,125) | (96,660) |
| Deferred GILTI tax liabilities | (2,654,817) | (2,824,332) |
| Right of use asset | (60,343) | (55,858) |
| Acquisition-related intangibles | (727,749) | (816,177) |
| Total gross deferred tax liabilities | (3,565,034) | (3,793,027) |
| Net deferred tax liabilities | $ (904,580) | $ (1,357,650) |
Income Taxes - Changes in Unrealized Tax Benefits (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Changes in the total amounts of unrealized tax benefits | |||
| Unrealized tax benefits, beginning balance | $ 165,327 | $ 132,521 | $ 21,291 |
| Additions for tax positions related to current year | 5,895 | 11,800 | 4,713 |
| Additions for tax positions related to prior years | 17,096 | 9,704 | 19,790 |
| Additions for tax positions related to the Acquisition | 15,267 | 91,179 | |
| Reductions due to lapse of applicable statute of limitations | (903) | (3,965) | (4,452) |
| Unrealized tax benefits, ending balance | $ 187,415 | $ 165,327 | $ 132,521 |
Revolving Credit Facility (Details) - Revolving Credit Facility - USD ($) |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Jun. 23, 2021 |
Jan. 28, 2023 |
Oct. 28, 2023 |
|
| Line of Credit Facility [Line Items] | |||
| Debt instrument, term (in years) | 5 years | ||
| Line of credit facility, maximum borrowing capacity | $ 2,500,000,000 | ||
| Credit spread adjustment | 0.10% | ||
| Long-term debt | $ 0 | ||
| Minimum | |||
| Line of Credit Facility [Line Items] | |||
| Commitment fee (as a percent) | 0.06% | ||
| Minimum | SOFR | |||
| Line of Credit Facility [Line Items] | |||
| Debt instrument, basis spread on variable rate (as a percent) | 0.69% | ||
| Maximum | |||
| Line of Credit Facility [Line Items] | |||
| Commitment fee (as a percent) | 0.20% | ||
| Maximum | SOFR | |||
| Line of Credit Facility [Line Items] | |||
| Debt instrument, basis spread on variable rate (as a percent) | 1.175% |
Debt - Textual (Details) - USD ($) |
12 Months Ended | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 26, 2023 |
Apr. 14, 2023 |
Sep. 15, 2022 |
Oct. 20, 2021 |
Oct. 07, 2021 |
Oct. 05, 2021 |
Apr. 08, 2020 |
Dec. 05, 2016 |
Dec. 14, 2015 |
Oct. 28, 2023 |
Apr. 27, 2023 |
Oct. 29, 2022 |
Oct. 08, 2022 |
Oct. 07, 2022 |
Oct. 30, 2021 |
Aug. 26, 2021 |
|
| Debt Instrument [Line Items] | ||||||||||||||||
| Aggregate principal amount of debt | $ 7,064,301,000 | $ 6,576,865,000 | ||||||||||||||
| Commercial paper notes | 547,224,000 | 0 | ||||||||||||||
| Line of Credit | Commercial Paper | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Line of credit facility, maximum borrowing capacity | $ 2,500,000,000 | |||||||||||||||
| Debt instrument, term (in days) | 397 days | |||||||||||||||
| the Maxim 2023 Notes | Maxim | Senior Notes | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Aggregate principal amount of debt | $ 500,000,000 | |||||||||||||||
| Interest rate (as a percent) | 3.375% | |||||||||||||||
| Senior Notes | the 2025 Notes and the 2045 Notes | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Net proceeds of notes offering | $ 1,200,000,000 | |||||||||||||||
| Senior Notes | the 2025 Notes | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Aggregate principal amount of debt | $ 850,000,000 | |||||||||||||||
| Interest rate (as a percent) | 3.90% | |||||||||||||||
| Redemption amount | $ 325,500,000 | |||||||||||||||
| Percentage of principal amount redeemed (as a percent) | 38.30% | |||||||||||||||
| Redemption face amount | $ 850,000,000 | |||||||||||||||
| Redemption price (as a percent) | 110.381% | 111.213% | ||||||||||||||
| Senior Notes | the 2045 Notes | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Aggregate principal amount of debt | $ 400,000,000 | 332,587,000 | 332,587,000 | |||||||||||||
| Interest rate (as a percent) | 5.30% | |||||||||||||||
| Redemption amount | $ 67,400,000 | |||||||||||||||
| Percentage of principal amount redeemed (as a percent) | 16.85% | |||||||||||||||
| Redemption face amount | $ 400,000,000 | |||||||||||||||
| Redemption price (as a percent) | 140.067% | |||||||||||||||
| Senior Notes | Notes Due December 2021, 2023, 2026 and 2036 | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Net proceeds of notes offering | $ 2,100,000,000 | |||||||||||||||
| Senior Notes | the 2021 Notes | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Aggregate principal amount of debt | $ 400,000,000 | |||||||||||||||
| Interest rate (as a percent) | 2.50% | |||||||||||||||
| Redemption amount | $ 71,200,000 | |||||||||||||||
| Percentage of principal amount redeemed (as a percent) | 17.80% | |||||||||||||||
| Redemption face amount | $ 400,000,000 | |||||||||||||||
| Redemption price (as a percent) | 100.098% | 100.177% | ||||||||||||||
| Senior Notes | the December 2023 Notes | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Aggregate principal amount of debt | $ 550,000,000 | |||||||||||||||
| Interest rate (as a percent) | 3.125% | |||||||||||||||
| Redemption amount | $ 282,700,000 | |||||||||||||||
| Percentage of principal amount redeemed (as a percent) | 51.41% | |||||||||||||||
| Redemption face amount | $ 550,000,000 | |||||||||||||||
| Redemption price (as a percent) | 105.017% | 105.378% | ||||||||||||||
| Senior Notes | the 2026 Notes | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Aggregate principal amount of debt | $ 900,000,000 | 900,000,000 | 900,000,000 | |||||||||||||
| Interest rate (as a percent) | 3.50% | |||||||||||||||
| Senior Notes | the 2036 Notes | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Aggregate principal amount of debt | $ 250,000,000 | 144,278,000 | 144,278,000 | |||||||||||||
| Interest rate (as a percent) | 4.50% | |||||||||||||||
| Redemption amount | $ 105,700,000 | |||||||||||||||
| Percentage of principal amount redeemed (as a percent) | 42.29% | |||||||||||||||
| Redemption face amount | $ 250,000,000 | |||||||||||||||
| Redemption price (as a percent) | 123.996% | |||||||||||||||
| Senior Notes | the April 2025 Notes | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Aggregate principal amount of debt | $ 400,000,000 | 400,000,000 | 400,000,000 | |||||||||||||
| Interest rate (as a percent) | 2.95% | |||||||||||||||
| Percentage of principal amount redeemed (as a percent) | 100.00% | |||||||||||||||
| Proceeds from issuance of unsecured debt | $ 395,600,000 | |||||||||||||||
| Senior Notes | the Maxim 2027 Notes | Maxim | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Aggregate principal amount of debt | 0 | $ 0 | 59,788,000 | $ 59,800,000 | $ 440,200,000 | $ 500,000,000 | ||||||||||
| Interest rate (as a percent) | 3.45% | 3.45% | ||||||||||||||
| Redemption amount | $ 59,800,000 | |||||||||||||||
| Senior Notes | the Floating Rate Note, the Sustainability-Linked Senior Notes, the 2031 Notes, the 2041 Notes, the 2051 Notes | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Redemption price (as a percent) | 100.00% | |||||||||||||||
| Senior Notes | the Floating Rate Note | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Aggregate principal amount of debt | $ 500,000,000 | $ 500,000,000 | 500,000,000 | |||||||||||||
| Interest rate, effective (as a percent) | 0.30% | |||||||||||||||
| Senior Notes | the Floating Rate Note | SOFR | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Credit spread adjustment | 0.25% | |||||||||||||||
| Senior Notes | the Floating Rate Note | Sustainability Performance Target | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Interest rate, increase (decrease) over period | 0.30% | |||||||||||||||
| Senior Notes | the Sustainability-Linked Senior Notes | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Aggregate principal amount of debt | $ 750,000,000 | $ 750,000,000 | 750,000,000 | |||||||||||||
| Interest rate (as a percent) | 1.70% | 1.70% | ||||||||||||||
| Senior Notes | the 2031 Notes | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Aggregate principal amount of debt | $ 1,000,000,000 | $ 1,000,000,000 | 1,000,000,000 | $ 1,000,000,000 | ||||||||||||
| Interest rate (as a percent) | 2.10% | 2.10% | ||||||||||||||
| Senior Notes | the 2041 Notes | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Aggregate principal amount of debt | $ 750,000,000 | 750,000,000 | 750,000,000 | |||||||||||||
| Interest rate (as a percent) | 2.80% | |||||||||||||||
| Senior Notes | the 2051 Notes | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Aggregate principal amount of debt | $ 1,000,000,000 | 1,000,000,000 | 1,000,000,000 | |||||||||||||
| Interest rate (as a percent) | 2.95% | |||||||||||||||
| Senior Notes | the 2032 Notes | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Aggregate principal amount of debt | $ 300,000,000 | $ 300,000,000 | $ 300,000,000 | |||||||||||||
| Interest rate (as a percent) | 4.25% | |||||||||||||||
| Net proceeds of notes offering | $ 296,100,000 | |||||||||||||||
| Redemption price (as a percent) | 100.00% | |||||||||||||||
| Senior Notes | the 2032 Notes | Treasury Rate | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Interest rate, increase (decrease) over period | 0.20% | |||||||||||||||
| Senior Notes | the Unregistered 2027 Notes | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Aggregate principal amount of debt | $ 440,200,000 | |||||||||||||||
| Interest rate (as a percent) | 3.45% | |||||||||||||||
| Private exchange offer amount | $ 500,000 | |||||||||||||||
| Senior Notes | the Unregistered 2027 Notes | Maxim | ||||||||||||||||
| Debt Instrument [Line Items] | ||||||||||||||||
| Redemption price (as a percent) | 101.255% |
Debt - Schedule of Debt (Details) - USD ($) |
Oct. 28, 2023 |
Apr. 27, 2023 |
Oct. 29, 2022 |
Oct. 08, 2022 |
Oct. 07, 2022 |
Sep. 15, 2022 |
Oct. 30, 2021 |
Oct. 05, 2021 |
Aug. 26, 2021 |
Apr. 08, 2020 |
Dec. 05, 2016 |
Dec. 14, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Instrument [Line Items] | ||||||||||||
| Principal | $ 7,064,301,000 | $ 6,576,865,000 | ||||||||||
| Unamortized discounts, debt issuance costs and fair value adjustments | 115,568,000 | 28,240,000 | ||||||||||
| Long-Term Debt | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 6,017,077,000 | 6,576,865,000 | ||||||||||
| Unamortized discounts, debt issuance costs and fair value adjustments | 114,620,000 | 28,240,000 | ||||||||||
| Current Debt | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 1,047,224,000 | 0 | ||||||||||
| Unamortized discounts, debt issuance costs and fair value adjustments | 948,000 | 0 | ||||||||||
| Senior Notes | 2024 Notes, due October 2024 | Current Debt | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 500,000,000 | 0 | ||||||||||
| Unamortized discounts, debt issuance costs and fair value adjustments | 948,000 | 0 | ||||||||||
| Commercial Paper | Current Debt | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 547,224,000 | 0 | ||||||||||
| Unamortized discounts, debt issuance costs and fair value adjustments | 0 | 0 | ||||||||||
| Senior Notes | 2024 Notes, due October 2024 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 500,000,000 | 500,000,000 | $ 500,000,000 | |||||||||
| Senior Notes | 2024 Notes, due October 2024 | Long-Term Debt | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 0 | 500,000,000 | ||||||||||
| Unamortized discounts, debt issuance costs and fair value adjustments | 0 | 1,973,000 | ||||||||||
| Senior Notes | 2025 Notes, due April 2025 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 400,000,000 | 400,000,000 | $ 400,000,000 | |||||||||
| Senior Notes | 2025 Notes, due April 2025 | Long-Term Debt | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 400,000,000 | 400,000,000 | ||||||||||
| Unamortized discounts, debt issuance costs and fair value adjustments | 1,261,000 | 2,145,000 | ||||||||||
| Senior Notes | 2026 Notes, due December 2026 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 900,000,000 | 900,000,000 | $ 900,000,000 | |||||||||
| Senior Notes | 2026 Notes, due December 2026 | Long-Term Debt | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 900,000,000 | 900,000,000 | ||||||||||
| Unamortized discounts, debt issuance costs and fair value adjustments | 3,983,000 | 5,258,000 | ||||||||||
| Senior Notes | Maxim 2027 Notes, due June 2027 | Maxim | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 0 | $ 0 | 59,788,000 | $ 59,800,000 | $ 440,200,000 | $ 500,000,000 | ||||||
| Senior Notes | Maxim 2027 Notes, due June 2027 | Maxim | Long-Term Debt | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 0 | 59,788,000 | ||||||||||
| Unamortized discounts, debt issuance costs and fair value adjustments | 0 | (5,311,000) | ||||||||||
| Senior Notes | 2027 Notes, due June 2027 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 440,212,000 | 440,212,000 | ||||||||||
| Senior Notes | 2027 Notes, due June 2027 | Long-Term Debt | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 440,212,000 | 440,212,000 | ||||||||||
| Unamortized discounts, debt issuance costs and fair value adjustments | (28,750,000) | (37,182,000) | ||||||||||
| Senior Notes | 2028 Notes, due October 2028 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 750,000,000 | 750,000,000 | 750,000,000 | |||||||||
| Senior Notes | 2028 Notes, due October 2028 | Long-Term Debt | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 750,000,000 | 750,000,000 | ||||||||||
| Unamortized discounts, debt issuance costs and fair value adjustments | 7,314,000 | 8,795,000 | ||||||||||
| Senior Notes | 2031 Notes, due October 2031 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 1,000,000,000 | 1,000,000,000 | $ 1,000,000,000 | 1,000,000,000 | ||||||||
| Senior Notes | 2031 Notes, due October 2031 | Long-Term Debt | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 1,000,000,000 | 1,000,000,000 | ||||||||||
| Unamortized discounts, debt issuance costs and fair value adjustments | 92,599,000 | 12,381,000 | ||||||||||
| Senior Notes | 2032 Notes, due October 2032 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 300,000,000 | 300,000,000 | $ 300,000,000 | |||||||||
| Senior Notes | 2032 Notes, due October 2032 | Long-Term Debt | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 300,000,000 | 300,000,000 | ||||||||||
| Unamortized discounts, debt issuance costs and fair value adjustments | 3,438,000 | 3,822,000 | ||||||||||
| Senior Notes | 2036 Notes, due December 2036 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 144,278,000 | 144,278,000 | $ 250,000,000 | |||||||||
| Senior Notes | 2036 Notes, due December 2036 | Long-Term Debt | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 144,278,000 | 144,278,000 | ||||||||||
| Unamortized discounts, debt issuance costs and fair value adjustments | 1,577,000 | 1,696,000 | ||||||||||
| Senior Notes | 2041 Notes, due October 2041 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 750,000,000 | 750,000,000 | 750,000,000 | |||||||||
| Senior Notes | 2041 Notes, due October 2041 | Long-Term Debt | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 750,000,000 | 750,000,000 | ||||||||||
| Unamortized discounts, debt issuance costs and fair value adjustments | 12,190,000 | 12,868,000 | ||||||||||
| Senior Notes | 2045 Notes, due December 2045 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 332,587,000 | 332,587,000 | $ 400,000,000 | |||||||||
| Senior Notes | 2045 Notes, due December 2045 | Long-Term Debt | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 332,587,000 | 332,587,000 | ||||||||||
| Unamortized discounts, debt issuance costs and fair value adjustments | 3,623,000 | 3,787,000 | ||||||||||
| Senior Notes | 2051 Notes, due October 2051 | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 1,000,000,000 | 1,000,000,000 | $ 1,000,000,000 | |||||||||
| Senior Notes | 2051 Notes, due October 2051 | Long-Term Debt | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Principal | 1,000,000,000 | 1,000,000,000 | ||||||||||
| Unamortized discounts, debt issuance costs and fair value adjustments | $ 17,385,000 | $ 18,008,000 |
Subsequent Events (Details) - Subsequent Event - Common Stock $ / shares in Units, $ in Millions |
Nov. 20, 2023
USD ($)
$ / shares
|
|---|---|
| Subsequent Event [Line Items] | |
| Common stock cash dividends per share, declared (in dollars per share) | $ / shares | $ 0.86 |
| Dividends | $ | $ 426.8 |
Valuation and Qualifying Accounts (Details) - Valuation Allowance for Deferred Tax Asset - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Oct. 28, 2023 |
Oct. 29, 2022 |
Oct. 30, 2021 |
|
| Accounts Receivable Reserves and Allowances: | |||
| Balance at Beginning of Period | $ 339,105 | $ 315,434 | $ 154,130 |
| Additions (Reductions) Charged to Income Statement | (6,641) | 29,737 | 13,263 |
| Other | 0 | (6,066) | 148,041 |
| Balance at End of Period | $ 332,464 | $ 339,105 | $ 315,434 |
$7QU7]4?U%[*)OIT*$KU[<6^:8XOGC]7Z5X>A!I51UG"
M+]NJ/H@&OM:[Y^I82Y'10X?B>3(>+YX?1%Y>O'Y%U][5KU]5;5/DI7Q71ZH]
M'$3]\$86U?VW%Y,+<^%]OMLW>.'YZU='L9-WLOG[\5T-WY[;4;+\($N55V54
MR^VW%S>3%V]F>#_=\)^YO%?>YPA7LJFJ#_CE;?;MQ1@!DH5,&QQ!P)^/\E86
M!0X$8/RAQ[RP4^*#_F 8X1^$!=O__RG9#Y^]03ETX;R
MZ5.K_VO4]^06PPP\>]\__VF9)HM7;G?_IS/EMN"E8;_M!#WFY9%M0?25B9C2
M;,>-_2KRB!G'7')YK7M_Q9D35-KK+=V6^
MS5-1-M%-FE9MV>3E+GI7%7F:2_7J>0/SX5//4SWV&QX[.3'V)(E^J%1\I!:5 ]-?8Z/-4W8H_
MFHO\?_9F:1?3D.41<*,G1*0YO:ACCW\9:$95Q6UP;5J=#1J.?!KJ+G/6>_'B
M5'##9:=YQSQDE)>3=;R:+:Z")U3G$
\NQ)&S#](T\- '2L^-K&EHF.5VW>
*0?A#8QD? -B=FZ1) C3DW'$UG7EE_?F6!R;C7%-\1UU
M"4L?%9D3KU@.!A1WP"%7P$&I*J=YI-\:R:;6)$YGXAU.<&+C X78\NQXWA5B
ML!,4<.D,Z%%6.VO<&4PQ$A]&72D;2&J$]8!?^'>Y!X-:G?&4%_2* (:T@XQ;
M!OY)>&O6C=D-V0&$2;6&ESY2@HM"HP?[3X69PTT./!Q<+(HP#[X ]<%AP-
M!%UQ4U>U]MXXJ'*@;AG/_ND5 R:L(.\$Z"2S420I1%4*#6N6D(VI#&16RCU9Y54-*AD^#?B.UIJD-.:R,8ZRO3
M0W&8T/H12JL)A5;5^X $8P,3[C&0"777!9?<2).!=BQ ME]2VJ;]GL"6.<4=
MBDF^W&J(2
MQKI_0W^Z(N/ZA$;P5V\$-IK\ZL+#Y])6Y!2U+.!0ZC;,=1A:0FBSBBW(A%"K
M>VM,SL>OO(]3?',;(\#Q(JMQ$LWOFFHWB-7&YY/OP'B_7MUGD#>#"G&XI1TT
M)XHF"^CH(P'D!J,MU&,O W"*.(V:PVI%.0>*C>W:7I!^ZQ>D"L@/0"[FDLVG
M4_:WOAS$=Z$S">YR *05@'#363P>&$=K7O4Q<329Q),9!.=&F"^'MC@( O$'
M!1*6!1KK9!9/V$]/C$7/(0:.@FL@'J@Z':VE^7JUT4)0YH3A@FFD 7#/PZ02=:6ONKH2B(\F@/"G8_\SLX(2=K):(U8['ED1(1B
M9;W'! ;,:L-=XAM6*5+G5P>N8;:W7=.UE*S6 .-5@>EJ(2'G-S:K1(,4WV$A
M@VE9;
"$OQ.4OUQ<(X!XL2(HPNG:3FX
MY(ZJHB4B.?(?7/'&%0HOX#\M$O(=W&>.Y'?JPK[ */RZY>>*MR^I;=@?JVUH
MW[&B6;+O3H2X9'$L!=W%93,1"CZY]_2A;QAU?